National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/10/2021 release of VAERS data:

Found 306 cases where Vaccine is COVID19 and Manufacturer is PFIZER/BIONTECH and Symptom is Aortic thrombosis or Arterial thrombosis or Arterial thrombosis limb or Atrial thrombosis or Axillary vein thrombosis or Basilar artery thrombosis or Brachiocephalic vein thrombosis or Carotid artery thrombosis or Cavernous sinus thrombosis or Cerebral artery thrombosis or Cerebral thrombosis or Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coronary artery thrombosis or Deep vein thrombosis or Hepatic vein thrombosis or Iliac artery thrombosis or Injection site thrombosis or Intracranial venous sinus thrombosis or Jugular vein thrombosis or Mesenteric vein thrombosis or Ophthalmic artery thrombosis or Ophthalmic vein thrombosis or Pelvic venous thrombosis or Peripheral artery thrombosis or Portal vein thrombosis or Postpartum venous thrombosis or Pulmonary artery thrombosis or Pulmonary thrombosis or Retinal artery thrombosis or Retinal vascular thrombosis or Retinal vein thrombosis or Spinal artery thrombosis or Splenic vein thrombosis or Subclavian vein thrombosis or Superior sagittal sinus thrombosis or Thrombosis or Thrombosis in device or Transverse sinus thrombosis or Truncus coeliacus thrombosis or Umbilical cord thrombosis or Vena cava thrombosis or Venous thrombosis or Venous thrombosis limb and Patient Died

Table

   
AgeCountPercent
17-44 Years103.27%
44-65 Years268.5%
65-75 Years3712.09%
75+ Years7022.88%
Unknown16353.27%
TOTAL306100%



Case Details

This is page 1 out of 2

Result pages: 1 2   next


VAERS ID: 934745 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Female  
Location: Iowa  
Vaccinated:2021-01-09
Onset:2021-01-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-01-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1284 / 1 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Heart rate increased, Musculoskeletal stiffness, Oxygen saturation decreased, Peripheral coldness, Presyncope, Pulse absent, Respiratory rate increased, Seizure like phenomena, Skin discolouration, Skin warm, Thrombosis, Unresponsive to stimuli
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Parkinson-like events (broad), Thrombophlebitis (broad), Acute central respiratory depression (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Arthritis (broad), Respiratory failure (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-12
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Exelon 13.3 mg daily, APAP 500 mg three times a day, Namenda 10 mg two times a day, Senna 8.6 mg two tablets daily, Mirilax 27 grams two times a day, 2 cal 4oz three times a day, Amlodipine 5 mg daily
Current Illness: NA
Preexisting Conditions: Alzheimers, dementia, hypertension,
Allergies: NKA
Diagnostic Lab Data: Family requested comfort cares. No tests provided.
CDC Split Type:

Write-up: Resident had seizure like activity followed by a vagel response with large bowel movement. Resident then began to show signs of blood clot to left lower extremity. No pedal pulse, area on leg warm to touch. Left lower leg now cold to touch, stiff, purple and white in color. No other signs of modeling, body warm to touch, no fever noted. Respirations and pulse increased with low oxygen levels. Resident not responding to stimuli.


VAERS ID: 1000670 (history)  
Form: Version 2.0  
Age: 87.0  
Sex: Female  
Location: Alabama  
Vaccinated:2021-01-19
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-02-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Chest pain, Death, Myocardial infarction, Pain in extremity, SARS-CoV-2 test negative, Stent placement, Thrombosis
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-26
   Days after onset: 25
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes
Allergies:
Diagnostic Lab Data: Test Name: Covid-19; Test Result: Negative
CDC Split Type: USPFIZER INC2021094694

Write-up: she was hurting at her chest/ Chest pain; on her left arm hurt real bad that''s what the clot on her left arm; on her left arm hurt real bad that''s what the clot on her left arm; She passed away; heart attack; This is a spontaneous report from a contactable consumer. An 87-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 at single dose for COVID-19 immunisation. Medical history included diabetes mellitus, for which she was taking a pill like an hour before she would take her meal. On Monday (Jan2021) the patient experienced was hurting at her chest/ chest pain, her left arm hurt real bad as she had a blockage in her left arm/clot on her left arm, and they wanted to put in a stent and after the surgery it went well and she all go home in two days. The patient was hospitalized in Jan2021 due to the events. She had a heart attack and that the chamber between the dividers had a hole in it and her heart tissue was too thin so much thin she couldn''t repair it. The patient passed away on 26Jan2021. The patient was tested negative for COVID-19 on unknown date. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: She passed away


VAERS ID: 1012703 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Male  
Location: New Hampshire  
Vaccinated:2021-01-07
Onset:2021-01-14
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-02-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Blood calcium normal, Blood chloride increased, Blood creatinine increased, Blood glucose increased, Blood potassium normal, Blood sodium normal, Blood urea increased, COVID-19, Carbon dioxide normal, Confusional state, Cough, Differential white blood cell count normal, Ear haemorrhage, Fibrin D dimer increased, Full blood count, Glomerular filtration rate decreased, Haematocrit decreased, Haemoglobin normal, Mean cell haemoglobin concentration decreased, Mean cell haemoglobin normal, Mean cell volume normal, Mean platelet volume normal, Metabolic function test, Nucleated red cells, Platelet count normal, Rales, Red blood cell count decreased, Red cell distribution width normal, SARS-CoV-2 test positive, Thrombosis, Vomiting, White blood cell count normal
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Haematopoietic erythropenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Chronic kidney disease (broad), Tumour lysis syndrome (broad), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-20
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Aspirin Tablet 81 MG clonazePAM Tablet 0.5 MG Colace Capsule 100 MG DULoxetine HCL Furosemide Tablet 20 MG Norvasc Tablet 10 MG Potassium Chloride ER CapsulE QUEtiapine Fumarate Tablet Galantamine Hydrobromide Tablet
Current Illness: Intermittent delusional periods-followed by Generations Mental Health.1/6 Increased BLE edema, BP trending up. Acute visit with APRN, N.O. started Lasix & KCL. CBC and BMP ordered for 1/8 with elevation in BMP/Creatinine. Lasix and KCL placed on hold. On palliative services presently.
Preexisting Conditions: Alzheimer?s Disease/Depression; HTN; CAD, CKD, AAA w/o Rupture, no surgical intervention per ADPOA, Dyslipidemia, GERD.
Allergies: HEPARIN LATEX BLEACHED SHEETS
Diagnostic Lab Data: 1/14-Covid Antigen test positive 1/14-11:49 am D-DIMER-32.33 WBC 8.71 RBC 4.55 HGB 12.9 HCT 41.4 MCV 91.0 MCH 28.4 MCHC 31.2 RDW-CV 12.6 MPV 10.1 Platelet Count 225 NRBC Automated 0.0 RDW-SD 41.7 Glucose 125 BUN 29 Creatinine 2.34 Calcium 9.4 Sodium 140 Potassium 4.2 Chloride 107 CO2 24 BUN/Creatinine Ratio 12.39 GFR 27
CDC Split Type:

Write-up: 1/14/2021-0545, blood noted left and right ear. 0715, vomited x 1. Covid Antigen positive. Acute MD visit-basilar crackles right and coughing. Increased confusion.


VAERS ID: 1017129 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Nevada  
Vaccinated:2020-12-17
Onset:2020-12-28
   Days after vaccination:11
Submitted: 0000-00-00
Entered: 2021-02-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK5730 / 1 AR / IM

Administered by: Private       Purchased by: ?
Symptoms: Autopsy, Coronary artery thrombosis, Sudden cardiac death
SMQs:, Torsade de pointes/QT prolongation (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, arterial (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2020-12-28
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Losartan, aspirin.
Current Illness:
Preexisting Conditions: Hypertension. Diet & exercise-controlled diabetes. History of DVT 4 yrs prior to event. After completing a course of Xarelto has been on aspirin ever since.
Allergies: None known
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Sudden cardiac death. Autopsy report: right coronary artery thrombosis.


VAERS ID: 1026980 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-01-22
Onset:2021-01-23
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Public       Purchased by: ?
Symptoms: Computerised tomogram abdomen abnormal, Computerised tomogram pelvis abnormal, Computerised tomogram thorax abnormal, Death, Nausea, Pulmonary embolism, Thrombosis
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-25
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: METFORMIN, PIOGLITAZONE, NORTRIPTYLINE, TERAZOSIN, RISPERDONE, VIT D 3, DEPO-TESTOSTERONE, LOSARTAN, FLUTICASONE, NTG SL, CRESTOR, PROSCAR, ZOLOFT, MONTELUKAST, HYDROXYZINE, CARAFATE, OMEPRAZOLE, REGLAN, CENTRUM SILVER.
Current Illness: NONE
Preexisting Conditions: DIABETES, MOOD DISORDER, ELEV CHOL, CAD, HTN, BPH, DIABETIC NEUROPATHY, ENVIROMENTAL ALLERGIES, LOW VIT D, HYPOGONADISM, GERD
Allergies: NKDA
Diagnostic Lab Data: CT CHEST , CT ABDOMEN PELVIS, (01/23/2021) AUTOPSY 02/03/21??
CDC Split Type:

Write-up: Patient reported to Emergency room on 01/23/2021 with complaint of nausea. According to ER record patient reported he received a COVID 19 vaccine Pfizer the day before. Work up in the ER (CT ABD PELVIS) reveal a clotted of SMA. CT CHEST REVEALED BILATERAL PULMONARY EMBOLUS. THE PATIENT WAS TRANSFERRED TO THE STATE HOSPITAL. HE WAS SCHEDULED FOR EMERGENT VASCULAR SURGERY WHICH WAS CANCELLED AS THE PATIENT DIED SHORTLY AFTER HIS ARRIVAL.


VAERS ID: 1033682 (history)  
Form: Version 2.0  
Age: 95.0  
Sex: Male  
Location: Wisconsin  
Vaccinated:2021-02-04
Onset:2021-02-05
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9269 / 2 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Arterial disorder, Contusion, Death, Dysphagia, Haematoma, Haemorrhage, Limb mass, Oedema peripheral, Peripheral swelling, Skin discolouration, Suture insertion, Thrombosis, Vein disorder
SMQs:, Cardiac failure (broad), Angioedema (broad), Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypotonic-hyporesponsive episode (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-12
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: metoprolol tartrate 25 mg, 81 mg aspirin, 10 mg lisinopril, 2 mg glimepride, 20 mg furosemide (lasix)
Current Illness: polycythemia vera, dementia, type 2 diabetes mellitus, HTN
Preexisting Conditions: Type II DM
Allergies: none
Diagnostic Lab Data:
CDC Split Type:

Write-up: L hand edema, hematoma which burst and caused bleeding sending pt to the ER for pressure dressing and 2 stitches. L hand and arm progressively got more edematous and bruised looking (severely black/blue/purple) and the hand continued to bleed and swell on 2/6/21. Severe arterial and venous issues and apparent blood clots. On 2/7/21 there were also lumps noted on left inner thigh. Pt. stopped eating or drinking on 2/8/21 and expired on 2/12/21.


VAERS ID: 1035850 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Male  
Location: North Carolina  
Vaccinated:2021-02-04
Onset:2021-02-06
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9264 / 1 UN / IM

Administered by: Work       Purchased by: ?
Symptoms: Cerebrovascular accident, Computerised tomogram, Echocardiogram, Laboratory test, Magnetic resonance imaging, Neurological symptom, Thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-13
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Advair 250-50mcg Allegra-D 24 hour 180-240mg Amlodipine 2.5mg Buspirone 10mg Carvedilol 12.5mg Montelukast 10mg Prednisone 20mg Albuterol Zoloft 100mg Spiriva Nasacort AQ
Current Illness: Sinus Infection being treated with steroids and antibiotics
Preexisting Conditions: Asthma Allergies Chronic Sinus infections Depression History of heart attack
Allergies: Aspirin Erythromycin
Diagnostic Lab Data: Multiple CT scans, MRI''s, echo''s, labs
CDC Split Type:

Write-up: Patient woke up on the morning of 2/6 with symptoms of a stroke. Rushed to hospital where clot found in brain. Recovered from initial stroke but then had another major stroke on 2/8 and never recovered.


VAERS ID: 1059421 (history)  
Form: Version 2.0  
Age: 91.0  
Sex: Female  
Location: Minnesota  
Vaccinated:2021-02-10
Onset:2021-02-11
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9264 / 2 AR / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Brain injury, Cerebrovascular accident, Death, Hypoaesthesia, Magnetic resonance imaging abnormal, Magnetic resonance imaging brain abnormal, Malaise, Surgery, Thrombectomy, Thrombosis
SMQs:, Peripheral neuropathy (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-26
   Days after onset: 15
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Not Known
Current Illness: None
Preexisting Conditions: Arthritis - Macular Degeneration
Allergies: None Known
Diagnostic Lab Data: Clot removal surgery was conducted on March 19th, 2021. Subsequent MRI revealed stroke damage on both left and right side of the brain.
CDC Split Type:

Write-up: After the second vaccine dose she reported not feeling well with unspecified symptoms for a few days. On February 18th, 2021 she visited her doctor with numbness in her hand. They thought it may be carpal tunnel and sent her home. The morning or March 18th , 2021 she had a severe stroke and was transferred to Hospital and then to other hospital. She was in the hospital until Tuesday March 23rd when she was transferred back to her home for hospice care. She died on March 26th, 2021.


VAERS ID: 1065435 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: North Carolina  
Vaccinated:2021-01-19
Onset:2021-01-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Cardiac disorder, Fatigue, Nausea, Thrombosis
SMQs:, Acute pancreatitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-20
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: HEPARIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Heart disorder; Pacemaker insertion (cardiac)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021206257

Write-up: blood clot; death cause: Heart Problems; tired; nauseous; This is a spontaneous report from a contactable consumer. An 81-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot number EL3248), via an unspecified route of administration at single dose in the left arm on 19Jan2021 14:00 for covid-19 immunisation. Medical history included heart problems, pacemaker. Concomitant medication included heparin. The patient experienced death cause: heart problems on 20Jan2021, blood clot on an unspecified date with outcome of unknown that required hospitalization, tired on 19Jan2021 with outcome of unknown, nauseous on 19Jan2021 with outcome of unknown. The patient was hospitalized for blood clot from 16Jan2021 to 18Jan2021. The patient died on 20Jan2021. An autopsy was not performed. The events were described as follows: The patient was tired and nauseous about 3 hours after her vaccine. She had been in the hospital 16Jan2021 to 18Jan2021 for a blood clot. The patient died at her home on 20Jan2021 between 4 and 7 pm. No treatment required. The vaccine was administered at Hospital Facility. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19.; Reported Cause(s) of Death: death cause: Heart Problems


VAERS ID: 1068762 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-01-11
Onset:2021-03-02
   Days after vaccination:50
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3249 / 1 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-02
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: DEATH Narrative: patient''s wife reported he had gone in an outside hospital, had held his brilinta as advised anticipating shoulder surgery "and he threw a big clot and died."


VAERS ID: 1068886 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-01-26
Onset:2021-01-26
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9261 / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Acute myocardial infarction, Arrhythmia, Chest discomfort, Chills, Death, Deep vein thrombosis, Dyspnoea, Intensive care, Pain, Pulmonary embolism
SMQs:, Anaphylactic reaction (broad), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-26
   Days after onset: 31
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: DEATH Narrative: Pt he reports he developed chills SOB body aches the same night as receiving the COVID vaccine on 1.26.2021-pt is currently reporting CheSt tightness and SOB Admitted to hosp: ICU with Bilateral Pulmonary Emboli, LLE DVT, NSTEMI, Arrhythmia.


VAERS ID: 1085254 (history)  
Form: Version 2.0  
Age: 90.0  
Sex: Male  
Location: New Jersey  
Vaccinated:2021-03-01
Onset:2021-03-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6198 / 1 - / SYR

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain, Aspiration, Cardiac arrest, Death, Feeding disorder, Gastric aspiration procedure, Gastric lavage, Gastrointestinal necrosis, Insomnia, Mechanical ventilation, Pulmonary necrosis, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Interstitial lung disease (narrow), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (narrow), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-05
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: furosemide metaprolol eliquis lisprinopril pravastatin doxazosin glimeperide omperozole diltiazem potadsium
Current Illness:
Preexisting Conditions: stroke in 2016
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Severe abdominal pain unable to eat or sleep for 36 hours. He went by ambulance to the Hospital emergency room. They tried to pump his stomach but he aspirated and and went into cardiac arrest. He was revived but never regained consciousness. (The ICU Dr said that he had blood clots in his abdomen from a recent stroke. We were unaware of him having a stroke other than in 2026. The same Dr. said that he had necrosis in his lungs from aspirating. The necrosis was from his bowel dying) He was put on a ventilator and given drugs to increase his heart rate. On 3-5-21 the heart drugs were reduced and he died. I was with him when he recieved the vaccination and he was healthy, just old. I think that the shot killed him.


VAERS ID: 1090240 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: New York  
Vaccinated:2021-02-10
Onset:2021-02-01
Submitted: 0000-00-00
Entered: 2021-03-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9264 / 1 LA / -

Administered by: Private       Purchased by: ?
Symptoms: Blood pressure measurement, Body temperature, COVID-19 pneumonia, Cardiac arrest, Chest X-ray, Decreased appetite, Dehydration, Heart rate, Hypotension, Hypoxia, Investigation, Oxygen saturation, Physical examination, Pulmonary embolism, Pyrexia, Renal failure, Respiratory arrest, Respiratory failure, SARS-CoV-2 test, Thrombosis, Ventricular tachycardia
SMQs:, Torsade de pointes/QT prolongation (narrow), Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Anaphylactic reaction (narrow), Asthma/bronchospasm (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Ventricular tachyarrhythmias (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (narrow), Hypersensitivity (broad), Tumour lysis syndrome (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Dehydration (narrow), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-04
   Days after onset: 31
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 18 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cataract extraction; Rotator cuff repair
Allergies:
Diagnostic Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:normal, it hardly ever went above 120; Test Date: 2021; Test Name: blood pressure; Result Unstructured Data: Test Result:low; Test Date: 20210212; Test Name: temperature; Result Unstructured Data: Test Result:102; Test Date: 20210213; Test Name: temperature; Result Unstructured Data: Test Result:102; Test Date: 20210214; Test Name: temperature; Result Unstructured Data: Test Result:99.8; Test Date: 2021; Test Name: Chest x-ray; Result Unstructured Data: Test Result:mild pneumonia; Test Date: 2021; Test Name: heart rate; Result Unstructured Data: Test Result:135; Comments: highest heart rate was after intubation; Test Date: 2021; Test Name: fluid challenge; Result Unstructured Data: Test Result:his labs were a little better than the labs kept c; Comments: his labs were a little better than the labs kept creeping up until the doctor inserted a shiley catheter for dialysis; Test Date: 20210215; Test Name: numbers; Result Unstructured Data: Test Result:patient''s numbers were getting better after the; Comments: fluid challenge and then his numbers kept creeping up after that.; Test Date: 2021; Test Name: rhythm strip; Result Unstructured Data: Test Result:rhythm strip which showed a flat line and then she; Comments: rhythm strip which showed a flat line and then she noticed ventricular tachycardia, then a flat line; Test Date: 2021; Test Name: oxygen saturation; Result Unstructured Data: Test Result:The patient started de-saturating; Test Date: 202012; Test Name: physical; Result Unstructured Data: Test Result:A1C was 5.7; Comments: The patient had no cholesterol or hypertension; Test Date: 20210214; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: USPFIZER INC2021248929

Write-up: Cardiac arrest; Pulmonary embolus; Renal failure; Fever; Dehydration; Not eating or drinking; COVID-19 confirmed by positive COVID-19 test / COVID pneumonia; blood clot; blood pressure was low; Respiratory arrest; Respiratory failure; Hypoxemia; ventricular tachycardia; This is a spontaneous report from a contactable nurse reporting on behalf of the husband. A 71-year-old male patient received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL9264) on 10Feb2021 at about 19:00 (at the age of 71 years), in left deltoid, for COVID-19 immunisation. No other vaccines were given on the same day or within 4 weeks. The patient declined flu vaccine and pneumococcal vaccine (PNEUMOVAX), he had never had another vaccine except maybe his childhood vaccines. Medical history included rotator cuff surgery and cataract removed in 2020. The patient exercised regularly, he was healthy, he walked for miles and didn''t eat any non-sense, he did not eat out, he did not smoke. The patient''s mother was 100 years old and fully competent. The patient had two sisters older than him, the oldest one had hypertension the second sister did not have anything that they were aware of. The patient''s father lived until he was 98 years old. The patient concomitant medications were none. The patient was told to take vitamin D 50,000 units but didn''t even take them (he still had 9 of them in the bottle and they gave him 13). The patient experienced fever on 11Feb2021, renal failure on 14Feb2021, pulmonary embolus on 28Feb2021, cardiac arrest on 04Mar2021, dehydration and not eating or drinking on an unspecified date in Feb2021. These events required ER visit and were reported as serious as involved hospitalization from 14Feb2021 to 04Mar2021 and as fatal events. The patient died on 04Mar2021. Clinical course of the events included the following information. The patient received the first vaccine on 10Feb2021, the next day he developed a fever. The reporter spoke with the patient''s doctor who told to give the patient paracetamol (TYLENOL) thinking the fever was from the vaccine. On 12Feb2021 and 13Feb2021, the patient''s temperature was 102. Then the doctor advised to take the patient to the hospital. The patient''s temperature was still 102, he was in renal failure, and they had to dialyze him. The patient was otherwise healthy, the patient''s last physical was in Dec2020 and the only thing it showed was that his A1C was 5.7. The patient had no cholesterol or hypertension. The doctor advised the patient to decrease sugar and carbs because the holidays were coming up. The patient''s follow up was scheduled on Mar2021. The reporter felt that the vaccine has something to do with the patient renal failure. The reporter spoke with the doctors at the hospital who didn''t want to commit to anything. The reporter believed this was an adverse event. The caller mentioned that she had her vaccine before and she was fine. The patient was admitted on 14Feb2021 and by Wednesday he was not eating or drinking, he was dehydrated. The patient''s admitting diagnoses was elevated temperature and ruling out COVID. The patient tested positive for Covid on 14Feb2021 (COVID-19 PCR test). The patient''s temperature was 99.8 and then kept creeping up, on Saturday it was 102. The caller gave the patient Tylenol cold and flu (lot T0CL001021, expiry date Oct2021) took the edge off but in three hours the temperature was back up again. The patient never complained of pain and didn''t want to take Tylenol. On 15Feb2021 the patient''s numbers were getting better after the fluid challenge and then his numbers kept creeping up after that. The patient had the fever a week until they had it under control. The fever went away, it was gone for like 5 days, then it spiked again. The patient was started on piperacillin/tazobactam (ZOSYN) for like 3 or 5 days and the fever went away but then it kept getting worse. On 28Feb2021, the medical personnel thought the patient had a pulmonary emboli but because of the renal failure, they couldn''t do a computerized tomography on the patient. The doctors mentioned that the patient was in renal failure and they thought they heparinized the patient and he had a blood clot who led to pulmonary embolus, cardiac arrest, and death. The patient was diagnosed with a pulmonary emboli on 28Feb2021. The patient started de-saturating and the doctors intubated and sedated him that whole time until this. Dialysis was started on 01Mar2021 and the patient received it every day except 04Mar2021. The patient''s blood pressure was normal, it hardly ever went above 120. The patient was on the medical floor from 22Feb2021 to 04Mar2021. When the patient was on the medical surgical floor, he was on high flow 5 liters. After the patient started desaturating, he went to the intensive care unit and was put on a non-rebreather on 45%. The patient''s highest heart rate was after intubation was 135, but the patient''s blood pressure was low so they started him on some vasopressors. They did the fluid challenge on the patient and his labs were a little better than the labs kept creeping up until the doctor inserted a shiley catheter for dialysis. Respiratory: Respiratory arrest and then cardiac arrest. Respiratory failure, they intubated the patient. The reporter assumed dyspnea because the patient was intubated. Tachypnea was when the patient was in the intensive care unit already intubated. Hypoxemia, they intubated the patient so the caller guessed it was for the oxygen saturation drop. Covid pneumonia: yes. Chest x-ray showed mild pneumonia. The caller requested a follow up x-ray and the doctors said they were going to do another one but the caller is unsure if they did or when. The patient received additional therapies for COVID-19: remdesivir. Other radiological investigations: unable because of the patient''s kidney function. They were looking at the D dimer and BMP to come up with the embolus since the patient couldn''t have the scan. ARDS: no. Cardiovascular: The patient had a heart attack on 04Mar2021. The reporter thought it was from the pulmonary embolus which led to cardiac arrest. Arrhythmia: the caller guessed so, the patient was being worked on for 10 minutes before the caller got there. The caller saw a rhythm strip which showed a flat line and then she noticed ventricular tachycardia, then a flat line. The patient did not have SARS-CoV2 antibodies at diagnosis. Gastrointestinal/Hepatic, neurological, hematological, dermatological: none. Vascular: pulmonary embolus: yes, deep vein thrombosis, limb ischemia, vasculitis: no. Renal: renal failure: yes, acute kidney injury: no. The patient was scheduled for his second vaccine dose on 03Mar2021 at 04:15 but did not receive it. Time of death was 4:15 in the afternoon on 04Mar2021. The reporter considered renal failure, fever, dehydration, not eating or drinking, cardiac arrest and pulmonary embolus as fatal and related to the suspect vaccine. The outcome of the other events was unknown. Cause of death was unknown. No autopsy was performed.; Sender''s Comments: Based on current information available, the company considered there is a possibility that all reported events are consequence of COVID-19 pneumonia on the basis of advanced age. The positive COVID-19 test occurred 4 days after the first injection of suspect vaccine BNT162B2. No complete effect can be achieved for short time interval. The COVID-19 is more likely pre-existing colonization or intercurrent condition, unrelated to suspect vaccine BNT162b2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: Renal failure; Fever; Dehydration; Not eating or drinking; Cardiac arrest; Pulmonary embolus


VAERS ID: 1092477 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-02-17
Onset:2021-03-07
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-03-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 RA / SYR

Administered by: Other       Purchased by: ?
Symptoms: Computerised tomogram, Pericardial effusion, Portal vein thrombosis
SMQs:, Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-08
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Pacemaker
Allergies: None
Diagnostic Lab Data: CAT scans - 3/8/2021
CDC Split Type:

Write-up: Pericardial effusion; multiple blood clots in portal vein.


VAERS ID: 1105772 (history)  
Form: Version 2.0  
Age: 93.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-02-11
Onset:2021-02-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 AR / IM

Administered by: Private       Purchased by: ?
Symptoms: Atrial fibrillation, Blood pressure decreased, Constipation, Death, Gait disturbance, Gait inability, Thrombosis, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Supraventricular tachyarrhythmias (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Parkinson-like events (broad), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-19
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Vitamin D, Docusate Softgel, Amlodipine, Trazodone, Multivitamin, Clonidine, Sea, Lisinopril, Citalopram, Acetamin, Pantoprazole, Santyl Ointment, Calcium Antacid Chew, Olanzapine
Current Illness: Dementia with associated mental illness, and high blood pressure. Bed sore on foot.
Preexisting Conditions: Dementia with associated mental illness, high blood pressure, recovery from broken hip
Allergies: None known
Diagnostic Lab Data: I do not have all this information at hand. Hospital would have it all.
CDC Split Type:

Write-up: My mother died on February 19, 2021. She had her 2nd dose vaccine on 2/11, on 2/12 it was noted that she was not able to walk, on 2/13 she was walking at 30%, on 2/14 she was walking with difficulty, on Monday 2/15 she was throwing up violently and her blood pressure dropped, so she was sent to Clinic. My sister was told she was just constipated and she had A Fib (never reported before to us). My sister was then told on 2/16 early a.m. that she had a blood clot that destroyed her colon. Due to age surgery would likely not be successful. She then died on the Friday. We are reporting in the event that the Pfizer vaccine was somehow a contributing factor to the A fib or to the Clot. She has no history of A fib or clotting prior to this incident. She was 93, and did have dementia, but was able to eat normal foods prior to this. What was unusual was the challenge in walking the day after the shot. Other than that no difference was observed until the day she was admitted to the hospital emergency room. She was a resident at Assisted Living, Memory Care, and that is where she received the vaccine. The mailing address I provided is her mailing address prior to death.


VAERS ID: 1349979 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-01-03
Onset:2021-03-04
   Days after vaccination:60
Submitted: 0000-00-00
Entered: 2021-03-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK5730 / 2 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Cerebrovascular accident, Deep vein thrombosis, Haemorrhagic transformation stroke, Ischaemic stroke
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-04
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Deceased Narrative: Patient was a 82 yo male with multiple co-morbidities consisting of AF (on warfarin), prio PE, HFrEF, CAD, HTN, mixed CSA/OSA, hypothyroidism, COPD and GERD. Patient was admitted to facility on 7/12/20 after he was found down in his home for 3 days, dx with right MCA ischemic stroke with hemorrhagic conversion. Etiology of CVA was presumed to be secondary to AF/warfarin failure. No treatment with tPA or thrombectomy was initiated as he was outside the window for intervention. Patient was also found to have bilateral DVTs. Patient was then admitted to facility 08/14/20 for end of life care.


VAERS ID: 1113713 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Female  
Location: Florida  
Vaccinated:2021-02-01
Onset:2021-02-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Cerebral haemorrhage, Cerebral thrombosis, Constipation, Contusion, Death, Endotracheal intubation, Flatulence, Gastrointestinal oedema, General physical health deterioration, Haemoptysis, Intensive care, Intestinal haemorrhage, Intracardiac thrombus, Malaise, Peripheral swelling, Pulmonary haemorrhage, Pulmonary thrombosis
SMQs:, Cardiac failure (broad), Angioedema (broad), Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Gastrointestinal haemorrhage (narrow), Accidents and injuries (narrow), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad), Respiratory failure (broad), Infective pneumonia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-17
   Days after onset: 43
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Diabetes
Allergies: None
Diagnostic Lab Data: I don''t know what lab work they did. My brother who lives with her works in their lab at the location and may know. My other who is a pharmacist works in the hospital''s location and was her proxy. The proxy refused to consider that her condition was due to the vaccine stating that February was too long ago for the two to be related. He was in denial. I feel the hospital staff was in denial. They wouldn''t consider that the vaccine caused blood clots in my mom. My mother died.
CDC Split Type:

Write-up: My mother called me when she was going to get her second vaccination. She was alive and well and living independently at her home. She could walk, talk, make her own food, wash and dry her own clothes and take her own baths. After taking the second vaccination she went down hill. She became sicker and sicker and eventually she started coughing up blood. She decided to go to the hospital, another Hospital of facility. I don''t know what the treatment was at that hospital but she was soon transferred to facility and that is where I was notified she was in the hospital and visited her there. After arriving they intubated her and said she had blood clots in her brain and heart. When I saw her after she transferred from Hospital to the Hospital I noticed one arm was swollen. Her legs were as they have been for the last 20 years and looked okay to me--no discoloration other than her regular discoloring at one right ankle and the same old same old slight swelling in the left ankle. The doctors and nurses were putting the blame on her legs but you could tell things were happening else where. But as she got worse and worse at the hospital her right arm become more and more swollen with dark bruises appearing--the hospital staff took pictures. The left arm continued to swell and did not look normal at all. She apparently had bleeding in her left lung from a blood clot. She had three areas of her brain that add clots and some bleeding. She was constipated and gaseous when they cleaned her. They didn''t treat her constipation which made being intubated worse because I feel that caused her intestines to swell, thus she also had bleeding in her intestines. My mother died on March 17, 2021 at hospital in ICU. I was told they could not treat the blood clots because of the bleeding in her lung, intestines and brain.


VAERS ID: 1140696 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-02-02
Onset:2021-02-04
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9261 / 2 RA / -

Administered by: Public       Purchased by: ?
Symptoms: Acute myeloid leukaemia, Band neutrophil count, Band neutrophil count increased, Blast cell count increased, Blast cells, Cerebral haemorrhage, Disseminated intravascular coagulation, Haemorrhagic stroke, Ischaemic stroke, Leukaemia, Metamyelocyte count, Metamyelocyte count increased, Monocyte count, Monocyte count increased, Myelocyte count, Myelocyte count increased, Neutrophil count, Neutrophil count decreased, Pain in extremity, Platelet count, Platelet count decreased, Red cell distribution width, Red cell distribution width increased, SARS-CoV-2 test, Thrombosis
SMQs:, Agranulocytosis (broad), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Blood premalignant disorders (narrow), Thrombophlebitis (broad), Myelodysplastic syndrome (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Haematological malignant tumours (narrow), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-02-23
   Days after onset: 19
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: VITAMIN C [ASCORBIC ACID]; CALCIUM CITRATE + D3; GLUCOSAMINE; MAGNESIUM CITRATE; OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHERYL ACETATE]; TURMERIC [CURCUMA LONGA]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Breast cancer (Breast Cancer 8 Years ago. No Chemo just radiation); Radiation therapy
Allergies:
Diagnostic Lab Data: Test Date: 20210204; Test Name: Band Neutrophils; Result Unstructured Data: Test Result:High; Comments: Band Neutrophils H; Test Date: 20210204; Test Name: Other Cell Type Blast Like Cells; Result Unstructured Data: Test Result:High; Comments: Other Cell Type Blast Like Cells H; Test Date: 20210204; Test Name: Metamyelocytes; Result Unstructured Data: Test Result:High; Comments: Metamyelocytes H; Test Date: 20210204; Test Name: Monocytes; Result Unstructured Data: Test Result:High; Comments: Monocytes H; Test Date: 20210204; Test Name: Myelocytes; Result Unstructured Data: Test Result:High; Comments: Myelocytes H; Test Date: 20210204; Test Name: Absolute Neutrophils; Result Unstructured Data: Test Result:Low; Comments: Absolute Neutrophils L; Test Date: 20210204; Test Name: Neutrophils; Result Unstructured Data: Test Result:Low; Comments: Neutrophils L; Test Date: 20210204; Test Name: Platelet Count; Result Unstructured Data: Test Result:Low; Comments: Platelet Count L, Platelet Vol; Test Date: 20210204; Test Name: Red cell distribution width; Result Unstructured Data: Test Result:Dev. H; Comments: RDW Stand. Dev. H; Test Date: 20210204; Test Name: Red cell distribution width; Result Unstructured Data: Test Result:Var H; Comments: RDW Coeff Var H; Test Date: 20210219; Test Name: Covid-19; Test Result: Negative
CDC Split Type: USPFIZER INC2021308114

Write-up: Multifocal Intracerebral Hemorrhage; Disseminated Intravascular Coagulopathy; strokes, Ischemic and Hemorrhagic; strokes, Ischemic and Hemorrhagic; AML; Leukemia; Blood clot diagnosis; Sore lower leg; RDW Stand. Dev. H/RDW Coeff Var H; Platelet Count L, Platelet Vol L; Neutrophils L; Band Neutrophils H; Monocytes H; Metamyelocytes H; Myelocytes H; Absolute Neutrophils L; Other Cell Type Blast Like Cells H; This is a spontaneous report from a contactable consumer. A 70-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number: EL9261, via an unspecified route of administration, administered in Arm Right on 02Feb2021 08:30 (Batch/Lot Number: EL9261) as SINGLE DOSE for covid-19 immunisation. Medical history included breast cancer (8 years ago no chemo just radiation). Historical vaccine included first dose of BNT162B2 (lot number: EL0140) on 11Jan2021 for Covid-19 immunization. Concomitant medication included vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]), calcium citrate, colecalciferol (CALCIUM CITRATE + D3), glucosamine, magnesium citrate, docosahexaenoic acid, eicosapentaenoic acid, tocopheryl acetate (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHERYL ACETATE]) and curcuma longa (TURMERIC [CURCUMA LONGA]). On 04Feb2021, the patient''s blood work result showed red cell distribution width (RDW) stand. dev. high; RDW coeff var high, platelet count low, platelet vol low; neutrophils low; band neutrophils high; monocytes high; metamyelocytes high; myelocytes high; absolute neutrophils low; other cell type blast like cells high. On 15Feb2021, the patient experienced sore lower leg. On 16Feb2021, the patient was diagnosed with blood clot. On 19Feb2021, the patient was diagnosed with leukemia. On 20Feb2021, the patient was diagnosed with acute myeloid leukemia (AML). On 21Feb2021, the patient had tow types of stroke, ischemic and hemorrhagic, the patient was intubated. On 23Feb2021, the patient was extubated and died due to multifocal intracerebral hemorrhage, disseminated intravascular coagulopathy, acute myeloid leukemia with blast crisis. The patient received chemotherapy and leukapheresis as treatment. The patient died on 23Feb2021. An autopsy was not performed.; Reported Cause(s) of Death: Disseminated Intravascular Coagulopathy; Acute Myeloid Leukemia With Blast Crisis; Multifocal Intracerebral Hemorrhage


VAERS ID: 1146761 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: Indiana  
Vaccinated:2021-02-06
Onset:2021-03-04
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Unknown       Purchased by: ?
Symptoms: Cardiogenic shock, Coronary artery occlusion, Myocardial infarction, Thrombosis
SMQs:, Cardiac failure (narrow), Myocardial infarction (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-06
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: SPIRONOLACTONE; VALSARTAN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Blood pressure abnormal (treated successfully with medication for about 10 years); Breast cancer female
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021312390

Write-up: "widow maker" type heart attack where the LAD artery suddenly became 100% blocked by a blood clot; "widow maker" type heart attack where the LAD artery suddenly became 100% blocked by a blood clot; "widow maker" type heart attack where the LAD artery suddenly became 100% blocked by a blood clot; Cardiogenic shock; Anterior myocardial infarction; This is a spontaneous report from a contactable consumer. An 81-years-old female patient received BNT162B2, dose 2 via an unspecified route of administration, administered in left arm on 06Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included very sensitive to medication effects (usually takes only 1/2 dose with strong efficacy to avoid side effects). Breast cancer survivor (2014 onset, 2019 declared permanent remission) and mild blood pressure treated successfully with medication for about 10 years. Concomitant medications included spironolactone and valsartan, both taken for blood pressure. The patient previously received first dose of BNT162B2 on 16Jan2021 in left arm for COVID-19 immunization. The reporter''s mother died 3 weeks and 6 days after having received the second dose of the Pfizer covid vaccine. The cause of death was a "widow maker" type heart attack where the LAD artery suddenly became 100% blocked by a blood clot; the event began about 11:45pm on 04Mar2021. The blockage was confirmed via cardiac cath procedure performed within 2 hours of the onset by Doctor, he removed the clot and placed a stent. However her heart was too damaged and could not recover. Doctor confirmed to us that she did not have excessive or evidence of any prior blockage and not excessive plaque. The blood clot likely came on and caused the cardiac event within roughly an hour, he explained. The patient had no prior symptoms and no comorbidities for blood clotting and was full of life and energy on 05Mar up to when she went to bed that night. She died 06Mar at 4:04 am at hospital. The strat date of the events was reported as 04Mar2021 at 11:45 PM. AE resulted in emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). The patient died on 06Mar2021. An autopsy was not performed. The death cause: Triggered by the sudden 100% blockage of the LAD by a blood clot, the cause of death is listed as (A) Cardiogenic shock (B) Anterior myocardial infarction. Treatment was received for the events which included multiple resuscitations and angioplasty surgery. No covid prior vaccination, no covid tested post vaccination. The outcome of the events was fatal. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: "widow maker" type heart attack where the LAD artery suddenly became 100% blocked by a blood clot; "widow maker" type heart attack where the LAD artery suddenly became 100% blocked by a blood clot; "widow maker" type heart attack where the LAD artery


VAERS ID: 1151636 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-02-03
Onset:2021-02-12
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN5318 / UNK UN / SYR

Administered by: Other       Purchased by: ?
Symptoms: Abdomen scan, Asthenia, Bacterial infection, Bilevel positive airway pressure, Blood test abnormal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Death, Dyspnoea, Electrocardiogram, Enterocolitis infectious, Feeling abnormal, Mechanical ventilation, Nausea, Oxygen saturation decreased, Pneumonitis, SARS-CoV-2 test positive, Thrombosis, Tremor, Vomiting, Walking aid user
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Dementia (broad), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (narrow), Hypersensitivity (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-14
   Days after onset: 30
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Rosuvastatin, Metoprolol, St Joesph aspirin
Current Illness:
Preexisting Conditions: CLL, CKD
Allergies: sulfa
Diagnostic Lab Data: Covid test - positive, chest xray - covid pneumonia, blood work - E Coli bacterial infection, EKG, chest xray - blood clots
CDC Split Type:

Write-up: My father received his first Pfizer vaccine on 02/03/21. On 2/12/21 I rushed him to the ER. He was vomiting uncontrollably and had shortness of breath. Once arrived at ER, they immediately put him on oxygen. Vomiting lasted several hours. They tested him for Covid and did a chest x-ray. Tested positive for Covid. Chest x-ray showed Covid pneumonia. Was admitted. Stayed in hospital for 5 days and was then released to nursing home for physical and occupational therapy. He was very weak and on days experienced what they called Covid fog. After 2 weeks of therapy, he was released on 03/06/21 to go back home to his apartment, with extended visiting nurse therapy. On 3/10/21, was the first visiting nurse appointment. At 12:00 an RN came to his apartment from Home Health Care. She checked his vitals. She said his blood pressure was good, lungs sounded good and oxygen level was 98. She said he was doing good and that she would not need to continue to come out and check on him weekly. She left. At 2:30 the same day, a Physical Therapist from Home Health Care came. She asked him lots of questions and adjusted my fathers'' walker for him. He showed her how he was doing using the walker. Walked approximately 15-20 feet in his apartment. She checked his vitals before she left. His oxygen level was now at 91. She had him take a few deep breathes until his oxygen level was up to 93. She left and said she would be back on Friday the 12th to begin the actual physical therapy then. Within 10 minutes after she left my father started shaking uncontrollably and was having difficulties breathing. I called 911. Paramedics arrived. My fathers'' oxygen level was all the way down to 74. They took him to the ER. When getting him out of ambulance he began vomiting. Vomiting lasted for hours just like when he went to the hospital back in February. They tried 3 different drugs to control the nausea. They did EKG, chest and abdomen scans. Was found that he had multiple blood clots and inflammation in his lungs and a bacterial infection in his blood. After testing, bacteria was found to be E Coli. Treated him with heparin for clots and antibiotics for infection and had him on oxygen in nose. Every day thereafter, he felt worse. They switched him to a high flow oxygen mask to keep his oxygen levels up. By Saturday night (early morning Sunday) on 03/14, they had taken the high flow oxygen mask off and hooked him up to a BiPap oxygen machine because his oxygen levels were dropping too low. We were then told by the lung doctor, that the damage to his lungs was extreme and that the next step would be to put him on a ventilator and feeding tube. My father did not want this per his will and his discussion with Dr earlier in the week. Dr indicated that he would not get better just being on the BiPap machine and we then chose to have them take him off of the machine because he did not want to go on life support. My father passed away on Sunday, March 14th around 6:30pm.


VAERS ID: 1152698 (history)  
Form: Version 2.0  
Age: 68.0  
Sex: Male  
Location: North Carolina  
Vaccinated:2021-02-19
Onset:2021-02-21
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Private       Purchased by: ?
Symptoms: Cerebrovascular accident, Computerised tomogram head abnormal, Haemorrhage intracranial, Venous thrombosis
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-07
   Days after onset: 14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: atorvasatin,trazadone,nexium, allopurinol
Current Illness: gout,hyperlipedemia
Preexisting Conditions: na
Allergies: na
Diagnostic Lab Data: Head CT with venous thrombosis and intracranial bleed
CDC Split Type:

Write-up: stroke -venous thrombosis


VAERS ID: 1160713 (history)  
Form: Version 2.0  
Age: 74.0  
Sex: Female  
Location: Michigan  
Vaccinated:2021-03-07
Onset:2021-03-16
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6206 / 1 - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Activated partial thromboplastin time prolonged, Acute kidney injury, Angiogram abnormal, Aspiration, Atelectasis, Blood culture, Blood lactic acid increased, Brain injury, Brain natriuretic peptide increased, Breath sounds absent, Bronchoscopy abnormal, Cardiac arrest, Chest X-ray normal, Chest wall haematoma, Cholelithiasis, Coagulopathy, Computerised tomogram abdomen, Computerised tomogram abnormal, Computerised tomogram head normal, Computerised tomogram thorax, Death, Electroencephalogram abnormal, Haemoglobin decreased, Haemorrhage, Haemothorax, Hepatic enzyme increased, Hypotension, Intensive care, International normalised ratio increased, Lung infiltration, Lung opacity, Magnetic resonance imaging head abnormal, Mediastinal haematoma, Mydriasis, Nitrite urine present, Protein urine present, Pulmonary hypertension, Pulmonary oedema, Pulse absent, Pulseless electrical activity, Pupil fixed, Resuscitation, Rib fracture, Seizure, Status epilepticus, Sternal fracture, Thrombosis, Transfusion, Troponin increased, Unresponsive to stimuli
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Cardiac failure (narrow), Liver related investigations, signs and symptoms (narrow), Liver-related coagulation and bleeding disturbances (narrow), Anaphylactic reaction (broad), Haematopoietic erythropenia (broad), Lactic acidosis (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (narrow), Gallbladder related disorders (narrow), Gallstone related disorders (narrow), Pulmonary hypertension (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Cardiac arrhythmia terms, nonspecific (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Osteoporosis/osteopenia (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow), Chronic kidney disease (broad), Tumour lysis syndrome (broad), Proteinuria (narrow), Tubulointerstitial diseases (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (broad), Hypokalaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-20
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol HFA, aspirin EC, atorvastatin, dabigatran, furosemide, gabapentin, isosorbide mononitrate CR, losartan, metoprolol succinate-XL, potassium chloride SA
Current Illness: NA
Preexisting Conditions: Chronic kidney disease, Cardiomyopathy, UTI, hemothorax, chronic atrial fibrillation
Allergies: contrast dye, warfarin
Diagnostic Lab Data:
CDC Split Type:

Write-up: DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Cardiac arrest (HCC) [I46.9] HOSPITAL COURSE: Patient is a 74 year old female who receives care through healthcare clinic and second healthcare clinic with past medical history of HTN, CKD, cardiomyopathy/congestive heart failure, atrial fibrillation on Pradaxa who presented to the ED 3/16 after suffering an out of hospital cardiac arrest at her dentist''s office. Per report, patient had SBP in the 80s on arrival but was asymptomatic. Prior to start of any procedure (no reports of being given sedative medications), she became unresponsive. CPR was initiated and was found to be in asystole. She received 3 rounds of CPR with ROSC. CT head without acute abnormality. Chest XR showing mild vascular congestion and interstitial edema. Initial labs showing AKI, elevated liver enzymes, BNP $g29,000, troponin 39, lactic acid of 11, INR of 6.6, PTT 62, APTT 87. UA with protein, nitrite, moderate blood. Urine culture ordered. Blood cultures ordered. In ED, patient was hypotensive requiring addition of vasopressors. Targeted temperature management was started. Ceftriaxone and flagyl started for possible urinary tract infection and aspiration. Patient with profound coagulopathy, INR increasing to 12.0 on arrival to the ICU. Two units FFP and vitamin K were given. Patient with escalating pressor requirements at this time so CT t/a/p was ordered showing multiple bilateral rib fractures, nondisplaced sternal fracture with small anterior mediastinal retrosternal hematoma, small right sided hemothorax, right chest wall hematoma, patchy bilateral airspace disease consistent with atelectasis/infiltrate/aspiration, diffuse GGO consistent with interstitial edema, enlarged pulmonary arteries consistent with pulmonary hypertension, cholelithiasis. FDP elevated and 2 units of cryoprecipitate given 3/16. Hemoglobin decreased to 5.9 3/17 with INR of 5.4. Two additional units of FFP and additional dose of vitamin K ordered. Two units RBCs ordered. CTA thorax and abdomen 3/17 re-confirmed hemothorax and chest wall hematoma but no active bleeding noted. CT bilateral LE showed no evidence of hematoma. Trauma consulted who recommended chest tube placement. Overnight 3/16-3/17, patient also noted to have seizure activity on EEG and patient loaded with Keppra. Head CT 3/17 negative for hemorrhage or other acute processes. Patient remained in status epilepticus 3/17am and additional Keppra load was given and neurology consulted. Received Praxbind for continued bleeding/coagulopathy. 3/17pm went into PEA arrest with 10 minutes of CPR with ROSC. Bronchoscopy following ROSC noted evidence of bleeding from multiple areas, clots removed. MRI brain showing diffuse anoxic brain injury. Propofol stopped 3/19am. After goals of care discussion this morning, all first degree relatives (daughter and son) all in agreement to transition to comfort care measures. I received call from bedside RN that patient had passed away. On exam, no heart or breath sounds appreciated upon auscultation for 2 minutes. No spontaneous movement or chest rise noted. No pulse palpated for two minutes. Pupils fixed and dilated. No response to noxious stimuli. Time of death 1400 3/20/2021.


VAERS ID: 1163369 (history)  
Form: Version 2.0  
Age: 84.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-02-12
Onset:2021-02-22
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK LA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-07
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Blood clots


VAERS ID: 1183985 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: New York  
Vaccinated:2020-09-18
Onset:2020-09-19
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Blood pressure fluctuation, Blood pressure measurement, Death, Dysphonia, Fatigue, Headache, Heart rate, Illness, Muscular weakness, Pneumonitis, Pulmonary oedema, Pulmonary thrombosis, Pulse abnormal, Vaccination complication
SMQs:, Rhabdomyolysis/myopathy (broad), Cardiac failure (narrow), Peripheral neuropathy (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Embolic and thrombotic events, venous (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-01
   Days after onset: 135
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: PANTOPRAZOLE; ASPIRIN (E.C.); FUROSEMIDE; FIRDAPSE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Brain metastases; Gait disturbance; Lambert-Eaton myasthenic syndrome (Cannot walk without FIRDAPSE); Metastases to liver; Metastases to lymph nodes; Migraine (Ever since he was a kid); Muscular weakness; Radiotherapy (of his head and lung for his cancer); Small cell lung cancer (In liver and lymph nodes; brain metastases)
Allergies:
Diagnostic Lab Data: Test Name: Blood pressure; Result Unstructured Data: Test Result:not stable; going up and down; Test Name: pulse; Result Unstructured Data: Test Result:pulse incomplete
CDC Split Type: USPFIZER INC2021368470

Write-up: Fluid in his bottom right lobe of his lung where the cancer is; Inflammation in the bottom of his lung; in lower right lobe of lung; Blood pressure isn''t stable; going up and down; Blood pressure issues; Exhausted; fatigue; Trying to control his blood pressure and his pulse issues, pulse incomplete; Muscle weakness was severely progressing; Bad reaction to the Covid vaccine; Blood clot on his lung; Raspy voice; the patient had been sick; Moderate headaches; Passed away; This is a spontaneous report from a contactable consumer (patient) based on the information received by Pfizer from Pharmaceuticals (Manufacturer control number 2020CAT00505). A 74-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunisation. Co-suspect drug included amifampridine phosphate (FIRDAPSE) orally, from 18Sep2020 to an unspecified date at 10 mg thrice daily, from 02Oct2020 to an unspecified date at 20 mg thrice daily, for Lambert-Eaton myasthenic syndrome. Medical history included Lambert-Eaton myasthenic syndrome (he could not walk without FIRDAPSE), migraine ever since he was a kid, small cell lung cancer (in liver and lymph nodes; brain metastases), metastases to liver, metastases to lymph nodes, radiotherapy of his head and lung for his cancer, gait disturbance from an unknown date and unknown if ongoing, muscular weakness from an unknown date and unknown if ongoing. Concomitant medications included pantoprazole, acetylsalicylic acid (ASPIRIN (E.C.), furosemide. The patient experienced blood clot on his lung in Jan2021 with outcome of unknown, fluid in his bottom right lobe of his lung where the cancer was on an unspecified date with outcome of not recovered, inflammation in the bottom of his lung; in lower right lobe of lung on an unspecified date with outcome of not recovered, raspy voice in 2021 with outcome of recovered, blood pressure not stable; going up and down; blood pressure issues on an unspecified date with outcome of not recovered, exhausted; fatigue on an unspecified date with outcome of not recovered, sick in 2021 with outcome of unknown, trying to control his blood pressure and his pulse issues, pulse incomplete on an unspecified date with outcome of unknown, moderate headaches from 19Sep2020 with outcome of recovered, muscle weakness severely progressing on an unspecified date with outcome of unknown, 10 mg 3 times a day wasn''t enough (therapeutic product effect incomplete), on an unspecified date with outcome of unknown, he''d switch and do a couple doses of 15 mg and it was better but not enough (intentional product use issue) on an unspecified date with outcome of unknown, after he received the COVID vaccine, he experienced a bad reaction (unspecified) on an unspecified date with outcome of unknown. The events were reported as serious as involved hospitalization. The patient passed away on an unspecified date in Feb2021. It was not reported if an autopsy was performed. The clinical course of the events included the following information. On 21Sep2020, a spontaneous report was received from a consumer, via a company representative, regarding a 74-year-old male who was being treated with FIRDAPSE 10 MG (amifampridine). On 22Sep2020, additional information was received from a consumer. On 02Oct2020, additional information was received from a consumer and chemotherapy was added as a co-suspect. On 01Feb2021, additional information was received from a consumer via a company representative. On 09Feb2021, additional information was received from a consumer, and this case was determined to be the master case for cases 2021CAT00039 and 2021CAT00052 (both invalid, duplicate cases) and the information was merged into this case (2020CAT00505). This case was re-assessed as serious/unexpected, and COVID vaccine was added as co-suspect. On 18Feb2021, additional information was received from a consumer via a company representative. On 19Feb2021, additional information was received from a patient ambassador via a company representative. Medical history included LEMS (Lambert-Eaton myasthenic syndrome) and migraines. Concomitant products included: an unknown statin, pantoprazole, and acetylsalicylic acid (ASPIRIN) 81 mg. On 18Sep2020, the patient started treatment with FIRDAPSE 10 mg at 10 mg, 3x/day orally for LEMS. On 19Sep2020 and 20Sep2020, after starting the product, the patient experienced moderate headaches. On 21Sep2020, the patient did not experience a headache. On 22Sep2020, the patient experienced a headache that was "4/10." He had taken acetaminophen; aspirin; caffeine (EXCEDRIN) and ibuprofen as treatment and it "helped." The patient had not spoken to his HCP (health care provider) about the event but was going to call his HCP and ask to increase his dose of FIRDAPSE. The product was working and he was walking better, but he had heard people taking up to 80 mg a day. As of 22Sep2020, product use was ongoing and headaches were improved. On 02Oct2020, it was learned that his medical history included being prone to headaches (also reported as migraines ever since he was a kid) and "chemo" for small cell lung cancer stage 4 which was in his liver and lymph nodes. Concomitant products included furosemide. It was noted that the patient had been on the product for 4 to 5 days when he experienced his moderate headaches. He had the headaches for just a couple days, but he wasn''t sure if it was due to the FIRDAPSE or it was the chemo. He took "a couple" of ibuprofen and he was "alright." On an unspecified date, the patient was in contact with his HCP and he was told to "keep an eye on it" (presumed headaches) and see if it got worse. They agreed that it could have been the chemo or a "fluke" thing. He also spoke to his HCP about his FIRDAPSE dose of 10 mg, 3x/day not being enough. He would switch and do a couple doses of 15 mg and it was better, but not enough. His HCP thought he should be taking 20 mg 3x/day, so he was working with the patient''s insurance and pharmacy to get it changed. As of 02Oct2020, FIRDAPSE and chemo treatment were ongoing and moderate headaches were resolved (reported as he''d been good for a few days). On 01Feb2021 and 09Feb2021, it was learned that on 02Oct2020, the patient''s FIRDAPSE dose increased to 20 mg, 3x/day. On an unspecified date, the patient received the COVID vaccine at an unreported dose, route, and frequency of administration for an unreported indication. After the patient received the COVID vaccine, he experienced a bad reaction (unspecified). Since 27Jan2021 (reported as since Wednesday, relative to 01Feb2021), the patient had been sick. On 31Jan2021, the patient went to the emergency room, and they thought he had a blood clot on his lung. Subsequently, he was admitted to the hospital. Initially, when the patient was in the hospital, they took all his medications away, including his FIRDAPSE, as the pharmacy was managing his medication. The patient wife was able to get the doctors to let the patient keep his FIRDAPSE in his room with him before he missed any doses because he could not walk without his FIRDAPSE. On an unspecified date in 2021, the patient had radiation of his head and lung for his cancer (previously reported medical history), and "they" (presumed his medical provider) said he could have a raspy voice and headache, which he did experience but then resolved. While in the hospital, the patient''s blood pressure was not stable. It went "up and down, up and down." He had fluid in the bottom right lobe of his lung, where the cancer was, and they could not "tap it" due to the blood pressure issues. They were trying to get the fluid out every other way they could. The doctors said he had inflammation in the bottom of his lung. He was given a "good dose" of prednisone, but he was just exhausted. They were trying to control his blood pressure and his pulse. When they got one of them "up," the other went "down." The doctors said that the patient''s LEMS had nothing to do with why he was in the hospital. His wife expressed her gratitude for the FIRDAPSE and how it had helped him. As of 09Feb2021, treatment with FIRDAPSE was ongoing. The patient was still in the hospital and not doing well, also reported that he was still the same, he had not improved but he had not worsened. The blood clot on his lung, blood pressure fluctuation and pulse issues, fluid in the bottom right lobe of his lung, inflammation in the bottom of his lung, and exhaustion were not resolved. The status of the bad reaction to the COVID vaccine was not reported. No additional information was provided. On 18Feb2021 and 19Feb2021, it was learned that the patient''s medical history included: muscle weakness and lung cancer with brain metastases. On unspecified dates, after starting FIRDAPSE, the patient''s muscle weakness began severely progressing, and he experienced fatigue. The weakness was worsening significantly, even after being on the medication (presumed FIRDAPSE). On 14Feb2021 or 15Feb2021, the patient was discharged from the hospital. On 18Feb2021, the patient took his last dose of FIRDAPSE. On 18Feb2021 or 19Feb2021 (reported as last night, relative to 19Feb2021; yet also reported as either 18Feb2021 or 19Feb2021), the patient passed away. The cause of death was unknown. A 74-year-old male, with a history of migraines and chemotherapy for metastatic small cell lung cancer, was taking an unknown statin, furosemide, pantoprazole, and Aspirin. He added FIRDAPSE for LEMS on 18Sep2020 and experienced headaches for a couple days, but he wasn''t sure if it was due to the FIRDAPSE or chemo. After COVID vaccine, he experienced a bad reaction (unspecified). Since 27Jan2021, he was hospitalized with a blood clot on his lung. He had brain and lung radiation for cancer. While in the hospital, he had fluid and inflammation in the bottom right lobe of his lung, where the cancer was, which count not be drained due to labile blood pressure. His muscle weakness began progressing and he experienced fatigue. In Feb2021, he was discharged on FIRDAPSE. A few days post-discharge, he died. Based on the information provided, the events were assessed as unrelated. Information on the batch/lot number has been requested.; Reported Cause(s) of Death: Passed away


VAERS ID: 1199422 (history)  
Form: Version 2.0  
Age: 98.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-01-28
Onset:2021-02-25
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-04-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK LA / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Malaise, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient passed away from blood clot, did not feel well after 2nd shot


VAERS ID: 1205071 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Unknown  
Location: Ohio  
Vaccinated:2021-02-11
Onset:2021-02-18
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3251? / 1 RA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9200? / 2 RA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Balance disorder, Blood test, Cerebral venous thrombosis, Cerebrovascular accident, Computerised tomogram, Contusion, Death, Fall, Intensive care, Ischaemic stroke, Pulmonary thrombosis, SARS-CoV-2 test negative, Skull fracture, Subdural haematoma, Syncope, Thrombectomy
SMQs:, Torsade de pointes/QT prolongation (broad), Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Accidents and injuries (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-04
   Days after onset: 14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Amlodipine 5 mg Besylate Norvasc Lupin Donepezil HCL 10 mg Solco Eliquis 5 mg Apixaban BMS Losartan 50 mg Cozaar Aurobindo Simvastatin Oral 20 mg Aurobindo
Current Illness: none
Preexisting Conditions: Hypertensive and Atherosclerotic Cardiovascular Disease Hypertrophic Cardiomyopathy Alzheimer''s Disease Cataracts
Allergies: Chlorthalidone hypokalemia Dexamethasone Penicillin Hydroxymethylglutaryl-CoA (HMG-CoA) Statins-muscle cramps with statins
Diagnostic Lab Data: Transport to the Hospital via Emergency Unit for treatment and testing: Multiple blood tests and several CT scans were performed. On March 2, 2021 at 10:30 am moved to a Medical Center after a minor ischemic stroke. During the course of the illness and treatment several COVID-19 tests were performed and all showed negative results.
CDC Split Type:

Write-up: On February 18, 2021 between hours 18:20-18:40 and a week after taking the second shot, patient lost balance (fainting) at home, fell, bruised a rib and fractured skull, causing subdural hematoma (bleeding outside of the brain). Bleeding stopped and several CT scans were performed. Under medical supervision, an anticoagulant medication was stopped to allow for healing. On February 20, 2021, moved from ICU to regular hospital room and on February 23 moved to another hospital for intense rehabilitation. Within days a thrombus developed causing a minor Cerebrovascular Accident, which was immediately identified by a medical doctor and nursing staff. On March 2, 2021 at 10:30 am moved to a Medical Center for further treatment. An endovascular thrombectomy for the removal of a thrombus was performed by a doctor. After recovery in the Neurosciences Critical Care ICU, under amazing care by the doctors, further thrombi developed on patient''s lungs and around the bowel. Patient expired at 8:01 on March 4, 2021 due to Ischemic Complications of Thrombi/Thromboemoli.


VAERS ID: 1211001 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-03-22
Onset:2021-03-28
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN 6202 / 1 RA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER 8727 / 2 RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Brain injury, Cerebral thrombosis, Cerebrovascular accident, Death, Endotracheal intubation
SMQs:, Angioedema (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: High blood pressure; diabetes
Allergies:
Diagnostic Lab Data: 03/28. Flown to another state after suffering a massive stroke due to a blood clot in the brain 03/29. Put into surgery to try to relieve pressure on her brain due to the blood clot. 04/2. Removed breathing tube due to 80% brain loss. 04/05. Mom died. My kids found her while she was having the stroke and called 911 on 03/28.
CDC Split Type:

Write-up: Patient is deceased. Had a blood clot travel to her brain and causes an un recoverable stroke


VAERS ID: 1213306 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Female  
Location: New York  
Vaccinated:2021-03-01
Onset:2021-03-06
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Anticoagulant therapy, Biopsy, Blood test, Cerebrovascular accident, Colonoscopy, Computerised tomogram, Echocardiogram, Magnetic resonance imaging, Pulmonary thrombosis, Thrombosis, Ultrasound scan, X-ray
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-07-01
   Days after onset: 116
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 11 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Biotin
Current Illness: None
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: Hospitalization 3/27-3/31: CAT, X-ray, pap, MRI, colonoscopy, blood tests, echocardiogram Hospitalization 4/10 - present: CAT, MRI, echocardiogram, ultrasound, heparin drip, blood tests, biopsy
CDC Split Type:

Write-up: blood clotting in legs, lungs, resulting in hospitalization. Second clotting event resulting in stroke and hospitalization, ongoing treatment and evaluation


VAERS ID: 1213431 (history)  
Form: Version 2.0  
Age: 47.0  
Sex: Female  
Location: New York  
Vaccinated:2021-03-01
Onset:2021-03-16
   Days after vaccination:15
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Infection, Platelet count decreased, Portal vein thrombosis
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-06
   Days after onset: 21
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol HFA (PROVENTIL HFA) 108 (90 Base) MCG/ACT Aerosol Solution inhaler Ammonium Lactate (LAC-HYDRIN) 12 % Lotion ibuprofen 600 MG Tablet
Current Illness: na
Preexisting Conditions: Mild intermittent asthma without complication
Allergies: Ciprofloxacin-ciproflox Hcl ErNausea/GI Upset Peanut
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient admitted with massive portal vein thrombosis and low plt in setting of infection. Symptoms started one week prior


VAERS ID: 1218764 (history)  
Form: Version 2.0  
Age: 72.0  
Sex: Female  
Location: Illinois  
Vaccinated:2021-02-10
Onset:2021-04-06
   Days after vaccination:55
Submitted: 0000-00-00
Entered: 2021-04-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM9089 / UNK - / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM9089 / UNK - / IM

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time shortened, Brain herniation, Cerebral haemorrhage, Cerebral mass effect, Chest X-ray abnormal, Computerised tomogram head abnormal, Condition aggravated, Deep vein thrombosis, Haemoglobin decreased, International normalised ratio increased, Leukaemia recurrent, Leukapheresis, Leukocytosis, Lung infiltration, Lung opacity, Oedema peripheral, Platelet count decreased, Prothrombin time prolonged, Respiratory viral panel, Subdural haemorrhage, Thrombocytopenia, Viral test negative, White blood cell count increased
SMQs:, Cardiac failure (broad), Liver-related coagulation and bleeding disturbances (narrow), Angioedema (broad), Haematopoietic erythropenia (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Accidents and injuries (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Haematological malignant tumours (narrow), Infective pneumonia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Carvedilol (Coreg), acyclovir, Lipitor, HCTZ, lisinopril, metformin, Ivosidenib (Tibsovo), Allopurinol (Zyloprim), Acetaminophen (Tylenol)
Current Illness: AML, CKD, T2DM, HTN, HLD
Preexisting Conditions: AML
Allergies: Sulfa drug, citrus, latex
Diagnostic Lab Data: INR 1.8. PT 20.1, PTT 24.7, WBC 102K, Hgb 6.7, platelet 57, respiratory viral panel negative. CXR: Patchy ground-glass opacities in the right upper lobe and right lower lobe. Mild interstitial infiltrates in the upper lobes bilaterally. Extensive DVT from the right common femoral vein through the distal popliteal vein. CT brain: Left occipital intraparenchymal hemorrhage measuring 5.8 x 2.8 x 3.1 cm as well as diffuse left hemispheric subdural hemorrhage measuring 11 mm, resulting in 16 mm rightward midline shift, subfalcine, and left uncal herniation.
CDC Split Type:

Write-up: Patient with Hx of AML received 1st dose COVID vaccine 2/10/2021, 2nd dose 3/4/2021. She developed DVT of the right leg, AML relapse. The patient has been diagnosed with AML back in 2016 and underwent several lines of therapy including chemotherapy with 7 and 3 and the last treatment was decitabine with maintenance treatment with ivosidenib. Having severe leukocytosis and right-sided leg edema with DVT raised concern about blast crisis and leukostasis. Patient was admitted to hospital and received. ceftriaxone and azithromycin for possible pneumonia. She underwent leukophoresis on the 4/6/2021, 4/7/2021. Patient received IV heparin gtt for DVT but later on was on hold given worsening thrombocytopenia. She was transferred from one hospital to another hospital. I do not think the development of DVT was due to COVID vaccine. But prior to COVID vaccine, patient was in AML remission.


VAERS ID: 1224177 (history)  
Form: Version 2.0  
Age: 29.0  
Sex: Female  
Location: Georgia  
Vaccinated:2021-02-24
Onset:2021-03-12
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-04-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6198 / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Cerebrovascular disorder, Death, Life support, Mobility decreased, Thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Thrombophlebitis (broad), Acute central respiratory depression (broad), Respiratory failure (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-19
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Blood clot blocking blood flow to brain - 1st episode: ( 3/12/21) stabilized, minor limited movement left side - 2nd episode: (3/24/21) no blood flow to brain, death (maintained on life support for organ donation)


VAERS ID: 1227979 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Texas  
Vaccinated:0000-00-00
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021406715

Write-up: got clots all over the body; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced got clots all over the body in Mar2021 and he passed away. Pfizer has not been reporting any effects of blood clot. The patient died on an unspecified date. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: got clots all over the body


VAERS ID: 1227980 (history)  
Form: Version 2.0  
Age: 51.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-03-27
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP6955 / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Fall, Pain in extremity, Pulmonary thrombosis, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Accidents and injuries (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-02
   Days after onset: 31
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety (Her brother in law had anxiety about even getting the vaccine); Clot blood
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021406778

Write-up: Blood Clot/The Blood clot was in the legs and went to his lungs; Blood Clot/The Blood clot was in the legs and went to his lungs; fell; Leg pain; This is a spontaneous report from a contactable consumer. A 51-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 27Mar2021 (Batch/Lot Number: EP6955) as single dose for covid-19 immunisation. Medical history included thrombosis from 2020 to an unknown date, it was Months ago in 2020, He was prescribed a medicine for blood clots, but since then he has had no issues, anxiety from an unknown date and unknown if ongoing. Her brother in law had anxiety about even getting the vaccine. The patient experienced leg pain on Mar2021 , pulmonary thrombosis, leg thrombosis and fall on an unspecified date. The patient died on 02Apr2021. An autopsy was not performed. The clinical course was the following: The Blood clot was in the legs and went to his lungs, his leg never got red or anything and it was a blood clot. He was having such bad leg pain, it''s too bad, had there been some sort of warning, he would have thought to wait till next year. There was nothing the day he got vaccine, but that night his leg started hurting, his girlfriend said let me go get a cold wrap and she wrapped it, he''s a farmer. He wakes up the next day and his leg is still hurting, the 3rd day it goes on, his leg still hurting and no one is thinking it a blood clot, he calls the doctor and tells the doctor his leg is hurting, they suggest ibuprofen for inflammation, the next day thought maybe it''s better, by Friday he was making breakfast, fell and died. With his girlfriend she said what''s going on, and he went straight to hospital, they said the clot in his leg went to the lung. The Blood clot when it was in the leg it never got hot, red, or anything like that. He had the vaccine in the morning and on that same day the leg pain started later that night. It Started out with Leg Pain, she does not know if it was right or left but it was just one leg.; Reported Cause(s) of Death: Thrombosis pulmonary; Thrombosis leg; Fall; Leg pain


VAERS ID: 1230389 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-03-08
Onset:2021-03-15
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Night sweats, Pulmonary thrombosis, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-25
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Letrozol 2.5 mg Vit D3 500 iu, Corgard, Synthroid
Current Illness: Metastic Breast Cancer
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: High fever, severe night sweats, blood clots in lungs


VAERS ID: 1235815 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-03-11
Onset:2021-03-25
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / -

Administered by: Unknown       Purchased by: ?
Symptoms: Cerebral haemorrhage, Cerebral thrombosis, Cerebrovascular accident
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-02
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021410670

Write-up: stroke; Brain bleed; Brain blood clot; This is a spontaneous report from a contactable consumer via a Pfizer sponsored program named Corporate (Pfizer) Social Media Platforms. A 53-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 11Mar2021 13:15 as single dose for covid-19 immunisation. Medical history reported as none. The patient''s concomitant medications were not reported. The patient experienced brain blood clot on 25Mar2021 08:00 , stroke and brain bleed on an unspecified date. The patient was hospitalized for brain blood clot, stroke, brain bleed for 7 days. Therapeutic measures were taken as a result of brain blood clot, stroke, brain bleed included Ventillator. The patient died on 02Apr2021. An autopsy was not performed. The outcome of events was fatal. No other vaccine in four weeks; No covid prior vaccination. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: Brain blood clot; stroke; Brain bleed


VAERS ID: 1237884 (history)  
Form: Version 2.0  
Age: 90.0  
Sex: Female  
Location: New Hampshire  
Vaccinated:2021-01-08
Onset:2021-04-03
   Days after vaccination:85
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3248 / 1 RA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN5318 / 2 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Blood creatinine increased, Blood urea increased, Chest X-ray abnormal, Condition aggravated, Death, Decubitus ulcer, Deep vein thrombosis, Dyskinesia, Dysphagia, Full blood count, Haematocrit decreased, Haemoglobin decreased, Hepatitis C RNA increased, International normalised ratio increased, Lung infiltration, Metabolic function test, Muscular weakness, Pleural effusion, Pneumonia, Red blood cell count decreased, Ultrasound Doppler abnormal, White blood cell count increased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Liver-related coagulation and bleeding disturbances (narrow), Liver infections (narrow), Haematopoietic erythropenia (narrow), Peripheral neuropathy (broad), Haemorrhage laboratory terms (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Dyskinesia (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (broad), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-03
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Aspirin, Calcium Carbonate, Ceftriaxone, Co-Q10, Cyanocobalamin, Lidocaine Patch 4%, Magnesium Lactate, Micro-K, Mirtazapine, MVI, Omeprazole, Senna-S, Tylenol , Venlafaxine, Anusol-HC cream , Chlorxihidine Gluconate Sol''n, Gabapentin, Met
Current Illness: Pneumonia, Abnormal blood levels and overall medical decline.
Preexisting Conditions: Exposed lumbar hardware, mulitple pressure injury, Pain, Dysphagia, Anemia, Chronic pain syndrome, HTN, GERD, A-fib, age-related osteoporosis, CKD, Chronic viral Hep C, Hx of MRSA, Hemiplegia and Hemiparesis following cerebral infarct, MDD, Insomnia, Anxiety, Dysarthria, Diverticulitis of the intestine, protein-calorie malnutrition, opoid dependence, Spondylosis without myelopathy or radiculopathy, Hx of DVT.
Allergies: Codeine, Celebrex, Diuretic
Diagnostic Lab Data: Chest X-ray ( 02/24 Diffuse bilateral infiltrates and 03/25/2021 Congestive failure with superimposed bilateral infiltrates and bilateral effusions) , Duplex Ultrasound of RLE and RUE= Extensive thrombus extending from the subclavian vein through the axilarry vein adn aslo involving brachial vein and radial vein and ulnar vein. DVT in popliteal vein. CBC and BMP- Multiple lab works were one. 02/24- BUN- 23, Crea- 1.10WBC- 13.93, RBC- 3.55, h/h- 8.8/29.1. INR- 1.3. 02/25- inr-1.6, 02/26- 4.2, 02/27 INR-5.5, She was on Lovenox bridge with Coumadin at the time and after high level of INR, Lovenox was then held.
CDC Split Type:

Write-up: Resident have had multiple PNA tx with IM Rocephin and IV Zosyn, Difficulty in swallowing, Elevated HCV RNA, 02/15 PCR Quant, ER visit following weakness and involuntary UE movements/jerking. Elevated amonia levels controlled with use of Lactulose. 02/22/2021 RUE and RLE extensive DVT. Worsening pressure wound and development of arterial wounds. Admitted to Hospice on 03/31/2021. Resident deceased on 04/03/2021.


VAERS ID: 1240013 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-02-09
Onset:2021-02-11
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9264 / 1 - / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Blood pressure decreased, Computerised tomogram thorax normal, Death, Dyspnoea, Malaise, Pulseless electrical activity, Resuscitation, Thrombosis
SMQs:, Anaphylactic reaction (narrow), Neuroleptic malignant syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow), Dehydration (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-04
   Days after onset: 51
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 51 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: chemo, acyclovir
Current Illness: multiple myeloma
Preexisting Conditions: multiple myeloma x 5.5 years
Allergies: none
Diagnostic Lab Data: HR 30s with low/no BP in ambulance. Team did CPR. CT after TPA showed no clots but he improved after TPA so still considering clot cause.
CDC Split Type:

Write-up: not feeling well and short of breath on 2/11/21, 2/12/21 more short of breath ambulance came. Went into PEA in ambulance with CPR. They gave TPA for suspected blood clot. He initially improved. He did not recover and died 4/4/21. He spent the entire time in hospital or TCU with complications. We brought him home 4/2 to die at home.


VAERS ID: 1255628 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Missouri  
Vaccinated:2021-03-28
Onset:2021-04-14
   Days after vaccination:17
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021416881

Write-up: died yesterday due to blood clots; This is a spontaneous report from a contactable consumer. A 55-year-old female patient (mother) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on 28Mar2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and the patient''s concomitant medications were not reported. The patient experienced blood clots and died due to the event. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested. ; Reported Cause(s) of Death: died yesterday due to blood clots


VAERS ID: 1255703 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Portal vein thrombosis, Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021425367

Write-up: Patient died; portal vein thrombosis; thrombocytopenia; This is a spontaneous report from a contactable physician. A 50-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient experienced portal vein thrombosis and thrombocytopenia 2 weeks after first Pfizer vaccine. Patient died. The patient died on an unspecified date. It was not reported if an autopsy was performed. The outcome of the events portal vein thrombosis and thrombocytopenia was unknown. The outcome of the event unknown cause of death was fatal. Information on the lot/ batch number has been requested.; Sender''s Comments: The information available in this report is limited and does not allow a medically meaningful assessment of the case. Based on temporal association, a causal association between the reported events and BNT162B2 cannot be fully excluded. Case will be reassessed when additional information is available including medical history and concomitant drug information. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and investigators, as appropriate. ; Reported Cause(s) of Death: Patient died


VAERS ID: 1255731 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, Organ failure, Thrombosis
SMQs:, Lack of efficacy/effect (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021432758

Write-up: Hot a fever then full blown covid; Hot a fever then full blown covid; blood clot; organ failure; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a male patient of an unspecified age received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported. Previously on an unknown date, the patient received the first dose of BNT162B2 vaccine. On an unspecified date, the patient experienced hot a fever then full blown COVID, blood clot and organ failure leading to patient death on an unknown date. It was not reported if an autopsy was performed. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected; Reported Cause(s) of Death: Drug ineffective; Covid-19; Blood clot; Organ failure


VAERS ID: 1256737 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Male  
Location: North Carolina  
Vaccinated:2021-02-01
Onset:2021-04-20
   Days after vaccination:78
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 AR / SYR

Administered by: Public       Purchased by: ?
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-20
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Diabetes
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: Died blood clot in brain


VAERS ID: 1259454 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-03-29
Onset:2021-04-23
   Days after vaccination:25
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Angiogram cerebral abnormal, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Magnetic resonance imaging head abnormal, Superior sagittal sinus thrombosis, Venogram abnormal
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: none
Current Illness: aneurysm, s/p coiling in 2014
Preexisting Conditions:
Allergies: noone
Diagnostic Lab Data: CTA and MRV 4/24 and 4/25. Large L frontal venous stroke.
CDC Split Type:

Write-up: venous sinus thrombosis of the superior sagital sinus, based on imaging likely occurred 1-2 weeks prior to presentation, ~ 1-3 weeks after vaccination no other clear reason for hypercoag state, no prior thromboembolic events, no h/o malignancy or rheumatological disease.


VAERS ID: 1261865 (history)  
Form: Version 2.0  
Age: 91.0  
Sex: Female  
Location: Ohio  
Vaccinated:2021-04-01
Onset:2021-04-25
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Pulmonary thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-25
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Death after experiencing blood clot to the lung


VAERS ID: 1263560 (history)  
Form: Version 2.0  
Age: 87.0  
Sex: Male  
Location: Washington  
Vaccinated:2021-03-31
Onset:2021-04-13
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6199 / 1 LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8737 / 2 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Computerised tomogram, Death, Small intestinal obstruction, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Gastrointestinal obstruction (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-22
   Days after onset: 9
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ? tramadol (ULTRAM) 50 MG Tab TAKE 1/2 TABLET BY MOUTH AT DINNER AND AT BEDTIME AND TAKE ONE TABLET EVERY 6 HOURS AS NEEDED. NOT TO EXCEED 6 TABLETS PER DAY ? butalbital-acetaminophen-caffeine (FIORICET, ESGIC) 50-325-40 MG Tab Take 1 Tab
Current Illness: ACTIVE MEDICAL PROBLEMS: Patient Active Problem List Diagnosis Date Noted ? Repeated falls 01/19/2021 Falls in home ? Weakness generalized 01/19/2021 ? Decreased mobility and endurance 01/19/2021 ? Neuropathy involving both lower extremities 05/07/2020 ? Chronic tension-type headache, intractable 05/07/2020 ? Palliative care patient 03/19/2020 ? Atrial flutter 03/05/2020 Seen in ER and started on eliquis and metoprolol ? Cervical (neck) region somatic dysfunction 02/06/2020 Now using a soft collar to support his head. Gets consistent head aches which he reports are like an ice pick in the top of his head. ? History of total replacement of right hip 6/27/16 10/14/2016 ? Primary osteoarthritis of right hip 05/12/2016 ? Allergic rhinitis 10/28/2015 ? BPH (benign prostatic hyperplasia) 10/02/2014 ? Degenerative disc disease, lumbar 01/15/2014 ? Mixed hyperlipidemia Hyperlipidemia ? Hypertension, benign Hypertension
Preexisting Conditions: ACTIVE MEDICAL PROBLEMS: Patient Active Problem List Diagnosis Date Noted ? Repeated falls 01/19/2021 Falls in home ? Weakness generalized 01/19/2021 ? Decreased mobility and endurance 01/19/2021 ? Neuropathy involving both lower extremities 05/07/2020 ? Chronic tension-type headache, intractable 05/07/2020 ? Palliative care patient 03/19/2020 ? Atrial flutter 03/05/2020 Seen in ER and started on eliquis and metoprolol ? Cervical (neck) region somatic dysfunction 02/06/2020 Now using a soft collar to support his head. Gets consistent head aches which he reports are like an ice pick in the top of his head. ? History of total replacement of right hip 6/27/16 10/14/2016 ? Primary osteoarthritis of right hip 05/12/2016 ? Allergic rhinitis 10/28/2015 ? BPH (benign prostatic hyperplasia) 10/02/2014 ? Degenerative disc disease, lumbar 01/15/2014 ? Mixed hyperlipidemia Hyperlipidemia ? Hypertension, benign Hypertension
Allergies: Dust Mold
Diagnostic Lab Data: Patient''s daughter states there were full body CT scans done while her dad was in the hospital with the clots. He was not admitted to my facility so I cannot see the labs or scans.
CDC Split Type:

Write-up: Per patient''s Daughter the patient developed blood clots in his small intestine on 4/13/2021 and died 4/22/21 with physicians unable to explain how or why he developed these clots while on apixaban. She requested his case be reported and reviewed in hopes it helps make the vaccines safer if that was what caused the clots.


VAERS ID: 1265810 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Puerto Rico  
Vaccinated:2021-03-21
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Blood test, Death, Deep vein thrombosis, Feeling cold, Hyperhidrosis, Insomnia, Pain in extremity, Pyrexia, SARS-CoV-2 test negative, Thrombosis
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-18
   Days after onset: 47
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 27 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetic (other medical history: Dialysis, Diabetic); Dialysis (other medical history: Dialysis, Diabetic)
Allergies: Allergy (known allergies: A7, Penicillin, Aspirin, Iodine, Povidone, Pepcid, dyes
Diagnostic Lab Data: Test Date: 20210329; Test Name: Blood test; Result Unstructured Data: Test Result:blood clot; Test Date: 202103; Test Name: Nasal Swab; Test Result: Negative
CDC Split Type: PRPFIZER INC2021448033

Write-up: sweating; felt cold/intense cold even in his bones; He was told by the professional health care that he had small clots in his blood; death cause: Medication; arm started to sore; Doctor identified he had DVT; her husband during that night was not able to sleep; He started having fever; This is a spontaneous report from a contactable consumer (patient''s spouse). A 61-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 21Mar2021 09:00 (Batch/Lot number was not reported) as single dose f(at the age of 61-year-old) or COVID-19 immunisation. Medical history included dialysis, diabetes mellitus, known allergies: A7, Penicillin, Aspirin, Iodine, Povidone, Pepcid, dyes, iodine allergy. The patient''s concomitant medications were not reported. The patient previously took Aspirin, povidone and pepcid ac and experienced drug hypersensitivity with all. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced death cause: medication on 18Apr2021, he was told by the professional health care that he had small clots in his blood in Mar2021, felt cold/intense cold even in his bones on 21Mar2021, sweating on 26Mar2021, her husband during that night was not able to sleep on 21Mar2021, he started having fever on 21Mar2021, arm started to sore and DVT on 29Mar2021. The patient was hospitalized for he had small clots in his blood, felt cold/intense cold even in his bones, sweating for 27 days. The event DVT was medically significant. The course of events was as follows: After getting the vaccine in 21Mar2021 her husband during that night was not able to sleep. He started having fever and felt cold. Days later he continued with the symptoms. On 26Mar2021 after vaccination he had dialysis same day in the afternoon. When arriving home the person notifies symptoms of intense cold even in his bones and then he started to sweat excessively on 26Mar2021 (Friday). The reporter decided to take her husband to the emergency room on 28Mar2021 (Sunday) where he had a general checkup. He was told by the professional health care that he had small clots in his blood. After some time he had health complications where they had suggested to amputate some of the limbs because of this, the reporter alleges those complications were due to the vaccine. On Monday 29Mar2021 same symptoms reappeared and he was admitted to Hospital. Had a blood test and notified to health professional that blood presents small clots. His arm started to sore severely after the sample. Doctor identified he had DVT. Doctor decided to proceed with various medications. Patient received treatment and he was injected: Percose, Morphine, Benadryl, Triphetarin for blood clot reduction. The patient underwent lab tests and procedures which included blood test: blood clot in Mar2021, Sars-cov-2 Nasal swab test: negative in Mar2021 post vaccination. The patient died on 18Apr2021. It was not reported if an autopsy was performed. The outcome of death cause: medication was fatal, of the other events was unknown. Information about the lot/batch number has been requested.; Reported Cause(s) of Death: death cause: Medication


VAERS ID: 1266361 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Kansas  
Vaccinated:2021-04-22
Onset:2021-04-23
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9096 / 1 AR / SYR

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Abdominal sepsis, Asthenia, Death, Defaecation urgency, Gastrointestinal necrosis, Intestinal ischaemia, Metabolic acidosis, Septic shock, Thrombosis, Vomiting
SMQs:, Acute pancreatitis (broad), Lactic acidosis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Retroperitoneal fibrosis (broad), Toxic-septic shock conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (narrow), Chronic kidney disease (broad), Noninfectious diarrhoea (narrow), Tumour lysis syndrome (broad), Sepsis (narrow), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-25
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: healthy
Preexisting Conditions: My auntie had kidney transplant 20+ years ago. She has been on schedule with her kidney medication and routine checkup.
Allergies: Penicillin
Diagnostic Lab Data:
CDC Split Type:

Write-up: April 22, 2021 morning my auntie got her first dose of Pfizer vaccine. She happily shared here vaccine experience with family member and relative. April 23 morning, she told us she has severe abdominal pain, has the need to have a bowel movement, but she was defecated. She also told us that she vomit couple times already, then she has no more energy to talk. She got into the hospital and she was announced death right after midnight at 12:04 April 25th. Reason of death given is "septic shock secondary to ischemic bowel & intra-abdominal sepsis". But it is the blood clots issue that is causing it. I was told that after my auntie got into hospital the very next day after Pfizer vaccine, hospital later found out that my auntie has blood blockage issue that is causing blood couldn''t flow to her intestines. The acid in her blood was very high, 6+. After more than 6 hours without blood to her intestines, her intestines tissues start dying and turned black color. Doctor found out about this at the night of April 23, 2021 nighttime. April 22, 2021 morning is the day my auntie got her Pfizer covid vaccine. There is a very high chances of the Pfizer vaccine is causing the blood clots that lead to blood blockages.


VAERS ID: 1270988 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-03-06
Onset:2021-03-08
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9266 / 1 LA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6203 / 2 LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Anticoagulant therapy, Chills, Death, Haemarthrosis, Herpes zoster, Illness, Malaise, Pain, Pericardial drainage, Pericardial effusion, Pulmonary thrombosis, Pyrexia, Vena cava filter insertion
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, venous (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Opportunistic infections (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-27
   Days after onset: 18
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 10 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Synthroid 100mg Amiodarone 100mg Furosemide 40mg & 20mg alternating days Aspirin 81 mg Omeprazole 20mg Forsinopril 5mg Allopurinol 100mg Cyclopento 1% 1 drop left eye daily Predn
Current Illness: None
Preexisting Conditions: Afib Congestive Heart Failure Kidney Disease COPD
Allergies: MetFormin HCI Losartan Patassium Zocor Cipro Lipitor Irbesartan
Diagnostic Lab Data: I am requesting her medical records from the hospital.
CDC Split Type:

Write-up: After 2nd Vaccine on 3/6/21, she became ill on 3/8/21, fever and chills was in bed all day on 3/9/21 with the same symptoms. Woke up on 3/9/21 with shingles, Her PCP was treating her with Famciclovir and Gabapentin for pain. She no longer had the fever or chills but still didn''t feel well. On 3/17/21 she was admitted at Medical Center which she was treated for a blood clot in her lung and for pericardial effusion. She was put on blood thinners which then caused a bleed in her hip bone. She had a surgery to put a filter in to stop more blood clots and to drain the fluid from her heart. She died on 3/27/21 around 3:30pm.


VAERS ID: 1281533 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-04-11
Onset:2021-04-14
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-05-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: School       Purchased by: ?
Symptoms: Death, Pulmonary thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-17
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Patient died 7 days later. Blood clot in lungs. Issues started 5 days after second dose.
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Blood clot in the lungs, Death


VAERS ID: 1283410 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2021-03-10
Onset:2021-03-15
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-05-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6207 / 1 - / UN

Administered by: Other       Purchased by: ?
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Death
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-15
   Days after onset: 0
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Levothyroxine Alprozalan Combivent Serevent Incruse Montelucart Qvar
Current Illness: Asthma - emphagsema
Preexisting Conditions: Anxiety
Allergies: Aspirin Penicillin
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient had a stroke on March 15, 2021 as described as a blood clot in her brain. Medical personnel were unable to correct it surgically and she passed away that evening in the hospital. Death was the final result.


VAERS ID: 1284449 (history)  
Form: Version 2.0  
Age: 82.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-04-12
Onset:2021-04-14
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8731 / 2 AR / SC

Administered by: Other       Purchased by: ?
Symptoms: Arterial thrombosis, Asthenia, Cardiogenic shock, Confusional state, Death, Deep vein thrombosis, Dyspnoea, Heart rate increased, Intracardiac thrombus, Lethargy, Malaise, Pain in extremity, Peripheral coldness, Pulmonary embolism
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Dementia (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-21
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Diltiazem, Hydralazine, Actos, Synthroid, Doxepin
Current Illness:
Preexisting Conditions: Diabetes, Afib, Hypertension
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: Approximately 40 hours after second Pfizer vaccine, patient complained of pain in lower right leg, and a cold foot, lethargy, weakness, feeling unwell. 3 days later, shortness of breath, difficulty breathing, rapid heartbeat, and confusion began. Went to Medical center on 4/20/21, diagnosed with DVT, PE and clots in and around the heart and passed away on 4/21/21 of cardiac shock in the setting of pulmonary and arterial thrombosis.


VAERS ID: 1285078 (history)  
Form: Version 2.0  
Age: 92.0  
Sex: Male  
Location: California  
Vaccinated:2021-01-11
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-05-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 RA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Atrial flutter, Death, Glucose tolerance impaired, Haemorrhage intracranial, Pain in extremity, Peripheral artery thrombosis, Peripheral coldness, Thrombectomy, Thrombophlebitis superficial, Ultrasound Doppler abnormal, Vasodilatation
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (narrow), Supraventricular tachyarrhythmias (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Cardiomyopathy (broad), Lipodystrophy (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: propranolol, other antihypertensive, antacid for GERD
Current Illness: none
Preexisting Conditions: hypertension, GERD, borderline DM, diagnosed while in rehab week before death - well controlled/no Rx.
Allergies: none
Diagnostic Lab Data: Available from Dr.
CDC Split Type:

Write-up: Patient was a well and active 92 year old man, who walked 2 miles daily with a walker. He received Covid vaccine dose 1 on 11 Jan. On or before 30 Jan, he noted pains in one leg while walking. Newly dilated veins on the lower leg were noted. On feb 2 a doppler US revealed a superficial saphenous vein venous thrombosis, also new onset A flutter. Aspirin begun. On Feb 5 he woke with a cold foot (same side) and was found to have an arterial thrombus from SFA through distal posterial tibial. He underwent emergency thrombectomy, went to rehab for recovery, on Feb 23 suffered intracranial hemorrhage and died on Mar 10.


VAERS ID: 1284864 (history)  
Form: Version 2.0  
Age: 96.0  
Sex: Female  
Location: West Virginia  
Vaccinated:2021-01-29
Onset:2021-02-01
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-05-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9265 / 2 - / -

Administered by: Military       Purchased by: ?
Symptoms: Cardiac arrest, Disease recurrence, Myocardial infarction, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-15
   Days after onset: 41
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ELIQUIS; FUROSEMIDE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anemic; Bone infection; Clot blood; Diabetic; Gangrene; Surgery
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021477402

Write-up: blood clot in her leg; blood clot in her leg; Cardiac arrest; Heart attack; This is a spontaneous report from a contactable consumer (patient''s daughter). A 96-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration on 29Jan2021 (Lot Number: EL9265) as SINGLE DOSE for COVID-19 immunization. Medical history included blood clots in her legs from an unknown date and unknown if ongoing , diabetec, bone infection, surgery and anemic; all from an unknown date and unknown if ongoing; and a family history of gangrene from an unknown date and unknown if ongoing of her mother. Concomitant medications included apixaban (ELIQUIS) taken as blood thinner and furosemide (FUROSEMIDE) taken for an unspecified indication; both start and stop date were not reported. The patient previously had BNT162B2 (Lot Number: EL1283) dose 1 on 08Jan2021 for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was in the military facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 15Mar2021, the patient died due to a heart attack and cardiac arrest. The patient developed a blood clot in her leg and had to have her leg taken off. The date of surgery was 05Feb2021, not early Mar2021 like was originally stated at the hospital. The patient was admitted either on 01Feb2021 or 02Feb2021 and discharged on 23Feb2021. They had a bunch of bad weather and then they put the patient in the nursing facility for about a month and when she was brought home she had a heart attack and died due to cardiac arrest. She doesn''t know about the blood clot and this being related to the COVID vaccines but the patient had surgery a week after she had her second shot. The heart attack was on 15Mar2021. The patient had a history of blood clots in her legs before and she had problems with that so that might of made it worse but she doesn''t know for sure. The patient died on 15Mar2021. An autopsy was not performed. The outcome of the event blood clot in her leg was unknown. No follow-up attempts are possible; information about lot/batch number has been obtained.; Reported Cause(s) of Death: heart attack; cardiac arrest


VAERS ID: 1288839 (history)  
Form: Version 2.0  
Age: 93.0  
Sex: Male  
Location: Virginia  
Vaccinated:2021-02-20
Onset:2021-04-23
   Days after vaccination:62
Submitted: 0000-00-00
Entered: 2021-05-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9264 / 2 LA / IM

Administered by: Senior Living       Purchased by: ?
Symptoms: Blood disorder, Death, Thrombosis
SMQs:, Haematopoietic cytopenias affecting more than one type of blood cell (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-23
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Systemic: Blood Disorder (diagnosed by MD)-Severe, Additional Details: Patient passed away on 4/23/21 and had blood clots throughout body. Patient did not have any other symptoms that were reported. Patients family requested a VAERS report be submitted.


VAERS ID: 1292206 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: New York  
Vaccinated:2021-03-27
Onset:2021-03-27
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Pulmonary thrombosis, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Pulmonary fibrosis
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Extreme blood clots in lungs and legs


VAERS ID: 1303074 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Male  
Location: West Virginia  
Vaccinated:2021-04-08
Onset:2021-04-10
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-05-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0158 / 2 UN / IM

Administered by: Other       Purchased by: ?
Symptoms: Anticoagulant therapy, Chest tube insertion, Death, Deep vein thrombosis, Lung neoplasm malignant, Pain in extremity, Pulmonary mass, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-05
   Days after onset: 25
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Anti-rejection medications status-post solid organ transplants
Current Illness: When went to hospital with concern for clots from vaccination, it was discovered that he had a lung nodule which was found to be cancerous.
Preexisting Conditions: Previous transplants of kidneys x 2, and pancreas. Broken ankle 2 years prior.
Allergies: Unkinown
Diagnostic Lab Data: Wife reported the event to the Coronavirus Hotline/Poison Center; she did not have his medical records from the hospital. Reported information on this from is from the wife.
CDC Split Type:

Write-up: 1st dose in series on 03-18-2021; 2nd dose in series on 04-08-2021 2 days after 2nd dose, he developed severe pain in both legs. He was taken to the hospital where clots were diagnosed in both legs and groin area. A previously undiagnosed lung nodule was found and he was given a cancer diagnosis. He was discharged home on apixaban (Eliquis) and comfort measures 2 days after admission. Over the following weeks, he had a permanent lung drain placed. He died on May 5th or 6th at home. No autopsy performed.


VAERS ID: 1304689 (history)  
Form: Version 2.0  
Age: 50.0  
Sex: Male  
Location: Pennsylvania  
Vaccinated:2021-04-01
Onset:2021-04-14
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-05-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 RA / -

Administered by: Other       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-22
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Lisinopril
Current Illness: High Blood Pressure, Diabetic
Preexisting Conditions: High Blood Pressure, Diabetic
Allergies: No
Diagnostic Lab Data:
CDC Split Type:

Write-up: Blood clot


VAERS ID: 1320362 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Male  
Location: Mississippi  
Vaccinated:2021-05-06
Onset:2021-05-07
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-05-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8633 / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Pulmonary thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021517148

Write-up: patient passed away, due to what was being told as possible blood clot in lungs; This is a spontaneous report from a contactable consumer. A 70-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06May2021 (Lot Number: ER8633) (at the age of 70-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not experienced COVID-19 prior or post vaccination. The patient passed away, due to what was being told as possible blood clot in lungs (on 07May2021). The event was serious (fatal) and required emergency room visit. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: blood clot in his lungs


VAERS ID: 1320378 (history)  
Form: Version 2.0  
Age: 78.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-03-20
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-05-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6201 / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Deep vein thrombosis, Laboratory test
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-12
   Days after onset: 41
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: INSULIN; SIMVASTATIN; HYDROCHLOROTHIAZIDE; COREG; PROTONIX [OMEPRAZOLE]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Blood pressure abnormal; Clot blood; Diabetes; High cholesterol; Kidney stone; Liver cirrhosis; Pacemaker insertion (cardiac); Sarcoidosis; Thrombocytopenia; Vena cava filter insertion
Allergies:
Diagnostic Lab Data: Test Date: 202103; Test Name: lab tests; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210322; Test Name: lab tests; Result Unstructured Data: Test Result:Unknown results
CDC Split Type: USPFIZER INC2021528357

Write-up: DVT was twice as bad; death/natural process; This is a spontaneous report from a contactable Nurse reporting for reporter''s husband. A 78-year-old male patient received bnt162b2 (reported as COVID vaccine), dose 2 via an unspecified route of administration on 20Mar2021 (Lot Number: EN6201; Expiration Date: 30Jun2021) as 2nd dose, single (at the age of 78-year-old) for COVID-19 immunisation. Medical history included diabetes, Liver cirrhosis, thrombocytopenia, Kidney stone, sarcoidosis, blood pressure abnormal, high cholesterol, pacemaker and they putted the IVC filter for blood clot. Concomitant medications included insulin, simvastatin, hydrochlorothiazide and omeprazole (PROTONIX), all taken for an unspecified indication, start and stop date were not reported; and carvedilol (COREG) taken for blood pressure, start and stop date were not reported. The patient previously received the first dose of bnt162b2 (Lot Number: EN6201; Expiration Date: 30Jun2021) on 27Feb2021 at the age of 78-year-old for COVID-19 immunization and experienced pulmonary embolism and deep vein thrombosis (DVT) on 12Mar2021, and went into the hospital 12Mar2021. Then the patient had the second COVID shot on 20Mar2021 and the reporter had taken him right back into the hospital couple days later because the DVT got twice as worst. The patient experienced DVT was twice as bad on an unspecified date in Mar2021, which required hospitalization on 22Mar2021. The patient underwent lab tests, he had lab tests on 22Mar2021 when he went in and he probably had them on 23rd and 24th of Mar2021. The reporter didn''t know what all the lab tests were done in the hospital. The patient died on 12Apr2021. The reporter stated they put Reason of death as natural process because she sent him in the Hospice. An autopsy was not performed. The outcome of event DVT was unknown. The reporter considered there was a causal relationship, when he got his second COVID shot on 20Mar2021 and then he went back in the hospital on 22Mar2021 and the DVT was twice as bad.; Sender''s Comments: Based on a positive temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported DVT. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.; Reported Cause(s) of Death: death/natural process


VAERS ID: 1330552 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: Iowa  
Vaccinated:2021-01-11
Onset:2021-01-29
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-05-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Work       Purchased by: ?
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Death, Laboratory test
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 23
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 23 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Insulin
Current Illness: Diabetes
Preexisting Conditions: Diabetes
Allergies: Na
Diagnostic Lab Data: Labs done from01/29-02/19
CDC Split Type:

Write-up: Blood clot in brain causing stroke then death


VAERS ID: 1333991 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Ohio  
Vaccinated:2021-01-25
Onset:2021-04-14
   Days after vaccination:79
Submitted: 0000-00-00
Entered: 2021-05-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL3249 / 2 - / SYR

Administered by: Senior Living       Purchased by: ?
Symptoms: Aortic thrombosis, Cardiac pharmacologic stress test, Death, Thrombosis
SMQs:, Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: N/A
Current Illness: N/A
Preexisting Conditions: N/A
Allergies: N/A
Diagnostic Lab Data: Stress test Lexiscan / Adenosine, Cardiology. 02/25/2021
CDC Split Type:

Write-up: Blot clot followed by fatal aortic thrombosis


VAERS ID: 1353752 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:2021-03-01
Onset:2021-04-26
   Days after vaccination:56
Submitted: 0000-00-00
Entered: 2021-05-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER6204 / UNK LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6204 / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Cautery to nose, Computerised tomogram abnormal, Coronary artery thrombosis, Death, Electrocardiogram abnormal, Epistaxis, Laboratory test, Myocardial infarction, Nasal cavity packing, Thrombosis, Thrombosis mesenteric vessel
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Ischaemic colitis (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-05-03
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Plavix, Lipitor, lisinopril, protonix, pottasium chloride,
Current Illness: ETOH, Smoker
Preexisting Conditions: HTN, CAD/CABG, hx of CVA, heavy ETOH, smoker
Allergies: nkda,none
Diagnostic Lab Data: 4/26 no tests, routine epistaxis care in nasal cavity provided- rhinorocket then cautery with ENT. 5/1 extensive labs, ECG and CT imaging done at MVH and MGH facilities.
CDC Split Type:

Write-up: He received both doses March 2021. second dose on 3/26. on 4/26 presented to ER with Epistaxis, came to about a month after Pfizer series pt went to Hospital ER 3 times that week for care of what was thought nose bleeds from picking, and later ENT for care that required travel. Pt stopped Plavix use and 6 days later on 5/1 returned to Hospital ER with serious symptoms, developed multiple thrombotic events that lead to clotting of leg/bowel/coronary. Transferred to Hospital on 5/1/2021. Multiple MI events and expired at Hospital on 5/3/2021


VAERS ID: 1384989 (history)  
Form: Version 2.0  
Age: 86.0  
Sex: Female  
Location: New York  
Vaccinated:2021-02-16
Onset:2021-04-12
   Days after vaccination:55
Submitted: 0000-00-00
Entered: 2021-06-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT AVAILABLE / 2 UN / UN

Administered by: Unknown       Purchased by: ?
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Anticoagulant therapy, COVID-19 pneumonia, Computerised tomogram abnormal, Computerised tomogram thorax, Death, Deep vein thrombosis, Fibrin D dimer increased, Full blood count, Hypoxia, Lung opacity, SARS-CoV-2 test positive, Scan with contrast, Ultrasound Doppler abnormal, Ventilation/perfusion scan, White blood cell count increased
SMQs:, Anaphylactic reaction (broad), Asthma/bronchospasm (broad), Haemorrhage laboratory terms (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-25
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 13 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Ibrutinib, amlodipine, benazepril, azithromycin, albuterol inhaler, rosuvastatin, cholecalciferol
Current Illness: Diagnosed with COVID "2 weeks ago" (COVID positive 3/26/21)
Preexisting Conditions: Chronic Lymphocytic Leukemia on Ibrutinib (immunocompromised)
Allergies: none
Diagnostic Lab Data: 2019nCoV amplified: 4/16/21 Positive, 4/17/21 Negative, 4/19/21 Negative CT Chest w/o contrast: 4/12/21 bilateral patchy groundglass consolidation is identified bilaterally in all lobes - consistent with diffuse COVID 19 pneumonia US Lower extremity venous doppler bilateral 4/18/21: Reason for Exam: elevated d.dimer and persistent hypoxemia. Nonocclusive DVT right posterior tibial vein. CTA Chest 4/18/21: Negative for PE NM LUNG SCAN PERFUSION PARTICULATE 4/19/21: Low probability for PE
CDC Split Type:

Write-up: Admitted to hospital 4/12/21 for acute hypoxic respiratory failure due to COVID-19 pneumonia. Treated with remdesivir (full course) and dexamethasone 10mg x1 then 6mg daily x 9 days. DVT treated with heparin IV Ibrutinib held -- CBC at baseline (WBC ranged 23.5 - 35.1) Infectious Disease MD ruled out other infections, including pneumocystis pneumonia Hypoxemia progressed to severe -- 60L high flow oxygen, unable to wean - patient does not want to be intubated On 4/22 the patient desired for comfort measures only and weaning of oxygen. The patient died on 4/25/21.


VAERS ID: 1385337 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-02-23
Onset:2021-04-20
   Days after vaccination:56
Submitted: 0000-00-00
Entered: 2021-06-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9266 / 1 LA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Amnesia, Blood test, Cerebral haemorrhage, Cerebrovascular accident, Computerised tomogram, Dementia, Depression, Disturbance in attention, Magnetic resonance imaging, Parkinson's disease, Seizure, Thrombosis, Ultrasound scan
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Dementia (narrow), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (narrow), Thrombophlebitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Depression (excl suicide and self injury) (narrow), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-06-08
   Days after onset: 49
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Insulin 2x''s a day.
Current Illness: Diabetes
Preexisting Conditions: Had a stent
Allergies: None
Diagnostic Lab Data: Hosptial completed MRI, ultrasound, CT scan, and blood work.
CDC Split Type:

Write-up: Was living happily and independently in a retirement community. After the second dose because losing his memory, focus, depression, followed by 2 strokes, brain bleed, blood clots, seizures, and a Dx of Parkinson''s and Parkinson''s dementia. He saw doctors monthly and never had any signs of any of these things.


VAERS ID: 1400337 (history)  
Form: Version 2.0  
Age: 41.0  
Sex: Male  
Location: Oklahoma  
Vaccinated:2021-04-27
Onset:2021-05-18
   Days after vaccination:21
Submitted: 0000-00-00
Entered: 2021-06-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0151 / 1 RA / SYR
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0167 / 2 RA / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Autopsy, Back pain, Death, Hypoaesthesia, Malaise, Respiratory arrest, Thrombosis, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-18
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Over the counter Ibuprofen
Current Illness: None
Preexisting Conditions: None
Allergies: No known allergies to food or other products
Diagnostic Lab Data: An autopsy was completed. The final report is pending.
CDC Split Type:

Write-up: On May 18, 2021, Patient said he was experiencing severe back pain and that both of his arms had gone numb and he had vomited. Patient called his mother to come help him with the baby because he wasn''t feeling well. When she got there 30 minutes later he was not breathing. They were not able to revive him. He died of a blood clot in the front of his heart.


VAERS ID: 1402395 (history)  
Form: Version 2.0  
Age: 61.0  
Sex: Male  
Location: Illinois  
Vaccinated:2021-03-30
Onset:2021-04-01
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-06-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8727 / 1 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Anosmia, COVID-19 pneumonia, Chest X-ray abnormal, Cyanosis, Death, Decreased appetite, Deep vein thrombosis, Diarrhoea, Dyspnoea, Fibrin D dimer increased, Heparin-induced thrombocytopenia, Lymphopenia, Multiple organ dysfunction syndrome, Oxygen saturation decreased, Pain, Respiratory distress, Respiratory failure, SARS-CoV-2 test positive, Shock
SMQs:, Anaphylactic reaction (narrow), Haematopoietic leukopenia (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Taste and smell disorders (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (narrow), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (narrow), Noninfectious diarrhoea (narrow), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Hypokalaemia (broad), Sepsis (broad), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-24
   Days after onset: 23
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: finasteride, tamsulosin
Current Illness:
Preexisting Conditions: multiple sclerosis, obesity
Allergies: ticfidera (diarrhea), tomato plant (hives)
Diagnostic Lab Data:
CDC Split Type:

Write-up: 2 days after vaccine developed diarrhea & body aches, then loss of smell and appetite. ED visit 4/8/2021, lymphopenia noted, COVID PCR positive. Returned to ED 4/11/2021 with SOB, oximetry low 70s, cyanotic, respiratory distress, elevated D dimer, CXR: COVID pneumonitis. "Deteriorated quickly despite maximal medical management" per Discharge Summary. Died 4/24/2021 from hypoxic respiratory failure and multiorgan failure, shock. Had also developed heparin induced thrombocytopenia during treatment for DVT Right lower and upper extremities.


VAERS ID: 1404274 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Male  
Location: Maryland  
Vaccinated:2021-03-01
Onset:2021-03-07
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-06-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Myocardial infarction, Sudden death, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Myocardial infarction (narrow), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-07
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Metformin, statin
Current Illness:
Preexisting Conditions: Diabetes, high blood pressure, high cholesterol
Allergies: none
Diagnostic Lab Data:
CDC Split Type:

Write-up: Death, sudden heart attack or blood clot


VAERS ID: 1410234 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-05-05
Onset:2021-05-05
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Loss of consciousness, Medical induction of coma, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-05-15
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Hay fever
Diagnostic Lab Data:
CDC Split Type:

Write-up: Blood clot?$g loss of consciousness-$g artificial coma ?$g death 10 days after vaccination


VAERS ID: 1411290 (history)  
Form: Version 2.0  
Age: 94.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-02-25
Onset:2021-03-25
   Days after vaccination:28
Submitted: 0000-00-00
Entered: 2021-06-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Autopsy, Death, Deep vein thrombosis, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Albuterol, amlodipine, aspirin, calcium, vitamin D, Miralax, Synthroid, Mucinex, Colace
Current Illness:
Preexisting Conditions: Heart block, heart failure, COPD, diabetes, dementia
Allergies: Codeine, morphine, sulfa antibiotics
Diagnostic Lab Data: An autopsy performed on 4/15/21 found deep venous thrombi in both legs and emboli in both lungs. There are a few case reports of DVT following the COVID-19 mRNA vaccines. I did not conclude that this patient''s DVT was caused by the vaccine but was advised by supervisor to report the death anyway.
CDC Split Type:

Write-up: Death due to PEs in bilateral lungs caused by DVTs in bilateral legs.


VAERS ID: 1413234 (history)  
Form: Version 2.0  
Age: 96.0  
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Death, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-25
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: TBD
Current Illness: Stomach cancer
Preexisting Conditions: TBD
Allergies: TBD
Diagnostic Lab Data: March 2021
CDC Split Type:

Write-up: Multiple blood clots that led to death on May 25, 2021.


VAERS ID: 1421500 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Male  
Location: Colorado  
Vaccinated:2021-02-18
Onset:2021-04-08
   Days after vaccination:49
Submitted: 0000-00-00
Entered: 2021-06-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: COVID-19, Cardiomyopathy, Pulmonary thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow), Cardiomyopathy (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-14
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Names unknown
Current Illness: Sarcoidosis
Preexisting Conditions: Sarcoidosis
Allergies: None known
Diagnostic Lab Data: Respirator - tests unknown
CDC Split Type:

Write-up: Covid 19, Blood Clot in Lung, Myocardia


VAERS ID: 1426917 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Kentucky  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021683252

Write-up: pass away recently due to blood clots; This is a spontaneous report from a contactable nurse (parent) and consumer. The nurse reported similar events for three patients. This is the first of three reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient pass away recently due to blood clots on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed. It was reported that even though the event was outside of reporting timelines & deemed by the PI to be unrelated to study drug. Information on batch and lot number is requested.; Sender''s Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of thrombosis with fatal outcome due to temporal relationship. However, the reported event may possibly represent intercurrent medical condition in this patient. There is limited information provided in this report. Additional information is needed to better assess the case, including complete medical history, diagnostics including vascular imaging studies, coagulation panel and autopsy results, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : PFIZER INC-2021688670 same reporter, event and suspect drug; different patient; PFIZER INC-2021688671 same reporter, event and suspect drug; different patient; Reported Cause(s) of Death: blood clots


VAERS ID: 1426921 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Kentucky  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-06-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021688670

Write-up: Patient died due to Blood clots; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 3 patients. This is the 2nd of 3 reports. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as unknown dose, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient pass away recently due to blood clots. The agency also stated that all 3 of these nurses had received the Pfizer vaccine. Document submitted for patient even though the event was outside of reporting timelines and deemed by the PI to be unrelated to study drug. It is not reported if autopsy was performed. information about lot/batch number has been requested.; Sender''s Comments: Based from current drug profile, the event thrombosis is assessed as unrelated to suspected drug BNT162B2 . It is difficult to provide possible cause of the event due to limited patient medical information or background.,Linked Report(s) : PFIZER INC-2021683252 same reporter, same drug, same event, different patient;PFIZER INC-2021688671 same reporter, same drug, same event, different patient; Reported Cause(s) of Death: Blood clots


VAERS ID: 1433813 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Female  
Location: Indiana  
Vaccinated:2021-02-28
Onset:2021-05-11
   Days after vaccination:72
Submitted: 0000-00-00
Entered: 2021-06-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6201 / 2 - / -

Administered by: Private       Purchased by: ?
Symptoms: Acute myocardial infarction, Acute respiratory failure, COVID-19, Condition aggravated, Coronary artery thrombosis, Death
SMQs:, Anaphylactic reaction (broad), Myocardial infarction (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, arterial (narrow), Acute central respiratory depression (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-12
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: COVID-19
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Death 5/12/2021 Causes of death listed on death certificate: 1) Acute Myocardial Infarction 2) Acute Coronary Artery Thrombosis 3) COVID-19 Other: Acute Respiratory Failure


VAERS ID: 1458628 (history)  
Form: Version 2.0  
Age: 35.0  
Sex: Male  
Location: Illinois  
Vaccinated:2021-04-17
Onset:2021-04-21
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-07-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0164 / 1 RA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Cardiac failure, Cerebrovascular accident, Death, Dyspnoea, Intensive care, Laboratory test, Pulmonary thrombosis, SARS-CoV-2 test negative, Thrombosis
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-02
   Days after onset: 11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 12 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions: N/A
Allergies: N/A
Diagnostic Lab Data: Yes a lot of test and lab were done, but like I said previously they have not given me his medical records so I don''t know all the exact dates to everything yet.
CDC Split Type:

Write-up: My previously healthy brother received the Pfizer vaccine (1st dose) and 4 days after he was hospitalized with shortness of breath, heart failure, blood clots in his arm, lungs and leg along with a stroke and many medical conditions kept arising as he was hospitalized. He was in the CICU for a week and a half. Unfortunately, my brother passed away from the Pfizer vaccine. Until his last day the doctors still "didn''t know" what was wrong with him. A lot happened during his hospital stay, but this is just a brief statement. They have been keeping his medical records from me. They tested him repeatedly there from covid and he wa salways negative. They had no other explanation to what was happening and all along they wanted it to be COVID-19 and were so quick to say it was not the vaccine.


VAERS ID: 1466124 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Washington  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021807766

Write-up: blood clots; This is a spontaneous report from a contactable physician via a sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient died one week after receiving Pfizer COVID vaccine, autopsy confirmed blood clots. Event took place after use of product. Information on the lot/batch number has been requested.; Sender''s Comments: A possible contributory role of the suspect drug to the reported event "blood clots" cannot be completely excluded based on temporal association. This case will be re-assessed when additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identifies as part of this review, as well as any appropriate action in response, will be promptly notifies to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: blood clots


VAERS ID: 1483629 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:2021-03-29
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-07-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Atrial fibrillation, Cytokine storm, Deep vein thrombosis, Haemophagocytic lymphohistiocytosis, Nervous system disorder, Platelet count
SMQs:, Supraventricular tachyarrhythmias (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Hypersensitivity (broad), Tumour lysis syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-06-12
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Platelets; Result Unstructured Data: Test Result:15,000
CDC Split Type: USPFIZER INC2021879891

Write-up: Neurologic damage (Shaking/memory/speech/motorskills); DVT; Afib; Secondary hlh; Cytokine Storm; This is a spontaneous report from a Pfizer-sponsored program. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 29Mar2021 as single dose for covid-19 immunization. The patient medical history was not reported. The patient''s concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection; Lot number: unknown), via an unspecified route of administration on unspecified date as single dose for COVID-19 immunization. The patient experienced neurologic damage (Shaking/memory/speech/motorskills), DVT, Afib, secondary hlh, cytokine storm on 2021. The patient was hospitalized for neurologic damage (Shaking/memory/speech/motorskills), dvt, Afib, Secondary hlh and cytokine storm from 12Apr2021 to an unknown date. The patient underwent lab tests and procedures which included platelet count: 15,000. The patient died on 12Jun2021. It was not reported if an autopsy was performed. The outcome of all the events was Fatal. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Based on temporal association, the causal relationship between BNT162B2 and the events cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available.,Linked Report(s) : US-PFIZER INC-2021879892 same source, different reporter/ patient; Reported Cause(s) of Death: The Pfizer shots killed my beautiful mother


VAERS ID: 1491659 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: New York  
Vaccinated:2021-02-01
Onset:2021-05-01
   Days after vaccination:89
Submitted: 0000-00-00
Entered: 2021-07-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 AR / SYR

Administered by: Pharmacy       Purchased by: ?
Symptoms: Balance disorder, Blood test, Cerebral thrombosis, Cerebrovascular accident, Computerised tomogram abnormal, Confusional state, Coronary artery thrombosis, Death, Dysarthria
SMQs:, Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Vestibular disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-31
   Days after onset: 30
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Insulin, pain meds, bladder meds, anxiety meds
Current Illness: None
Preexisting Conditions: Type II diabetes, fibromyalgia, arthritis
Allergies: Shrimp,
Diagnostic Lab Data: CT scans, blood work on May 24th. Major strokes, blood clots, possible heart attack. Death reported as related to complications to type II Diabetes
CDC Split Type:

Write-up: Blood clots, strokes, death I believe that there were subtle unrecognized signs starting in March - off balance, slurred speech, confusion- thought to be diabetes related. I would have her check her sugar and it would be fine, but I dismissed it as a good thing that her sugar was ok. It didn?t cross my mind until the major strokes that it could be related to the vaccine. She had major strokes in May as a result of blood clots in heart and head. I strongly believe that her death is related to the vaccine. She was well, and had her diabetes under control, and three months after getting the vaccine, she was dead.


VAERS ID: 1500766 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Male  
Location: New Mexico  
Vaccinated:2021-03-18
Onset:2021-03-22
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-07-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN602 / 1 UN / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN607 / 2 UN / IM

Administered by: School       Purchased by: ?
Symptoms: Amnesia, Balance disorder, Brain operation, Death, Thrombosis
SMQs:, Anticholinergic syndrome (broad), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Vestibular disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-30
   Days after onset: 69
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Gabapentin, mylaxocam, tylenol
Current Illness: None
Preexisting Conditions: Carpal tunnel left wrist, Arthritis right shoulder, Gi problems ie kidney stones.
Allergies: Unknown
Diagnostic Lab Data: unknown
CDC Split Type:

Write-up: Loss of balance, loss of memory, blood clots, hospitalization, brain surgery, death


VAERS ID: 1507895 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: New York  
Vaccinated:2021-02-01
Onset:2021-04-01
   Days after vaccination:59
Submitted: 0000-00-00
Entered: 2021-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Cerebrovascular accident, Thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-31
   Days after onset: 60
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: INSULIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthritis; Fibromyalgia; Type II diabetes mellitus
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202100924269

Write-up: Blood clots; strokes; This is a spontaneous report from a contactable consumer. A 81-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: FT8886), via an unspecified route of administration, administered in left arm on an unknown date in Feb2021 (at the age of 81-year-old) as dose 2, single dose for COVID-19 immunisation. Medical history included type II diabetes, arthritis and fibromyalgia. Prior to the vaccination, the patient was not diagnosed with COVID. The patient taken other medications in two weeks: insulin shots, prescription pain medications, urine medications and anxiety medications. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: not reported), administered in left arm on an unknown date in Feb2021 (at the age of 81-year-old) as dose 1, single for COVID-19 immunisation. The patient did not receive other vaccine in four weeks. Post vaccination, the patient had not been tested for COVID. On an unknown date in Apr2021, the patient had blood clots and strokes. The events resulted in emergency room/department or urgent care, hospitalized for 7 days. The patient did not receive any treatment in response to the events. The patient died on 31May2021. An autopsy was not performed. Cause of death was reported as blood clots and strokes. Outcome of the events was fatal. Information about lot/batch number has been requested.; Reported Cause(s) of Death: Blood clots; strokes


VAERS ID: 1508935 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Arkansas  
Vaccinated:2021-02-01
Onset:2021-02-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / -

Administered by: Unknown       Purchased by: ?
Symptoms: Blood test, Blood viscosity increased, Body temperature, Cough, Fatigue, Myocardial infarction, Product use issue, Pyrexia, Sinusitis, Thrombosis, Vomiting
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vasculitis (broad), Medication errors (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 20
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Dialysis (she had been on dialysis for 5 years before the shot)
Preexisting Conditions: Medical History/Concurrent Conditions: Renal failure (had renal failure before the shot.)
Allergies:
Diagnostic Lab Data: Test Date: 20210216; Test Name: blood work; Result Unstructured Data: Test Result:it was fine; Test Date: 202102; Test Name: temperature; Result Unstructured Data: Test Result:98-104
CDC Split Type: USPFIZER INC2021885179

Write-up: Stated that the coroner wrote the cause of death as a blood clot that caused a heart attack.; tired; coughing; sinus infection; throwing up; fever/started running a temperature; Stated that the coroner wrote the cause of death as a blood clot that caused a heart attack.; Stated that she went from her blood being thin to as thick as pancake syrup after the second shot; Patient previously received first dose of Moderna shot; This is a spontaneous report from a contactable consumer. A 62-year-old female patient received BNT162B2 [COVID-19 Vaccine-Manufacturer Unknown; Solution for injection; Lot number: unknown] via an unspecified route in left arm on an unspecified date in Feb2021 as single dose for COVID-19 immunization. Medical history of the patient included renal failure [she had been on dialysis for 5 years before the shot. Stated that she had renal failure before the shot. dialysis blood work done on 16Feb2021] and dialysis. Concomitant medications were not reported. Patient previously received first dose of Moderna shot via an unspecified route on an unspecified date in Jan2021 as single dose for COVID-19 immunization and experienced first shot left arm hurt. On an unspecified date in Feb2021, after receiving second dose of vaccination, patient started running a temperature which lasted for five days. On 14Feb2021, patient experienced coughing, throwing, sinus infection and on 15Feb2021 experienced being tired. Reportedly, four days after receiving second dose of vaccination patient started running temperature. The doctor asked patient to rotate with ibuprofen for a few days and during that time it was 98-104. Patient was given medicine for coughing and Zofran to settle her stomach because she was throwing up, all of this was after the second shot. On Friday, patient went to the doctor and they never drew blood work, but patient had blood work from where she does dialysis. The doctor said it was fine, patient worked 40 hours per week and with dialysis and was told that she was healthy despite renal failure. Patient was told that she would be okay in 3-4 days. Two days later on Sunday night at 20:05 patient passed away. The coroner wrote the cause of death as a blood clot that caused a heart attack. Patient did not have an autopsy done. Patient blood was as thick as pancake syrup. Reporter mentioned that sometimes they would pull the needle on dialysis and it would take 30 minutes to stop the bleeding because her blood was so thin. Patient went from her blood being thin to as thick as pancake syrup after the second shot on an unspecified date in 2021. Reporter said it was odd all of the coughing, throwing up, fever and blood thickening that happened after the second shot was given. Patient had been on dialysis for 5 years before the shot and had renal failure before the shot. Dialysis blood work was done on 16Feb2021. Reporter (patient husband) was very observant of wife and takes care of her. After the second shot patient missed whole a week of work [from 15Feb through 21Feb] and had never missed work. Patient was tired, fever, coughing and throwing up. Reporter believes that the medication caused all of these issues. Patient received treatment in response to the events fever, coughing, sinus infection and throwing up. Outcome of the event blood clot that caused a heart attack was fatal, for fever was recovered/resolved with sequel and for other events were unknown. Information on Lot/Batch information has been requested.; Reported Cause(s) of Death: blood clots leading to heart attack; blood clots leading to heart attack


VAERS ID: 1509660 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Male  
Location: Nebraska  
Vaccinated:2021-04-22
Onset:2021-04-22
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8731 / 2 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Arterial thrombosis, Autopsy, Malaise, Pain in extremity, Pyrexia, Syncope, Unresponsive to stimuli, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-06-19
   Days after onset: 58
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: none
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: pt developed fever later the day after getting his covid vax so he took ibuprofen and went to bed. Next day he went back to work. Pt showed no symptoms until the month of June when he started complaining about pain in both arms. He was using a heating pad on his shoulders to help with the pain. He was taking Aleve for the pain but it was not helping so he no longer wanted to take it. He had a vomiting episode on the afternoon of June 16th stating he thought he has eaten a bad lemon. He wasn''t feeling well the morning of June 18th, 2021 but continued working. He only wanted something light to eat since he didn''t feel well and was headed to bed. When his wife went to go to bed she found him collapsed on the bedroom floor with face forward in the bed. She turned him around and found him unresponsive. She contacted 911 and he was taken to Medical Center ER. They were not able to revive him. County conducted an autopsy where they found a blood clot in left artery.


VAERS ID: 1519067 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Female  
Location: Pennsylvania  
Vaccinated:2021-04-06
Onset:2021-04-30
   Days after vaccination:24
Submitted: 0000-00-00
Entered: 2021-08-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6204 / 1 - / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER8733 / 2 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Abdominal pain upper, Anticoagulant therapy, Catheter directed thrombolysis, Computerised tomogram abnormal, Death, Haemorrhagic stroke, Mesenteric artery thrombosis, Mesenteric vein thrombosis, Ultrasound scan
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-11
   Days after onset: 11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 12 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Idiopathic Thrombocytopenic Purpura, Diabetes type 2, Hypertension
Allergies:
Diagnostic Lab Data: CTs showed mesenteric vein and arterial thrombi.
CDC Split Type:

Write-up: Patient received the 2nd Pfizer Covid-19 Injection on 4/27/2021. She began having severe stomach pain the following day that did not resolve. She went to the hospital and was admitted on 4/30/2019. She underwent CTs, Ultrasounds. Found that she had 1 blood clot in a mesenteric artery. A second CT performed 2 days later showed that she had a 2nd blood clot that formed in a mesenteric vein. She has a condition ITP where she does not clot very well, however, it was stable at this time. She was started on heparin drips which made no improvement to the clots. Lysis catheter inserted with a TPA drip. This resulted in hemorrhagic stroke. She was placed on palliative care and passed away on 05/11/2021.


VAERS ID: 1528255 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Idaho  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Pulmonary thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 5 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Xeljanz
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202100972826

Write-up: blood clots in her lungs; This is a spontaneous report from a contactable consumer or other non hcp from a Pfizer sponsored program. A 86-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose unknown via an unspecified route of administration on an unspecified date in 2020 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation; tofacitinib citrate (XELJANZ), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient medical history and concomitant medications were not reported. The reporter stated that his neighbor was taking Xeljanz and got the COVID 19 vaccine (unknown manufacturer) and died from blood clots in her lungs. She died on an unspecified date and the family was blaming Xeljanz. The patient was diagnosis with blood clots about a month ago. She got COVID Vaccine around Christmas 2020. She was in hospital for 5 days with blood clots. The reporter inquired if vaccine cause blood clots. Seriousness of the event was reported as death and hospitalization. The action taken in response to the event for tofacitinib citrate was not applicable. The outcome of the event was fatal. It was not reported if an autopsy was performed. Follow-up attempts are needed. Information on the lot/batch number is expected.; Reported Cause(s) of Death: unknown cause of death


VAERS ID: 1530068 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Female  
Location: Illinois  
Vaccinated:2021-02-19
Onset:2021-03-24
   Days after vaccination:33
Submitted: 0000-00-00
Entered: 2021-08-06
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6198 / 1 LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6027 / 2 RA / IM

Administered by: Private       Purchased by: ?
Symptoms: Cerebrovascular accident, Death, Thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 12
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 13 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Stroke on March 24, 2021. Widespread blood clots discovered on April 3rd, 2021. Death on April 5th, 2021.


VAERS ID: 1534829 (history)  
Form: Version 2.0  
Age: 68.0  
Sex: Female  
Location: New York  
Vaccinated:2021-06-26
Onset:2021-08-05
   Days after vaccination:40
Submitted: 0000-00-00
Entered: 2021-08-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH LW0178 / 1 UN / UN
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0178 / 2 UN / UN

Administered by: Private       Purchased by: ?
Symptoms: Autopsy, Death, Embolism, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-08-05
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: none
Current Illness: none
Preexisting Conditions: none
Allergies: none
Diagnostic Lab Data: Autopsy = embolism
CDC Split Type:

Write-up: Death from blood clot


VAERS ID: 1582941 (history)  
Form: Version 2.0  
Age: 85.0  
Sex: Male  
Location: Georgia  
Vaccinated:2021-02-26
Onset:2021-03-02
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-08-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6202 / 2 AR / SYR

Administered by: Other       Purchased by: ?
Symptoms: Colon cancer, Condition aggravated, Death, Haemorrhage urinary tract, Nephrostomy, Prostate cancer, Pulmonary oedema, Thrombosis
SMQs:, Cardiac failure (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Prostate malignant tumours (narrow), Non-haematological malignant tumours (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-07-09
   Days after onset: 128
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Darifenacin, tamsulosin, ciprofloxacin, duloxetine, prednison, abiraterone, mupirocin, psyllium, ammonium lactate, urea topical, acetaminophen, leuprolide, multivitamin
Current Illness: Stage 4 cancers of prostate and colon
Preexisting Conditions: None
Allergies: Penicillin, some statins
Diagnostic Lab Data: Hospital stays, then nephrostomy, then hospital then death. Water on lungs
CDC Split Type:

Write-up: Four days after the shot, patient started having blood clots in the urine. After a few weeks, was able to get back to normal but seemed to stimulate previously stable cancers into growth. Four days after the 2nd (3/19/21) covid shot blood clots started again.


VAERS ID: 1628789 (history)  
Form: Version 2.0  
Age: 67.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-02-12
Onset:2021-08-09
   Days after vaccination:178
Submitted: 0000-00-00
Entered: 2021-08-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9262 / 1 UN / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9267 / 2 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Anticoagulant therapy, Blood loss anaemia, COVID-19, Cerebrovascular accident, Death, Deep vein thrombosis, Endotracheal intubation, General physical health deterioration, Hypotension, Retroperitoneal haematoma, SARS-CoV-2 test positive, Shock haemorrhagic, Unresponsive to stimuli
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Hypovolaemic shock conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Respiratory failure (broad), Hypoglycaemia (broad), Infective pneumonia (broad), Dehydration (broad), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-08-10
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: apixaban 5mg BID; Polycitra 1,100-334 mg/5mL TID; escitalopram 10mg daily; gabapentin 100mg TID
Current Illness:
Preexisting Conditions: CVA(2019), AFib (on Eliquis), pulmonary sarcoidosis, Gout, Kidney stones, HLD, CKD 3, coronary arteriosclerosis in native artery
Allergies: No known allergies
Diagnostic Lab Data:
CDC Split Type:

Write-up: Pfizer-BioNTech COVID-19 Vaccine EUA Patient received Pfizer-BioNTech COVID Vaccines on 1/20/2021 and 2/12/2021. Presented to ED on 8/9/21 from acute rehab with complaints of unresponsiveness at Rehab. PMH of CVA (2019). 2 weeks prior to admission patient with admitted to hospital and diagnosed with pontine stroke. Patient was scheduled for TEE and underwent routine COVID test and tested positive. Pt caregivers reported patient showed no respiratory symptoms prior to this admission. During this stay patient was treated with empiric antibiotics, Decadron for 10 days and Lovenox for treatment of a DVT and discharged to acute rehab. Upon arrival to ED pt was hypotensive, intubated and found to have a large retroperitoneal hematoma. Pt was also started on Cefepime, Vancomycin, and Doxycycline. Patient diagnosed with acute hemorrhagic shock and, acute blood loss anemia. Patient continued to decline and family decided to withdraw care and initiate comfort care. Patient expired on 8/10/2021.


VAERS ID: 1646449 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101000032

Write-up: developed it (blood clots) and died; This is a spontaneous report from a Pfizer-sponsored program from a non-contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) dose number unknown, single for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient developed it (blood clots) and died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: developed it (blood clots) and died


VAERS ID: 1646847 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Illinois  
Vaccinated:2021-03-01
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101024552

Write-up: developed widespread bloodclots; This is a spontaneous report from a contactable consumer for female patient (mother). A female patient of an unspecified age received bnt162b2 (COVID-19 vaccine), dose 2 via an unspecified route of administration on Mar2021 (Batch/Lot number was not reported) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical Vaccine included first dose bnt162b2 for covid-19 immunisation on Feb2021. The patient developed widespread bloodclots on 2021 with fatal outcome. The patient died on 2021. It was not reported if an autopsy was performed. The clinical course was reported as follows: patient received the COVID-19 vaccine and developed widespread blood clots. Her first dose was in February, her second dose in March and 13 days later she was gone. The lot number for the vaccine, bnt162b2, was not provided and will be requested during follow up.; Reported Cause(s) of Death: Developed widespread bloodclots


VAERS ID: 1654195 (history)  
Form: Version 2.0  
Age: 86.0  
Sex: Male  
Location: Texas  
Vaccinated:2021-07-27
Onset:2021-08-12
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-08-29
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 LA / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Brain stem syndrome, Cerebral haemorrhage, Cerebral thrombosis, Cerebrovascular accident, Death, Myocardial infarction
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Myocardial infarction (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-08-20
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: 08/19/2021-08/20/2021
CDC Split Type:

Write-up: Blood clots resulting in many strokes, brain bleeding due to strokes resulting in crushing the Brain Stem, heart attacks and death


VAERS ID: 1655104 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-08-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Cerebral thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101091230

Write-up: blood clot to the brain; This is a spontaneous report from a contactable consumer (patient''s relative). A female patient (mother-in-law) of an unspecified age received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient died from a blood clot to the brain on an unspecified date. The reporter personally think that it was from the Pfizer shot. The patient died on an unspecified date. It was not reported if an autopsy was performed. Information about lot/batch number not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.; Reported Cause(s) of Death: blood clot to the brain


VAERS ID: 1677599 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Cerebral thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hashimoto''s disease
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC202101139821

Write-up: Got a blood clot that went to his brain and died; This is a spontaneous report from a contactable consumer (patient''s friend) based on information received by Pfizer, on behalf of Moderna (Case: MOD21-136450). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number and expiration date was not reported) as dose 2, single for COVID-19 immunization. Medical history included Hashimoto''s disease. The patient''s concomitant medications were none. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Lot number and expiration date was not reported) as dose 1, single for COVID-19 immunization. On an unspecified date, the patient got a blood clot that went to his brain and had died on an unspecified date after 16-18 days of being fully vaccinated. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: Got a blood clot that went to his brain and died


VAERS ID: 1679166 (history)  
Form: Version 2.0  
Age: 81.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-04-05
Onset:2021-04-10
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Death, Dyspnoea, Dyspnoea exertional, Fear, Hepatic failure, Incomplete course of vaccination, Lethargy, Pulmonary thrombosis, Renal vascular thrombosis, Slow speech
SMQs:, Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Anaphylactic reaction (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Renovascular disorders (narrow), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-15
   Days after onset: 35
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 12 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Diabetes but was no longer needing medication. Kidney Disease, kidney had not changed in 5 years.
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: 4/5/2021 patient received 1st shot on 4/10/2021 noticed that she was lethargic, we thought that is might be her blood sugar but it was in normal range. we continued to check blood sugar daily thinking that was causing her to be lethargic and voice to be slow. 4/23/2021 my son and I spent the day with her noticing and she was getting worse but had also noticed that she was getting winded easily and would need to sit down. 4/26/2021 canceled 2nd covid shot. 4/30/2021 at about 1:30 pm she called me and said something was wrong something just happened she was scared! She called her Dr. and spoke to the the nurse PA. My sister was with her at the time so they checked for stoke signs none were found. Spoke to my mom through out the day on 5/1 & 5/2/2021 and she sounded out of breath and very lethargic. 5/3/2021 the Nurse PA called mom and said that she needed to go to the hospital where she stayed until she passed away on 5/15/2021. She had passed blood clots to her lungs then kidney and liver failure.


VAERS ID: 1679351 (history)  
Form: Version 2.0  
Age: 84.0  
Sex: Male  
Location: Illinois  
Vaccinated:2021-02-17
Onset:2021-02-17
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-09-07
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL9263 / 1 LA / IM
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6199 / 2 RA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Acute respiratory failure, COVID-19, Cardiomegaly, Chest X-ray abnormal, Chronic left ventricular failure, Condition aggravated, Cough, Death, Immunodeficiency, Mental status changes, Oxygen saturation decreased, Peripheral swelling, Pleural effusion, Pneumonia, SARS-CoV-2 test positive, Subclavian vein thrombosis, Ultrasound Doppler abnormal, Weight increased
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Angioedema (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Systemic lupus erythematosus (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-06-03
   Days after onset: 105
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Acetaminophen, allopurinol, amlodipine, aspirin, atorvastatin, calcitriol, donepezil, famotidine, tamsulosin, hydroxyzine, loperamide, losartan, metoprolol succinate, oxybutynin, prednisolone eye drops, prochlorperazine, montelukast, sodium
Current Illness:
Preexisting Conditions: CAD status post CABG x1 in 2014, ischemic cardiomyopathy, chronic diastolic CHF, paroxysmal atrial fibrillation, on Coumadin, pulmonary hypertension, sick sinus syndrome status post biventricular ICD, severe aortic stenosis status post TAVR, CKD stage 3, multiple myeloma, chronic anemia, hypertension and Alzheimer''s dementia.
Allergies: Amiodarone and tramadole
Diagnostic Lab Data: 3/20/21 Chest xray: Cardiomegaly with changes of CHF and bilateral pleural effusions. Superimposed pneumonia is also consideration. This has progressed since the prior. 3/20/21: Nonocclusive thrombus left subclavian vein. 3/20/21: COVID 19 positive
CDC Split Type:

Write-up: He was noted to have had a change in his mental status as per nursing home staff. Over the night his saturation dropped to 61% on room air because the patient took off his oxygen bed saturation came back to 90s after oxygen was replaced. He does have occasional cough. He has developed worsening swelling in his legs and has gained 20 lb since February 14th. Was placed on dexamethasone, azithromycin, cefepime and vancomycin due to immunocompromised state and chest xray showing pneumonia. Also received remdesivir. Resolved and discharged on 3/26/21. Came back on 4/27/21 for 8 days due to acute hypoxic respiratory failure and found to have CHF exacerbation. Was put on Hospice. Died 6/3/2021


VAERS ID: 971500 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-01-01
Submitted: 0000-00-00
Entered: 2021-01-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arrhythmia, Cardiac arrest, Cerebellar haemorrhage, Echocardiogram, Malaise, Pain in extremity, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Arrhythmia related investigations, signs and symptoms (broad), Haemorrhagic central nervous system vascular conditions (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow), Respiratory failure (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Overweight
Allergies:
Diagnostic Lab Data: Test Date: 202101; Test Name: cardiac echo; Result Unstructured Data: Test Result:large blood clots
CDC Split Type: ILPFIZER INC2021060959

Write-up: felt unwell in her home and was found lying on the floor with asystole; felt unwell in her home and was found lying on the floor with asystole; large blood clots; insignificant hand pain; Fatal cardiac arrhythmia; Cerebellar hemorrhage; This is a spontaneous report from a contactable healthcare professional received via the Health Authority. The regulatory authority report number was not reported. A 57-year-old female patient received second dose of bnt162b2, via an unspecified route of administration on 18Jan2021 at single dose for covid-19 immunization. Medical history included overweight from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced fatal cardiac arrhythmia, cerebellar hemorrhage, large blood clots, insignificant hand pain all in Jan2021, felt unwell in her home and was found lying on the floor with asystole on 20Jan2021. The female patient with overweight, no known background diseases. Received the second corona vaccine on 18Jan2021. After the vaccine she complained of insignificant hand pain. On 20Jan2021 she felt unwell in her home and was found lying on the floor with asystole at the arrival of MDA, after prolonged resuscitation, her death was determined in the trauma room in the emergency medical center, in a hospital in the north of the country. Emergency medical center diagnoses: Fatal cardiac arrhythmia; Cerebellar hemorrhage. It was further noted that a cardiac echo was performed by a cardiologist, diagnosed with large blood clots. The patient underwent lab tests and procedures which included cardiac echo: large blood clots in Jan2021. The outcome of events for fatal cardiac arrhythmia was death, for other events was unknown. The patient died in Jan2021. It was not reported if an autopsy was performed. No follow-up attempts are possible, information about batch/lot number cannot be obtained.; Reported Cause(s) of Death: Fatal cardiac arrhythmia


VAERS ID: 1035415 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-28
Onset:2021-01-30
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-02-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6163 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral venous sinus thrombosis, Coagulopathy, Fibrin D dimer, Platelet count
SMQs:, Haemorrhage laboratory terms (broad), Embolic and thrombotic events, venous (narrow), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-02
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Obesity
Allergies:
Diagnostic Lab Data: Test Name: Fibrin D dimer; Result Unstructured Data: Test Result:more than 80; Comments: D-dimer increase; Test Name: Platelet count; Result Unstructured Data: Test Result:59 000; Comments: Thrombocytopenia
CDC Split Type: ITPFIZER INC2021141118

Write-up: Sinus cerebral thrombosis. Discoagulopathy.; Sinus cerebral thrombosis. Discoagulopathy.; This is as spontaneous report received from a contactable physician downloaded from the Regulatory Agency MINISAL02-670914. A 55-year-old female patient received first dose of BNT162B2 (COMIRNATY, lot number: EL1484), on 07Jan2021 and second dose of BNT162B2 (COMIRNATY, lot number: EJ6163) on 28Jan2021, both intramuscular at single dose for COVID-19 immunization. The patient medical history included obesity from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. On 30Jan2021, the patient experienced sinus cerebral thrombosis and dis-coagulopathy. The events were serious (fatal). The patient underwent lab tests and procedures which included fibrin D dimer: more than 80 (D-dimer increased), platelet count: 59 000 (thrombocytopenia). Therapeutic measures were taken as a result of the events and included heparin. The patient died on 02Feb2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Coagulopathy; Cerebral venous sinus thrombosis


VAERS ID: 1044972 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-23
Onset:2021-01-24
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-02-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6797 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral thrombosis, Depressed level of consciousness
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-31
   Days after onset: 7
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: FURIX [FUROSEMIDE]; DIGOXIN DAK; PAMOL; HJERTEMAGNYL [ACETYLSALICYLIC ACID]
Current Illness: Heart failure; Living in nursing home
Preexisting Conditions: Medical History/Concurrent Conditions: Anticoagulant therapy; Diuretic therapy; Heart rate irregular; Pain
Allergies:
Diagnostic Lab Data:
CDC Split Type: DKPFIZER INC2021158671

Write-up: Consciousness decreased; Cerebral thrombosis (died on 31Jan2021); This is a spontaneous report downloaded from the Regulatory Authority-WEB [DK-DKMA-WBS-0030642]. The case was received from a contactable physician via The Agency. A 97-years-old female patient started to receive bnt162b2 (COMIRNATY,Batch numbers: EJ6797, Exp date: 30Apr2021) , intramuscular on 23Jan2021 at 1 DF, single dose for covid-19 immunisation. Medical history included ongoing heart failure, heart rate irregular and pain. She was in Diuretic therapy and Anticoagulant therapy. She was living in a nursing home. She was well before the vaccination on 23Jan2021. Concomitant medication included furosemide (FURIX [FUROSEMIDE]) oral from 09Jun2020 at 40 mg, daily for diuretic therapy, digoxin (DIGOXIN DAK) oral from 09Jun2020 at 62.5 ug, daily for heart rate irregular, paracetamol (PAMOL) oral from 27Dec2018 at 1000 mg, as needed for Pain, acetylsalicylic acid (HJERTEMAGNYL [ACETYLSALICYLIC ACID]) oral from 09Jun2020 at 75 mg, daily for Anticoagulant therapy. On 01Jan2021, the patient was vaccinated with first dose of COMIRNATY(Batch numbers: EJ6136, exp date 30Apr2021). On 24Jan2021, the day after the second vaccination the patient developed cerebral thrombosis and consciousness decreased. The ADRs were by the reporter reported as fatal and resulting in hospitalisation (24Jan2021). She is discharged to loving care at the nursing home and dies on 31Jan2021 at 00:51. The outcome of Cerebral thrombosis was fatal and the outcome of Consciousness decreased was unknown. Reported cause of death was cerebral thrombosis. Usual confirmation of death was performed on 31Jan2021 and here rigor mortis and livor mortis were found, nothing else. There is no information regarding test results. Causality: The physician does not know if it is an adverse reaction related to the vaccine, but due to the time context the physician is probably in doubt to report. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Cerebral thrombosis


VAERS ID: 1045496 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-01
Onset:2021-01-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-02-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6134 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute left ventricular failure, Arrhythmia, Myocardial infarction, Pulmonary artery thrombosis, Pulmonary oedema
SMQs:, Cardiac failure (narrow), Myocardial infarction (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, arterial (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension; Pulmonary embolism; Type 2 diabetes mellitus; Vascular dementia
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC2021151993

Write-up: Pulmonary artery thrombosis; acute left ventricular failure; pulmonary edema; arrhythmia; myocardial infarction; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) Regulatory Authority-WEB, Regulatory Authority number SE-MPA-2021-003041. Other case identifier number SE-MPA-1612771616648. A 78-years-old female patient received bnt162b2 (COMIRNATY, Batch/lot number: EJ6134), intramuscular on an unspecified date in Jan2021 at 0.3 mL single dose for covid-19 immunisation. Medical history included vascular dementia, type 2 diabetes mellitus, hypertension, pulmonary embolism, all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. According to the reporter the woman died of cardiac stress (left ventricular failure with pulmonary edema, arrhythmia or myocardial infarction can not be ruled out, according to the reporter) secondary to thrombosis in the pulmonary artery, three days after the vaccination with bnt162b2 in Jan2021. Indicated cause of death: acute left ventricular failure. The events outcome was fatal. It was not reported if an autopsy was performed. The report was assessed as serious, death. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: myocardial infarction; arrhythmia; Acute left ventricular failure; thrombosis in the pulmonary artery; pulmonary edema


VAERS ID: 1048601 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-26
Onset:2021-01-31
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-02-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Basilar artery thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: TEGRETOL; AMOXICILLIN/CLAVULANIC ACID; LEVETIRACETAM
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021163915

Write-up: Ischemic cerebrovascular accident; basilar thrombosis; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB NL-LRB-00442479. An adult female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 26Jan2021 at single dose for covid-19 immunization. The patient''s medical history was not reported. Concomitant medication included carbamazepine (TEGRETOL, tablet, strength: 100 mg), amoxicillin trihydrate, clavulanate potassium (AMOXICILLIN/CLAVULANIC ACID, strength: 500/125mg), levetiracetam. It was reported that 5 days after vaccination on 31Jan2021, the patient experienced an ischemic CVA (ischemic cerebrovascular accident), namely a basilar artery thrombosis. The patient was treated with thrombolysis and stenting. The patient deceased an unknown period in 2021 after the basilar artery thrombosis. It was not reported if an autopsy was performed. Sender Comment: The age of the patient is unknown, therefore "adult" was chosen as patient age group. Case Summary and Reporter''s Comments Text: ---------- BioNTech / Pfizer vaccine (Comirnaty) ---------------------- Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): unknown ---------- Ischemic CVA; basilar thrombosis ---------------------- Additional information ADR: - ---------- COVID19 -------- -------------- Previous COVID-19 infection: No ---------- Other ------------------ ---- diagnostic procedures: - No follow-up attempts possible, no further information expected. information about lot/batch number cannot be obtained.; Reporter''s Comments: ---------- BioNTech / Pfizer vaccine (Comirnaty) ---------------------- Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): unknown ---------- Ischemic CVA; basilar thrombosis ---------------------- Additional information ADR: - ---------- COVID19 -------- -------------- Previous COVID-19 infection: No ---------- Other ------------------ ---- diagnostic procedures: -; Reported Cause(s) of Death: Ischemic cerebrovascular accident; basilar thrombosis


VAERS ID: 1099567 (history)  
Form: Version 2.0  
Age: 56.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-12
Onset:2021-02-16
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-03-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6788 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Arterial thrombosis, Gastrointestinal necrosis, Hepatic failure, Renal failure
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Hepatic failure, fibrosis and cirrhosis and other liver damage-related conditions (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, arterial (narrow), Ischaemic colitis (narrow), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma; COPD; House dust allergy; Pollinosis
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021242210

Write-up: small intestinal necrosis; small bowel necrosis due to suspected arterial thrombosis; increasing liver failure; kidney failure; This is a spontaneous report from a non-contactable other health professional downloaded from the Agency DE-DCGMA-21188222. A 56-year-old female patient received second dose of BNT162B2 (COMIRNATY, solution for injection) lot number EJ6788 and expiry date unknown, intramuscular at the arm (deltoid muscle) on 12-Feb-2021 at single dose for Covid-19 immunization. Medical history included COPD, asthma, pollinosis, house dust allergy; all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. Historical vaccine included first dose of Comirnaty on 22-Jan-2021 for Covid-19 immunization and had been tolerated. On 16-Feb-2021, the patient experienced small intestinal necrosis (gastrointestinal necrosis), small bowel necrosis due to suspected arterial thrombosis (arterial thrombosis), increasing liver failure (hepatic failure), kidney failure (renal failure). The patient was hospitalized due to the events on unspecified date. The patient died on an unspecified date due to the events. It was not reported if an autopsy was performed. Reporter''s comment: Measures: OP on February 16, 2021 and relaparotomy on February 17, 2021. PEI: event assessment for all events/D. unclassifiable. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Measures: OP on February 16, 2021 and relaparotomy on February 17, 2021.; Reported Cause(s) of Death: small bowel necrosis due to suspected arterial thrombosis; increasing liver failure; kidney failure; small intestinal necrosis


VAERS ID: 1114115 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-20
Onset:2021-01-23
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Myocardial infarction, Pain in extremity, Thrombosis
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-23
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Parkinson''s disease ((mild and stable) for which she was taking medication)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021274681

Write-up: blood clots; Heart attack; sore arm; This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202103102255389050, Safety Report Unique Identifier GB-MHRA-ADR 24915706. This consumer reported similar events for three patients. This is the first of three reports. An 80-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on 20Jan2021 (Batch/Lot Number: Not known) as single dose for COVID-19 immunisation. The patient medical history included Parkinson''s (mild and stable) for which she was taking medication. Patient had not had symptoms associated with COVID-19. Not had a COVID-19 test. Patient was not enrolled in clinical trial. It was reported that the patient had absolutely no side effects other than a sore arm for a day. She had no signs of any illness or anything of concern. The patient experienced blood clots on an unspecified date, and heart attack on 23Jan2021. The outcome of the events blood clots and heart attack was fatal. The patient died on 23Jan2021. It was not reported if an autopsy was performed and the reported cause of death was thrombosis and myocardial infarction. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : GB-PFIZER INC-2021287274 Same reporter/drug, similar events in different patients;GB-PFIZER INC-2021287273 Same reporter/drug, similar events in different patients; Reported Cause(s) of Death: Clot blood; Heart attack


VAERS ID: 1114129 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Pulmonary oedema, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021287274

Write-up: This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory Agency (RA). Regulatory authority report number GB-MHRA-WEBCOVID-202103102255389050, Safety Report Unique Identifier GB-MHRA-ADR 24915706. This consumer reported similar events for three patients. This is the second of three reports. A 7-decade-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), on an unspecified date (Lot Number: unknown) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had the vaccine and then a couple days later had a blood clot that stopped the heart and caused fluid on the lungs and he died. The patient died on unknown date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : GB-PFIZER INC-2021274681 Same reporter/drug/events in different patients; GB-PFIZER INC-2021287273 Same reporter/drug/events in different patients; Reported Cause(s) of Death: fluid on the lungs; Clot blood; Heart arrest


VAERS ID: 1121527 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Pulmonary oedema, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Cardiac failure (narrow), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Respiratory failure (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none, Comment: had not health conditions
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021287273

Write-up: blood clots; stopped the heart; fluid on the lungs; This is a spontaneous report from a contactable consumer. This is the third of three reports. The first report is a report downloaded from from the Regulatory Agency (RA). The MHRA number is GB-MHRA-WEBCOVID-202103102255389050. A 7-decade-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration on an unknown date at single dose for COVID-19 immunisation. The patient medical history was none. The patient''s concomitant medication(s) were not provided. Patient had the vaccine and then a couple days later also died suddenly with the same circumstances (a blood clot that stopped the heart and caused fluid on the lungs), he was only in his 60s, had not health conditions and died suddenly. Reporter have serious concerns that the vaccine may be causing blood clots or something that is causing these sudden deaths. Reporter was sure there''s more cases like this and deeply concerned. Reporter only work in an office of 6 people and 3 of they have similar deaths in their family shortly after they took the vaccine. This is too much of a coincidence. The outcome of events was fatal. Patient was currently doing an autopsy. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Linked Report(s) : GB-PFIZER INC-2021274681 Same reporter/drug/events in different patients;GB-PFIZER INC-2021287274 Same reporter/drug/events in different patients; Reported Cause(s) of Death: fluid on the lungs; Clot blood; Heart attack


VAERS ID: 1122450 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-07
Onset:2021-01-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Cerebrovascular accident, Computerised tomogram, SARS-CoV-2 test, Thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-21
   Days after onset: 13
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Pacemaker insertion (cardiac); Stroke
Allergies:
Diagnostic Lab Data: Test Date: 20210107; Test Name: CT scan; Result Unstructured Data: Test Result:reuslts unkonwn; Test Date: 20210107; Test Name: SARS-CoV-2 test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021295132

Write-up: Stroke; blood clot; This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory authority report number GB-MHRA-WEBCOVID-202103151358357360, Safety Report Unique Identifier GB-MHRA-ADR 24945535. A 87-year-old female patient received bnt162b2 (BNT162B2) on 07Jan2021 at SINGLE DOSE for covid-19 immunization. Medical history included stroke an unknown date and pacemaker insertion on unknown date . Patient has not had symptoms associated with COVID-19 and is not enrolled in clinical trial. The patients concomitant medications were not reported. The patient experienced stroke (death, hospitalization) on 08Jan2021and blood clot an unknown date. The patient underwent lab tests and procedures which included computerized tomogram: unknown results on 07Jan2021 , sars-cov-2 test no - negative covid-19 test on 07Jan2021.The patient died on 21Jan2021. It was not reported if an autopsy was performed. The clinical course was reported as follows:Reporters mother in law had her first Pfizer vaccine on 07Jan2021. The following night the patient had a stroke caused by a blood clot. Patient has subsequently died. Patients family were told that it was not related but thought due to current news, Oxford vaccine should let you know in case it is relevant. The outcome of the event stroke was reported as fatal while the outcome of the other event was unkonwn. Patient has not tested positive for COVID-19 since having the vaccine. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender''s Comments: Events blood clot and stroke represent intercurrent medical conditions and unrelated to bnt162b2 . The history of stroke for this 87 years old patient may give an explanation.; Reported Cause(s) of Death: stroke


VAERS ID: 1135081 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-26
Onset:2021-02-01
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT KNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain upper, Arterial stenosis, Epistaxis, Laboratory test, Malaise, Myocardial infarction, Pain in extremity, Retroperitoneal haemorrhage, SARS-CoV-2 test, Thrombosis
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Tendinopathies and ligament disorders (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-28
   Days after onset: 27
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Clotting disorder; Diabetic
Allergies:
Diagnostic Lab Data: Test Name: more scans; Result Unstructured Data: Test Result:couldn''t find anything wrong; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021300649

Write-up: Stomach pain; Leg pain; Sickness; Retroperitoneal hemorrhage; Myocardial infarction; she had clots & slight narrowing of arteries; she had clots & slight narrowing of arteries; nose bleed; This is a spontaneous report from a contactable consumer. This is a report received from the Regulatory Agency. Regulatory authority report number GB-MHRA-WEBCOVID-202103151846019470, Safety Report Unique Identifier GB-MHRA-ADR 24949234. A 74-year-old female (also reported as 76-year-old) patient received bnt162b2 (BNT162B2, lot/batch number and expiry date were not reported), via an unspecified route of administration on 26Feb2021 as Single Dose for Covid-19 immunisation. Medical history included a diabetic and had problems with blood clotting like had a nosebleed they were very, very severe and she had to have it cauterized to stop it. Patient was not enrolled in clinical trial. Patient has not tested positive for COVID-19 since having the vaccine. Patient has not had symptoms associated with COVID-19. The patient''s concomitant medications were not reported. She admitted herself to hospital with severe pains in her stomach and leg (28Feb2021). The hospital scanned her and informed she had clots and slight narrowing of arteries. She never ever had heart issues before, they gave her blood thinners on arrival even though she said she had blood clotting issues, she brought up 4 pints of blood. On 28Feb2021 she was sick, had myocardial infarction and retroperitoneal hemorrhage. They stabilized her and she was booked in for bypass op. She was in the hospital, all was going then she took a turn for worse. She had nose bleeds. She had extreme pains in leg/stomach. After more scans in the hospital, they couldn''t find anything wrong but decided not well enough for the op. Then she started bleeding profusely in her stomach and severe leg pains. The hospital said they had never seen anything like it before and she died on 28Feb2021. The patient underwent laboratory test Sars-cov-2 test: No negative Covid-19 test on unknown date. It was reported that they cannot confirm that it was triggered by the vaccine and doctors are going to discuss her unusual case. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected. Information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: had clots and slight narrowing of arteries; had clots and slight narrowing of arteries; Myocardial infarction; Retroperitoneal hemorrhage; Stomach pain; Leg pain; nose bleed; Sickness


VAERS ID: 1135106 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-23
Onset:2021-03-07
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Cardiac failure, Pulmonary embolism, Pulmonary hypertension, SARS-CoV-2 test, Thrombosis
SMQs:, Cardiac failure (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Pulmonary hypertension (narrow), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-18
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac failure; Hypothyroidism; Pulmonary hypertension
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021305055

Write-up: Multiple segmental PEs; pulmonary hypertension; cardiac failure; Thrombosis; This is a spontaneous report from a contactable physician. This is a report received from a regulatory authority. Regulatory authority report number: GB-MHRA-WEBCOVID-202103181034119910, Safety Report Unique Identifier: GB-MHRA-ADR 24968966.A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number: Not reported) via an unspecified route of administration on 23Feb2021 as a single dose for COVID-19 immunisation. Medical history included pulmonary hypertension, cardiac failure, hypothyroidism. Patient has not had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced multiple segmental PEs causing severe pulmonary hypertension and cardiac failure on an unspecified date. The patient experienced thrombosis on 07Mar2021. The patient underwent lab tests and procedures which included COVID-19 virus test: no - negative covid-19 test on unknown date. The patient died on 18Mar2021. It was not reported if an autopsy was performed. The outcome of thrombosis was fatal. The outcome of other events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Thrombosis


VAERS ID: 1135193 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-21
Onset:2021-03-09
   Days after vaccination:16
Submitted: 0000-00-00
Entered: 2021-03-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Sarcoidosis
Preexisting Conditions: Medical History/Concurrent Conditions: Malignant neoplasm NOS
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021302432

Write-up: Pulmonary embolism; Thrombosis leg/DVT; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority. An 87-year-old male patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 21Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunization. Medical history included ongoing sarcoidosis and possibly malignancy. The patient''s concomitant medications were not reported. The patient experienced thrombosis leg/DVT (death, caused or prolonged hospitalization), pulmonary embolism (death, caused or prolonged hospitalization) after administration of covid-19 vaccine pfizer on 09Mar2021 (also reported as 3 weeks after the start of the product). Pulmonary embolism was treated with fraxiparine therapeutisch and thrombosis leg was treated with fraxiparine therapeutisch. The outcome of the events was fatal. The patient died on an unspecified date. It was not reported if an autopsy was performed. Reporter''s comment: BioNTech / Pfizer vaccine (Comirnaty); Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): unknown; Thrombotic bone and pulmonary embolism; Hospitalization information: DVT and pulmonary embolisms; Additional information Advers Reaction: However, probably no causal relationship with vaccine as there was underlying disease (mgl malignancy); confounding factors: sarcoidosis, and possibly malignancy, but inability to diagnose death; Previous COVID-19 infection: No. No follow-up attempts possible. No further information expected. Lot/Batch number can not be obtained.; Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty); Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): unknown; Thrombotic bone and pulmonary embolism; Hospitalization information: DVT and pulmonary embolisms; Additional information Advers Reaction: However, probably no causal relationship with vaccine as there was underlying disease (mgl malignancy); confounding factors: sarcoidosis, and possibly malignancy, but inability to diagnose death; Previous COVID-19 infection: No.; Reported Cause(s) of Death: Thrombosis leg/DVT; Pulmonary embolism


VAERS ID: 1146602 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-17
Onset:2021-03-15
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-03-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood test, Computerised tomogram, Death, Pneumonia, Pulmonary embolism, Thrombosis, Ultrasound scan
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ACENOCOUMAROL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anemia normocytic; Sarcoidosis
Allergies:
Diagnostic Lab Data: Test Name: blood test; Result Unstructured Data: Test Result:unknown results; Test Name: CT scan; Result Unstructured Data: Test Result:unknown results; Test Name: ultrasound; Result Unstructured Data: Test Result:unknown results
CDC Split Type: NLPFIZER INC2021317680

Write-up: First pneumonia, soon after the vaccine. Treated with antibiotics.; Then thrombotic leg, pulmonary embolism was diagnosed in hospital. Probably died of this.; Then thrombotic leg, pulmonary embolisms diagnosed in hospital. Probably died of this.; Death; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB NL-LRB-00476543, received from Regulatory Authority. An 87-years-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 17Feb2021 (Batch/Lot Number: Unknown) as SINGLE DOSE for covid-19 immunisation. Medical history included Anemia normocytic and sarcoidosis. There was no previous COVID-19 infection. Concomitant medication(s) included acenocoumarol. The patient experienced first pneumonia, soon after the vaccine. Treated with antibiotics. Then thrombotic leg, pulmonary embolisms diagnosed in hospital. Probably died of this. The patient was hospitalized for 4 days. Death was 26 days after start (15Mar2021). Death, lung embolism, thrombosis leg and pneumonia were all treated with Fraxiparine (as reported). The diagnostic procedures included: CT scan, ultrasound, blood tests. Confounding factors included sarcoidosis and possible lymphoma (unknown). The patient died on 15Mar2021. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reporter''s Comments: Comirnaty. Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): no Death Hospitalization information: 4 days ADR info: First pneumonia, soon after the vaccine. Treated with antibiotics.Then thrombotic leg, pulmonary embolisms diagnosed in hospital. Probably died of this. Patient number available: yes Confounding factors: Sarcoidosis. Possible lymphoma (unknown). COVID-19 Previous COVID-19 infection: No. diagnostic procedures: CT scan, ultrasound, blood tests.; Reported Cause(s) of Death: thrombotic leg; pulmonary embolism; death; pneumonia


VAERS ID: 1149898 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-01
Onset:2021-02-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0725 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Thrombosis
SMQs:, Acute pancreatitis (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Bipolar disorder; Blood sugar increased
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC2021311754

Write-up: SEVERAL OF THROMBOSES; severe abdominal pain; This is a spontaneous report from a contactable nurse downloaded from the regulatory authority-WEB, regulatory authority numberSE-MPA-2021-018721. Other Case identifier number: SE-MPA-1615843203133. An 83-year-old female patient received first dose of bnt162b2 (COMIRNATY; Lot Number: EL0725) via an unspecified route of administration, on Feb2021, as SINGLE DOSE for covid-19 immunisation. Medical history included blood glucose increased and bipolar disorder. The patient''s concomitant medications were not reported. In Feb2021, 6 day after the vaccine, the patient developed severe abdominal pain and went to a hospital, where multiple thrombosis in her body was discovered. The woman died the following day. This was completely unexpected and sudden, is described as an alert woman who managed her life on her own. Outcome of abdominal pain was unknown while it was fatal for several thromboses. Cause of death was reported as several of thromboses. No autopsy was performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: several of thromboses


VAERS ID: 1152835 (history)  
Form: Version 2.0  
Age: 90.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-02-21
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-03-31
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK4243 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arterial thrombosis, Malaise, SARS-CoV-2 test, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-21
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: SIMVASTATIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Blood pressure high
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021306489

Write-up: Felt unwell; a large blood clot was discovered in the artery to the bowel; Death sudden; This is a spontaneous report from a contactable consumer. This is a report received from the Agency Regulatory Authority (RA). Regulatory authority report number: GB-MHRA-WEBCOVID-202103201901276170, Safety Report Unique Identifier: GB-MHRA-ADR 24986407. A 90-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK4243, expiration date: unknown), via an unspecified route of administration on 21Jan2021 (at the age of 90 years old) at a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medication included simvastatin. The patient has not had symptoms associated with COVID-19 and was not enrolled in clinical trial. It was reported that the patient felt unwell on unspecified date immediately after the COVID vaccine. The patient continued to feel unwell and a large blood clot was discovered in the artery to the bowel and was admitted to hospital on Thursday, 04Feb2021. It was further reported that the patient deteriorated and died (sudden death) on 21Feb2021 (also reported as 10Feb2021). The patient underwent lab tests and procedures which included COVID-19 virus test: no - negative COVID-19 test on 05Feb2021. Since the vaccination, the patient had not tested positive for COVID-19. Outcome of the events felt unwell and a large blood clot was discovered in the artery to the bowel was unknown. The patient died on 21Feb2021. It was unknown whether an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Death sudden


VAERS ID: 1153633 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-19
Onset:2021-02-20
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL8723 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Lymphocytic infiltration, Pulmonary artery thrombosis, Pulmonary vasculitis
SMQs:, Interstitial lung disease (narrow), Embolic and thrombotic events, arterial (narrow), Eosinophilic pneumonia (narrow), Vasculitis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021328303

Write-up: ; This is as spontaneous report received from a non-contactable physician downloaded from there regulatory authority. The regulatory authority report number is DE-PEI-PEI2021003643. A 75-years-old female patient received bnt162b2 (COMIRNATY, Solution for injection), intramuscular on 19Feb2021 first/ second or other dose (Batch/Lot Number: EL8723) at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 20Feb2021 after vaccination the patient developed Thrombosis pulmonary artery and Lymphocytic infiltration and Pulmonary vasculitis, lasting for unknown. The patient was dead. The patient died on an unspecified date. It was not reported if an autopsy was performed. Outcome of the events was fatal. No follow-up attempts possible. No further information expected. Information on lot/batch number already obtained.; Reporter''s Comments: Autopsy follows; Reported Cause(s) of Death: Fulminant thrombosis of the pulmonary arteries bds; Lymphocytic infiltration of the right ventricular myocardium; Microvascular inflammatory reaction of the pulmonary end-stream pathway


VAERS ID: 1161676 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-29
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN3924 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea, Malaise, Pulmonary embolism, SARS-CoV-2 test, Thrombosis
SMQs:, Anaphylactic reaction (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-04
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ANASTROZOLE; VITAMIN D3
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Breast adenocarcinoma; Deep vein thrombosis; Pulmonary thromboembolism
Allergies:
Diagnostic Lab Data: Test Date: 20210205; Test Name: COVID-19 virus test; Test Result: Negative ; Comments: No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021336325

Write-up: thrombosis; Pulmonary thromboembolism; Breathlessness; feeling unwell; This is a spontaneous report from a contactable physician received from the Agency Regulatory Authority (RA). Regulatory authority report number is GB-MHRA-WEBCOVID-202103250735507320, Safety Report Unique Identifier is GB-MHRA-ADR 25017646. A 72-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN3924, expiry date not reported), via an unspecified route of administration at single dose on 29Jan2021 for COVID-19 immunization. Medical history included breast cancer, pulmonary embolism, and deep vein thrombosis. Previous low stage breast adenocarcinoma, grade 1. There was no detectable residual disease at post mortem. Patient was unsure if patient has had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. Concomitant medications included anastrozole taken for breast cancer, start and stop date were not reported; vitamin d3 taken for an unspecified indication, start and stop date were not reported. On an unspecified date, the patient experienced thrombosis, pulmonary thromboembolism, breathlessness, and feeling unwell. Narrative case summary and further information: Death occurred due to pulmonary thromboembolism following deep vein thrombosis. Breathlessness and feeling unwell since vaccine received. Died 4th February 2021. When thrombosis started is unclear as was not diagnosed in life. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 05Feb2021 No-Negative COVID-19 test. The patient died on 04Feb2021 due to the events. It was unknown if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Breathlessness; feeling unwell; thrombosis; Pulmonary thromboembolism


VAERS ID: 1165279 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-02
Onset:2021-02-10
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-04-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EK9788 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Chest X-ray, Computerised tomogram, Neoplasm, Pneumonia, Pulmonary thrombosis, SARS-CoV-2 antibody test, SARS-CoV-2 test
SMQs:, Embolic and thrombotic events, venous (narrow), Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Non-haematological tumours of unspecified malignancy (narrow), Infective pneumonia (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-16
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: COVID-19
Allergies:
Diagnostic Lab Data: Test Date: 202102; Test Name: chest X-ray; Result Unstructured Data: Test Result:Extensive bilateral interstitial alveolar opacitie; Comments: Extensive bilateral interstitial alveolar opacities that occupy all lung fields, more accentuated on the left side, suggestive in the current context of significant evolutionary inflammatory involvement (with fibrotic pattern) of a viral type. Increased cardiothoracic index. Free costophrenic angle; Test Date: 202102; Test Name: CT scan; Result Unstructured Data: Test Result:chronic thromboembolism; Test Date: 202012; Test Name: Ab; Test Result: Positive ; Test Date: 20210211; Test Name: COVID-19 antigen test; Test Result: Negative ; Test Date: 20210211; Test Name: COVID-19 PCR test; Test Result: Negative
CDC Split Type: ESPFIZER INC2021342298

Write-up: neoplasm; Bilateral pneumonia; Pulmonary thrombosis; This is a spontaneous report from a contactable physician downloaded from the regulatory authority ES-AEMPS-799829. A female patient of an unspecified age received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 02Feb2021 (Lot Number: EK9788) as single dose for covid-19 immunisation. Medical history included covid-19 from Nov2020 to an unknown date. The patient''s concomitant medications were not reported. The patient previously received the first dose of COMIRNATY on 12Jan2021 (lot no: EM0477) for COVID-19 immunisation. The patient experienced bilateral pneumonia and pulmonary thrombosis on 10Feb2021. Both events required were reported as serious (death). Clinical course was reported as follows. On 02Feb2021, began to have fever and progressive deterioration so was referred to the emergency room. Laboratory tests and radiography compatible with an inflammatory-thrombotic process similar to covid, with poor evolution despite empirical antibiotic therapy and high-dose corticosteroids, dying on 16Feb2021. Autopsy with pulmonary thrombosis and acute inflammatory changes, similar to those found in autopsies- covid. Also, neoplastic infiltration of the cervical ganglion (pending final report). Negative antigen and PCR detection test (11Feb2021). Chest X-ray (Feb2021): Extensive bilateral interstitial alveolar opacities that occupy all lung fields, more accentuated on the left side, suggestive in the current context of significant evolutionary inflammatory involvement (with fibrotic pattern) of a viral type. Increased cardiothoracic index. Free costophrenic angle. Chest CT showed: X-ray bilateral infiltrates. Covid in Nov2020 (Ab positive in Dec2020) with vaccination at the end of Jan2021. Description: Sufficiently enhanced pulmonary arterial vascularization, with basal motion artifact, with doubtful eccentric linear filling defect in the segmental branch of the right lower lobe, which could correspond to chronic thromboembolism. Pulmonary artery of normal caliber. Normally positioned interventricular septum. Aorta and cardiothoracic index within normal limits. Small bilateral pleural effusion. Diffuse, multilobar and bilateral parenchymal involvement, with increased density of the ground glass parenchyma, which in some areas respects the peripheral location. The pattern of involvement is nonspecific but by distribution it could correspond to interstitial edema, and less likely infectious process (non-typical COVID pattern), although the patient had previous COVID infection, unknown pneumonic involvement during the episode and/or residual lesions. Small increase in focal density in posterior aspect of T9, possible bone islet. Conclusion: Given that the CT scan (Feb2021) shows chronic thromboembolism, it cannot be ruled out that it is a sequel to COVID-19 that occurred 4 months ago (Nov2020). Also note that at autopsy it appears that he had a neoplasm. The patient died on 16Feb2021. Autopsy was done, unknown if results are available. Outcome of the events bilateral pneumonia and pulmonary thrombosis was fatal; while outcome of event neoplasm was unknown. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: bilateral pneumonia; pulmonary thrombosis


VAERS ID: 1185625 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-23
Onset:2021-03-24
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER7812 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral venous thrombosis, Computerised tomogram head, Delirium, Subarachnoid haemorrhage
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (narrow), Noninfectious meningitis (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-26
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Arterial hypertension
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210324; Test Name: CCT; Result Unstructured Data: Test Result:Cerebral vein thrombosis; Comments: Cerebral vein thrombosis with subsequent subarachnoid hemorrhage
CDC Split Type: DEPFIZER INC2021363109

Write-up: Acute delirium; Cerebral vein thrombosis with consecutive subarachn. Bleeding.; Cerebral vein thrombosis with consecutive subarachn. Bleeding.; This is a spontaneous report from a non-contactable consumer downloaded from the regulatory authority-WEB, regulatory authority number DE-PEI-CADR2021040021. Safety Report Unique Identifier DE-PEI-202100027662. An 89-year-old female patient received BNT162B2 (COMIRNATY), first dose intramuscular on 23Mar2021 (batch/lot number: ER7812) as a single dose for COVID-19 immunisation. Medical history included ongoing arterial hypertension. The patient''s concomitant medications were not reported. The patient experienced cerebral vein thrombosis with consecutive subarachnoid bleeding and acute delirium on 24Mar2021. The patient underwent lab tests and procedures which included cranial computed tomography (CCT): cerebral vein thrombosis with subsequent subarachnoid hemorrhage on 24Mar2021. Therapeutic measures were taken as a result of cerebral vein thrombosis and subarachnoid bleeding. The outcome was fatal for cerebral vein thrombosis and subarachnoid bleeding; and not recovered for acute delirium. The patient died on 26Mar2021. It was not reported if an autopsy was performed. The event assessment for all events as per PEI was unclassifiable. Sender Comment: Are you or the person concerned known of any allergies? If yes, which? no. Information on risk factors or previous illnesses easy kind. Hypertension / The patient developed delirium the day after a Comirnaty vaccination. The patient admission to acute neurology. One showed up in the CCT Cerebral vein thrombosis with subsequent subarachnoid hemorrhage. Despite therapy of the monitoring station with guideline-based therapy, she died on March 26, 2021 as a result of cerebral vein thrombosis. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Cerebral vein thrombosis with consecutive subarachn. Bleeding.; Cerebral vein thrombosis with consecutive subarachn. Bleeding.


VAERS ID: 1199890 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-30
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral thrombosis, Disease progression
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEPFIZER INC2021370489

Write-up: Blood clots in the head, resulting in death; Blood clots in the head, resulting in death; This is a spontaneous report received from a non-contactable consumer downloaded from the Regulatory Authority. The regulatory authority report number is DE-PEI-CADR2021040861, Safety report unique identifier DE-PEI-202100028706. A 91-years-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 30Jan2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (COMIRNATY) on 09Jan2021 and experienced blood clot on 25Jan2021, dizziness on 10Jan2021 and exhaustion on unknown date. The patient experience blood clots in the head, resulting in death in 2021. The patient died on 11Feb2021. An autopsy was not performed. It was reported that the patient passed away on 11Feb2021 in the nursing home administration of a second Covid-19 vaccination with a blood clot in her head. She had received the first vaccination on 09Jan2021 and the second on 30Jan2021. A few days after the first vaccination, she developed weakness and dizziness and was found sitting on the floor in the bathroom at night, according to the nursing home. She was admitted to the district hospital (here the blood clot was diagnosed but not treated), discharged after a few days on 30Jan2021 and despite her weakened condition still received the 2nd Covid vaccination on the day of discharge in the nursing home. Information on lot and batch numbers cannot be obtained. No further information expected.; Reported Cause(s) of Death: disease progression; Blood clot


VAERS ID: 1200084 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-07
Onset:2021-01-31
Submitted: 0000-00-00
Entered: 2021-04-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Echocardiogram, Loss of consciousness, Pulmonary embolism, Pulmonary hypertension, Syncope, Thrombosis, Ultrasound scan
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Pulmonary hypertension (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-16
   Days after onset: 16
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Pleuropneumonia (already been described about 20 years ago); Postphlebitic syndrome (already been described about 20 years ago)
Preexisting Conditions: Medical History/Concurrent Conditions: Bronchitis (from time to time)
Allergies:
Diagnostic Lab Data: Test Date: 20210131; Test Name: echo; Result Unstructured Data: Test Result:pulmonary hypertension; Test Date: 20210131; Test Name: Sonography; Result Unstructured Data: Test Result:in the assessment tab; Comments: lower leg thromboses on both legs, found pulmonary hypertension
CDC Split Type: DEPFIZER INC2021380842

Write-up: Lung embolism/severe pulmonary embolism; syncopated; unconscious for a short time; lower leg thromboses on both legs; Pulmonary hypertension; This is a spontaneous report from a non-contactable consumer downloaded from the Agency Regulatory Authority-WEB, regulatory authority report number is DE-PEI-CADR2021040401. Safety report unique identifier DE-PEI-202100027932. A 100-year-old female patient received BNT162B2 (COMIRNATY), intramuscular , dose 1 on 17Jan2021 (Batch/Lot number was not reported) and dose 2 on 07Feb2021 (Batch/Lot number was not reported) at 0.3 mL (standard dose), single dose, for COVID-19 immunisation. Ongoing medical history included pleuropneumonia and postphlebitic syndrome already been described about 20 years ago, and bronchitis from time to time. The patient had no known allergies. The patient''s concomitant medications were not reported. On 31Jan2021 the patient experienced lung embolism. Further reported that on 31Jan2021, 2 weeks after first vaccination, the patient syncopated, was unconscious for a short time. The hospital found lower leg thromboses on both legs by sonography, found pulmonary hypertension in the echo. From GP''s point of view, this was wrongly seen as a hypertension problem with "primary pulmonary hypertension". The patient died on 16Feb2021, one week after second vaccination on 07Feb2021, under the picture of oppression and shortness of breath and chest pain in 2021 without coagulation-specific medication. The thromboses with pulmonary hypertension are mentioned in the discharge letter, but no one seems to have thought of the actually typical symptoms of a severe pulmonary embolism. The outcome was fatal for lung embolism, recovered for unconscious and unknown for the other events. It was not reported if an autopsy was performed. This report is serious for death. Sender Comment: Do you or the person concerned have any known allergies? If yes, which ones? : no No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Lung embolism/severe pulmonary embolism


VAERS ID: 1206818 (history)  
Form: Version 2.0  
Age: 74.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-30
Onset:2021-04-06
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-06
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension
Allergies:
Diagnostic Lab Data:
CDC Split Type: PLPFIZER INC2021389686

Write-up: thrombosis; This is a spontaneous report from a contactable consumer. A 74-years-old male patient received bnt162b2 (COMIRNATY; Batch/Lot number was not reported), via an unspecified route of administration on 30Mar2021, (at the age of 74-years-old) at single dose for covid-19 immunisation. Medical history included hypertension from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient died due to thrombosis on 06Apr2021 at 09:55. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: thrombosis


VAERS ID: 1210316 (history)  
Form: Version 2.0  
Age: 80.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-04
Onset:2021-03-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Pulmonary embolism, Venous thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-09
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: THYROXIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypothyroidism
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIPFIZER INC2021389403

Write-up: Pulmonary embolism; Venous thrombosis; This is a spontaneous report from a contactable consumer downloaded from the regulatory authority. Regulatory authority number FI-FIMEA-20211617. This is a spontaneous report from a contactable consumer or other non hcp downloaded from the regulatory authority, regulatory authority number FI-FIMEA-20211617. A 80-years-old female patient received the first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 04Mar2021 (at the age of 80) (Batch/Lot Number: UNKNOWN) as single dose for covid-19 immunisation. Medical history included hypothyroidism. Concomitant medication included levothyroxine sodium (THYROXIN) taken for hypothyroidism. Five days after taking the vaccine, on 09Mar2021, the patient was found dead at home. The patient experienced pulmonary embolism on 04Mar2021, venous thrombosis on 04Mar2021. The cause of death was determined in a forensic autopsy, and the cause of death was venous thrombosis and pulmonary embolism. Information about lot/batch number cannot be obtained. No further information expected.; Autopsy-determined Cause(s) of Death: Pulmonary embolism; Venous thrombosis


VAERS ID: 1227731 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-01
Onset:2021-03-01
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 29
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: MXPFIZER INC2021411383

Write-up: thrombosis/a huge thrombus that they were not able to break and unfortunately obstructed the entrance to the lung; This is a spontaneous report from a contactable consumer received via email. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: Unknown), on an unspecified date in Mar2021 as a single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. The patient experienced thrombosis on an unspecified date in Mar2021, which led to death. The patient died on 31Mar2021 and had between 2 1/2 weeks from being vaccinated and the physician commented it was all symptoms from vaccine, he was detected a huge thrombus that they were not able to break and unfortunately obstructed the entrance to the lung he did not suffer from any disease. It was not reported if an autopsy was performed. Information on lot/batch number has been requested.; Reported Cause(s) of Death: big thrombo which obstructed lung entrance


VAERS ID: 1234877 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2020-12-20
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0724 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Enuresis, Fibrin D dimer, Investigation, Platelet count, Pulmonary embolism, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Cardiomyopathy (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-14
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CITALOPRAM
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abstains from recreational drugs; Alcohol use (Wine drinker); Basal cell carcinoma; Blepharoplasty; Breast implant user; Contraception; D & C; Eyelid operation NOS; Lipoma; Liposuction; Smoker (20 cigarettes'' a day)
Allergies:
Diagnostic Lab Data: Test Name: D-dimer; Result Unstructured Data: Test Result:Unknown; Test Name: anti-PF4 antibodies; Result Unstructured Data: Test Result:Unknown; Test Name: Platelet count; Result Unstructured Data: Test Result:Unknown
CDC Split Type: GBPFIZER INC2021410797

Write-up: Sudden death; acute pulmonary embolism; bed cold; DVT; This is a spontaneous report from a contactable other healthcare professional. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202104131438452890, Safety Report Unique Identifier GB-MHRA-ADR 25132819. A 58-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EJ0724, expiration date were not reported), via an unspecified route of administration on 20Dec2020 at single dose for covid-19 immunisation. Medical history included other repair of eyelid in 13Jan2014, liposuction of subcutaneous tissue NEC in 04Apr2013, lipoma of other specified sites in 10Feb2013, blepharoplasty of upper eyelid in 24Sep2012, breast augmentation in 24Sep2012, basal cell carcinoma in 20Feb2012, contraception in 2005, dilation of cervix uteri and curettage of uterus in 1983, smoker (20 cigarettes'' a day), drinker (wine drinker). Unsure if patient has had symptoms associated with COVID-19. Not had a COVID-19 test. Unsure if patient is enrolled in clinical trial. Concomitant medication included citalopram. The patient experienced bed cold, acute pulmonary embolism and sudden death on an unspecified date. The events were reported as serious (Life-threatening and Fatal). It was reported that patient was found in bed cold and unresponsive on an unspecified date. Ambulance were called and attended and deemed CPR to be futile. No medical conditions that family are aware of. She smoked around 20 cigarettes per day. She drank wine but amount was unknown. No recreational drugs that family are aware of. It was reported that the report relate to possible blood clots or low platelet counts. The patient was diagnosed with acute pulmonary embolism due to DVT during post mortem examination. Platelet count, D-dimer and anti-PF4 anitbodies were unknown. The patient died on 14Jan2021. Follow-up attempts are completed. No further information is expected.; Reported Cause(s) of Death: Sudden death; Bed cold; Autopsy-determined Cause(s) of Death: Acute Pulmonary Embolism due to DVT; DVT


VAERS ID: 1234885 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-28
Onset:2021-02-01
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN3924 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, Chest pain, Death, Deep vein thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Arthritis (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Ex-smoker (from teens heavy smoker when younger, stopped 20+ years ago.)
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021410987

Write-up: hip pain; dvt; chest pains; Death; This is a spontaneous report from a contactable healthcare professional received from the Agency Regulatory Authority. Regulatory authority report number is GB-MHRA-WEBCOVID-202104131451180500, Safety Report Unique Identifier is GB-MHRA-ADR 25132875. An 81-year-old male patient received first dose of bnt162b2 (COVID-19 MRNA VACCINE BIONTECH), via unspecified route of administration on 28Jan2021 (lot number: EN3924, expiration date not reported), as single dose for COVID-19 immunization. Medical history included ex-tobacco user (from teens heavy smoker when younger, stopped 20+ years ago) and occasional drank whiskey. Concomitant medications were not reported. On an unspecified date in Feb2021, the patient experienced death. On an unspecified date, the patient experienced hip pain, dvt (deep vein thrombosis) and chest pains, all with outcome of unknown. The events hip pain, dvt and chest pains were reported as life-threatening. The patient died on an unspecified date in Feb2021. The clinical course was reported as follows: The patient had been complaining of chest pains over the last couple of days but wasn''t one to bother anyone or go to doctors. On 13Feb2021, he visited his daughter''s address as it was her birthday and seemed fine at that time. At approximately 17:00 hours that day, he was back home and spoke to his son and said he was having chest pains. At 1806 hours, he texted his daughter and it didn''t make sense but this wasn''t unusual. On 14Feb2021 at 10:30 am, a neighbour rang daughter to say that the downstairs blinds were still shut. Family attended home address and found him deceased sat in a chair in the living room. Family confirmed that the patient was mobile on his own using a stick, he would sometimes complain of hip pain if he''d been sat for a while. Patient was an ex-smoker - from teens heavy smoker when younger, stopped 20+ years ago. Alcohol - occasional whiskey. No recreational drug use. No industrial diseases/claims. It was unsure if patient has had symptoms associated with COVID-19. Patient had not had a COVID-19 test. It was unsure if patient was enrolled in clinical trial No follow-up attempts are possible. No further information is expected.; Sender''s Comments: The information provided is limited for reasonable medical assessment. There was no information provided regarding cause of death, autopsy results and diagnostic studies. However, per company causality assessment guidance, the event of death with unknown cause is assessed as related until the cause of death is clarified and re-assessed based on additional data. Queries are in place for the missing information. Other reported events are probably due to an underlying medical condition. This case will be updated once additional information is available.; Reported Cause(s) of Death: Death


VAERS ID: 1239704 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-07
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-21
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ1688 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: SARS-CoV-2 test, Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-01
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unsure if patient has had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative
CDC Split Type: GBPFIZER INC2021416276

Write-up: Clot blood; This is a spontaneous report from a contactable consumer received from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202104150730180020. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EJ1688) first dose, via an unspecified route of administration on 07Jan2021, as a single dose for covid-19 immunisation. The patient medical history was not reported. It was unsure if the patient has had symptoms associated with COVID-19 and the patient was not enrolled in a clinical trial. Concomitant medications were not reported. The patient experienced clot blood on an unspecified date. It was reported that the paramedics tried to save the patient''s life. The patient underwent lab tests and procedures, which included a negative COVID-19 virus test on an unspecified date. The patient had not tested positive for covid-19 since having the vaccine. The patient died on 01Mar2021. It was not reported if an autopsy was performed and the reported cause of death was blood clot. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: blood clot


VAERS ID: 1240334 (history)  
Form: Version 2.0  
Age: 75.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-10
Onset:2021-03-30
   Days after vaccination:20
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP9605 / 2 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral thrombosis, Depressed level of consciousness, Hemiplegia, Platelet count, Pneumonia, Respiratory failure, SARS-CoV-2 test, Thrombocytopenia
SMQs:, Anaphylactic reaction (broad), Haematopoietic thrombocytopenia (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Ischaemic central nervous system vascular conditions (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Eosinophilic pneumonia (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (narrow), Hypokalaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LIPITOR [ATORVASTATIN]; ESBRIET; PROSCAR; ACETYLSALISYLSYRE ACTAVIS; NEXIUM [ESOMEPRAZOLE MAGNESIUM]
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Acid reflux (esophageal); Fibrosis lung; Hypercholesterolaemia; Hyperplasia of prostate; Platelet abnormalities
Allergies:
Diagnostic Lab Data: Test Date: 20210330; Test Name: Thrombocyte count; Result Unstructured Data: Test Result:120 x10 9/l; Test Date: 20210401; Test Name: Thrombocyte count; Result Unstructured Data: Test Result:60 x10 9/l; Test Date: 20210330; Test Name: COVID-19 PCR test; Test Result: Negative
CDC Split Type: NOPFIZER INC2021414237

Write-up: Admission with severe pneumonia 3 weeks after the last vaccine dose.; dies of respiratory failure; After 2 days of ongoing antibiotics, there is a decrease in consciousness and half-sided paralysis; After 2 days of ongoing antibiotics, there is a decrease in consciousness and half-sided paralysis; thrombocytopenia, intracerebral thrombosis; thrombocytopenia, intracerebral thrombosis; This is a spontaneous report from a contactable physician downloaded from the regulatory authority NO-NOMAADVRE-FHI-2021-Ug4wdy Safety Report Unique Identifier NO-NOMAADVRE-E2B_00025961. A 75-years-old male patient received bnt162b2 (COMIRNATY), dose 2 intramuscular, administered in Arm Left on 10Mar2021 12:00 (Batch/Lot Number: EP9605) as SINGLE DOSE for covid-19 immunization, at the age of vaccination of 75 years old. Medical history included FIBROSIS LUNG from 2019 to an unknown date, hypercholesterolaemia, HYPERPLASIA OF PROSTATE , antiplatelet and ACID REFLUX (ESOPHAGEAL). Historical vaccine included first dose of comirnaty for covid-19 immunisation. Concomitant medications included atorvastatin (LIPITOR) taken for hypercholesterolaemia; pirfenidone (ESBRIET) taken for FIBROSIS LUNG from 2019 to 31Mar2021; finasteride (PROSCAR) taken for HYPERPLASIA OF PROSTATE; acetylsalicylic acid (ACETYLSALISYLSYRE ACTAVIS) taken for antiplatelet therapy; esomeprazole magnesium (NEXIUM) taken for ACID REFLUX (ESOPHAGEAL). The patient experienced admission with severe pneumonia 3 weeks after the last vaccine dose on 30Mar2021, thrombocytopenia, intracerebral thrombosis on 30Mar2021, died of respiratory failure on 01Apr2021, after 2 days of ongoing antibiotics, there was a decrease in consciousness and half-sided paralysis on 01Apr2021, thrombocytopenia, intracerebral thrombosis on 01Apr2021. The patient underwent lab tests which included platelet count: 120 x10 9/l on 30Mar2021, platelet count: 60 x10 9/l on 01Apr2021, COVID-19 PCR TEST: negative on 30Mar2021. Therapeutic measures were taken as a result of admission with severe pneumonia 3 weeks after the last vaccine dose. The patient died on 01Apr2021. It was not reported if an autopsy was performed. Reported on 30Mar2021 the patient developed severe PNEUMONIA and was admitted to the hospital. The thrombocyte count was 120 x 10 9/L. On 01Apr2021, after two days with antibiotic therapy, the patient developed DEPRESSED LEVEL OF CONSCIOUSNESS, PARALYSIS ONE SIDE OF BODY, THROMBOCYTOPENIA, CEREBRAL THROMBOSIS. The patient was not susceptible for thrombectomy due to widespread infarction changes at the time of diagnosis. Terminated intensive care therapy due to poor prospects for survival. The patient died of RESPIRATORY FAILURE. The patient''s outcome was Fatal, at the time of the report. The case was considered to be Serious. This case was received from a Physician. The reporting physician states that the event was reported due to pronounced thrombosis with low platelet count. Relatedness of drug to reactions:Source of assessment: Regional Pharmacovigilance Center. COMIRNATY the Result of Assessment was Possible for ALL EVENTS. Sender Comment: Since the vaccine is new, it is subject to special surveillance to detect new safety information as quickly as possible. It is especially important that serious and / or unusual side effects are reported. Your message is therefore important to increase knowledge about side effects that have not been discovered in the studies, and is an important contribution to international cooperation to maintain safe vaccination worldwide. Reports after coronary vaccination in the adverse reaction register are processed by the agency in collaboration with the information service. The agency publishes weekly summaries of reports of suspected side effects after vaccination. As additional information about the incident has been requested, the adverse reaction message is currently being processed. When new information is received, we will update the message. Reporter comment: 08Apr2021 agency/information service: requested additional information. If new medical information is received, report will be updated.Information in product tab:Dose no. in series: 2 Vaccination site: LeftArm. 10Mar2021:12:00. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: RESPIRATION FAILURE


VAERS ID: 1240407 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Thrombocytopenia
SMQs:, Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FURIX [FUROSEMIDE]; OXYCODONE; ENALAPRIL; VOLTAREN [DICLOFENAC SODIUM]; METFORMIN; TOUJEO; OMEPRAZOLE; INSULIN LISPRO SANOFI
Current Illness: Hypertension; Multiple sclerosis; Obesity; Pancreatic cancer metastatic (liver and spleen); Type 2 diabetes mellitus
Preexisting Conditions: Medical History/Concurrent Conditions: Impaired liver function; Skin disorder NOS
Allergies:
Diagnostic Lab Data:
CDC Split Type: SEPFIZER INC2021414361

Write-up: thrombocytopenia; bilateral high deep vein thrombosis of both veins saphena magna; This is a spontaneous report received from a contactable physician downloaded from the Medicine Agency (MA) -WEB. The regulatory authority report number is SE-MPA-2021-026203, other case identifier is SE-VISMA-1618071388697. This physician reported events for both doses. This is first of two reports. A 62-year-old female patient received the second dose of BNT162B2 (COMIRNATY, batch/lot number: unknown), via an unspecified route of administration on 2021 (at an unspecified age) at single dose for COVID-19 immunisation. Medical history included pancreatic cancer metastatic (liver and spleen) detected in Feb2021 and ongoing, ongoing type 2 diabetes mellitus, ongoing hypertension, ongoing obesity, ongoing multiple sclerosis, skin disease with blisters on the skin. The patient did not have any treatment for the multiple sclerosis and she had impaired liver function so she had not started any cancer treatment. Concomitant medications included furosemide (FURIX), oxycodone, enalapril, diclofenac sodium (VOLTAREN), metformin, insulin glargine (TOUJEO), omeprazole, insulin lispro (INSULIN LISPRO SANOFI). The patient previously took the first dose of BNT162B2 (COMIRNATY, batch/lot number: unknown), via an unspecified route of administration on 2021 (at an unspecified age) at single dose for COVID-19 immunisation, and experienced thrombocytopenia. The patient experienced trombocytopenia (death) on 2021, bilateral high deep vein thrombosis of both veins saphena magna (death) on 2021. The reporter stated that the thrombocytopenia started 8 days after the first dose of BNT162B2. Four weeks after the first dose the patient received the second dose of BNT162B2 and four days after that the patient started to get pain in her legs. A large bluish swelling was detected on the right thigh which has ruptured and emptied of blood and pus, the patient was inserted on ceftriaxone. The patient has previously had a skin disease with blisters on the skin. Suspicion initially of erysipelas. Three days later (one week after the second dose of BNT162B2) multiple thromboses in legs are detected bilaterally. Sharp deterioration of physical general condition. Large hematoma with thrombosis. According to the reporter DIC is suspected. Systemic organ failure. Rapid deterioration the next 1-2 days and the patient died 9 days after the second dose of BNT162B2. The outcome of the events was fatal. The patient died on an unspecified date in 2021. It was unknown if an autopsy was performed. Report was assessed as serious due to death. No follow-up attempts possible. No further information expected. Information on lot and batch numbers cannot be obtained.; Sender''s Comments: Linked Report(s) : SE-PFIZER INC-2021420065 the same reporter/patient, different event/dose; Reported Cause(s) of Death: Thrombocytopenia; bilateral high deep vein thrombosis of both veins saphena magna


VAERS ID: 1241492 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-09
Onset:2021-04-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2243 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Pulmonary haemorrhage, Pulmonary thrombosis, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Haemorrhage terms (excl laboratory terms) (narrow), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, venous (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-09
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: CO-DIOVAN; SIMVASTATINA; AMLODIPINO [AMLODIPINE]; ENANTYUM; ADIRO; FUROSEMIDA [FUROSEMIDE]; DILIBAN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthralgia; Chronic renal failure; Chronic venous insufficiency; COVID-19; Gonarthrosis; Hypercholesterolemia; Hypertension arterial; Morbid obesity (predominantly abdominal); Subclinical hypothyroidism
Allergies:
Diagnostic Lab Data:
CDC Split Type: ESPFIZER INC2021420766

Write-up: Sudden death; pulmonary hemorrhage associated mostly in the right lung; massive pulmonary thrombosis predominantly in the right lung; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB manufacturer report number ES-AEMPS-824376. A 77-year-old female patient received first dose of bnt162b2 (COMIRNATY, Lot Number: EW2243) on 09Apr2021 as single dose for covid-19 immunisation. Medical history included morbid obesity (predominantly abdominal), arterial hypertension and hypercholesterolemia, Gonarthrosis, Arthralgia, Chronic renal failure, Subclinical hypothyroidism, Chronic venous insufficiency, covid-19. Concomitant medications included hydrochlorothiazide, valsartan (CO-DIOVAN); simvastatina; amlodipino [amlodipine] (AMLODIPINO); dexketoprofen trometamol (ENANTYUM) from 30Mar2021; acetylsalicylic acid (ADIRO); furosemida [furosemide] (FUROSEMIDA); paracetamol, tramadol hydrochloride (DILIBAN). The patient previously took Nolotil and experienced pruritus. On 09Apr2021 patient experienced sudden death, pulmonary hemorrhage associated mostly in the right lung, massive pulmonary thrombosis predominantly in the right lung. Patient who had main personal history included morbid obesity, arterial hypertension and hypercholesterolemia, was polymedicated for her pathologies and for pain. The patient suffers syncope and subsequent sudden death approximately one hour after vaccination with the Pfizer''s Covid-19 vaccine. The main cause of death identified at the autopsy was the presence of a possible massive pulmonary thrombosis predominantly in the right lung and a haemorrhage right lung and an associated pulmonary haemorrhage also predominantly in the right lung. The patient''s baseline status with respect to procoagulant risk or hypercoagulability is likely to have been high due to the personal history described, as well as the possible systemic infection or sepsis of probable urological origin. The patient had also COVID-19 infection as she had positive IgG antibodies. The autopsy ruled out an immediate anaphylactic reaction after vaccination. Although there is suspicion, it is not possible to an obvious link between the vaccination, the pulmonary haemorrhage and the thrombogenesis observed. Nevertheless, the case is reported to the Pharmacovigilance Service. Autopsy Report: Digestive system: Oesophagus with food content, oesophageal mucosa whitish without ulcerations or varicose lesions. Stomach with food content, pink mucosa without macroscopic alterations. The intestinal tract presents faecaloid contents, a brownish polyp is identified in the distal colon. The distal colon has a 1 cm brownish polyp with a 0.9 cm pedicle, as well as diverticula. Liver, vesicle and biliary tract: Liver weight: 1755 g. Smooth liver capsule. In section Parenchyma brown, without nodulations or masses. Gall bladder with greenish-green velvety mucous membrane. Bile duct permeable. PANcreas: 190 g. Parenchyma of usual pink colour, with abundant fatty infiltration, without nodulations. Breast: 110 g. Consistency completely unstructured and malleable. Suprarenal Glands: Good corticomedullary demarcation, friable, without nodulations. Kidneys: Right: 115g. Left: 150 g. Decapsulated without difficulty. Smooth surface. Good Cortico-medullary delimitation, with the presence of cysts, the largest one being identified in the right kidney in the lower pole of 5 cm. Renal pelvis without alterations. Bladder and urinary tract: Ureters permeable throughout. Bladder mucosa of whitish colour without ulcerations. Whitish bladder mucosa without ulcerations or excrescent lesions. Urine of cloudy appearance. Internal genitals: Weight of the uterus and appendages: 65g. Adnexa without findings of interest. Endometrium Uniform, 0.1-0.2 cm thick with no excrescent lesions. Vessels: Multiple yellowish plaques in the abdominal aorta and iliac arteries, as well as in the root of the thoracic aorta, some of them calcified, without signs of rupture or intraplaque haemorrhage. Gangles: No findings of interest. ADDITIONAL TESTS: Covid test. Covid 19 test (Blood sample: Presence of positive IgG antibodies for Covid-19 compatible with past infection. See IgM antibodies are ruled out. DRUGCHECK 10 urine drug test: negative.Alcohol breath test in saliva BAC: negative. Macroscopic diagnoses: congestion and petechial pulmonary haemorrhage predominantly in the right lung. possible massive pulmonary thromboembolism in evolution, predominantly in the right lung (microscopic study pending). acute non-specific splenitis or spleen sepsis of probable urological origin. (very cloudy urine) complete costal fractures at the level of the angle area in both hemitorax (compatible with cpr) simple renal cysts. bilateral thyroid nodules. colonic polyp. diverticulitis. No follow-up attempts possible. No further information expected.; Autopsy-determined Cause(s) of Death: The main cause of death identified at autopsy was the presence of a possible massive pulmonary thrombosis predominantly in the right lung and an associated pulmonary hemorrhage, also mainly in the right lung.; The main cause of death identified.


VAERS ID: 1241530 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-04-08
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Carotid artery thrombosis
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FRPFIZER INC2021420682

Write-up: Thrombosis carotid artery/2 massive bi-carotid ischemic strokes; This is a spontaneous report received from a contactable pharmacist downloaded from the Agency Regulatory Authority -WEB. The regulatory authority report number is FR-AFSSAPS-TO20212489, Safety report unique identifier FR-AFSSAPS-2021036811. A 79-years-old female patient received bnt162b2 (COMIRNATY), intramuscular on an unspecified date (Batch/Lot Number: Unknown) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced thrombosis carotid artery /2 massive bi-carotid ischemic strokes on 08Apr2021. The patient died on 08Apr2021. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Thrombosis carotid artery


VAERS ID: 1244158 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-01-22
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Back pain, Computerised tomogram, Hypersomnia, Hypokinesia, Odynophagia, Pain, Pain in extremity, Thrombosis, Urinary incontinence
SMQs:, Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Thrombophlebitis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Depression (excl suicide and self injury) (broad), Hypotonic-hyporesponsive episode (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: SINEMET
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arthritis; Parkinson''s disease; Stroke
Allergies:
Diagnostic Lab Data: Test Name: CAT Scan; Result Unstructured Data: Test Result:she didn''t have a stroke and the scan didn''t show; Comments: she didn''t have a stroke and the scan didn''t show anything that would cause the pain
CDC Split Type: GBPFIZER INC2021386907

Write-up: blood clot; She didn''t seem to be able to control her bladder; with no movement in her legs and she was admitted to hospital.; she was sleeping a lot after the vaccine.; pain; Leg pain; Back pain; Swallowing painful; Ache; This is a spontaneous report from a contactable consumer received from the Medicines Healthcare products Regulatory Agency . Regulatory authority report GB-MHRA-WEBCOVID-202104070950023390, Safety Report Unique Identifier GB-MHRA-ADR 25093246. An 87-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 19Jan2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included arthritis, Stroke, Parkinsons. Concomitant medications included carbidopa, levodopa (SINEMET) taken for an unspecified indication, start and stop date were not reported. The patient experienced leg pain, back pain and swallowing painful all on 22Mar2021, ache on 22Jan2021, blood clot and pain on an unspecified date. The events seriousness was reported as medically significant and hospitalization (as reported). Clinical course: The patients son had phoned to log the side effects report as his mam had passed away and thinks the vaccine may have caused her death. The patient had aches all around her body that were painful and did get a check from her Parkinsons nurse and put her on a paracetamol product, which didn''t seem to help. She didn''t seem to be able to control her bladder while she was sleeping and she was sleeping a lot after the vaccine. Her husband contacted 111 as the patient was in really bad pain in her lower back with no movement in her legs and she was admitted to hospital. The patient was having difficulties taking her tablets and the hospital stated giving them to her via other methods. A patch was given to try and administer her parkinsons medication. The hospital did a CAT scan to check she didn''t have a stroke and the scan didn''t show anything that would cause the pain. The hospital found a blood clot in her arm where she had her vaccine administered. The sons had stated that the hospital stated the cause of death was caused by blood clots. The outcome of ache, leg pain, back pain and swallowing painful was not recovered, blood clot was fatal, while for other events was unknown. It was unknown if autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: blood clot


VAERS ID: 1244465 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-18
Onset:2021-03-17
   Days after vaccination:27
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Autopsy, Blood pressure measurement, Computerised tomogram abdomen, Heart rate, Hypotension, Intestinal ischaemia, Laparotomy, Mesenteric vein thrombosis, Platelet count, SARS-CoV-2 test, Tachycardia, Thrombocytopenia
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad), Hypokalaemia (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-21
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Abdominal pain; Colon adenoma; Gastrointestinal disorder; Intestinal malrotation (Known congenital malrotation of gut); Laparotomy (Previous neonatal laparotomy)
Allergies:
Diagnostic Lab Data: Test Date: 2021; Test Name: post-mortem; Result Unstructured Data: Test Result:revealed thrombosis of abnormal small bowel venous; Comments: revealed thrombosis of abnormal small bowel venous drainage (no superior mesenteric vein (SMV) and small bowel draining via dialted inferior mesenteric vein (IMV) into portal vein) with no obvious surgical cause; Test Date: 2021; Test Name: blood pressure; Result Unstructured Data: Test Result:hypotension; Test Name: Abdomen CT; Result Unstructured Data: Test Result:revealed abnormal venous drainage of small bowel,; Comments: revealed abnormal venous drainage of small bowel, Absent SMV with main drainage of small bowel via tortuous/dilated IMV to portal vein; Test Date: 2021; Test Name: heart rate; Result Unstructured Data: Test Result:tachycardia; Test Date: 2021; Test Name: re-look laparotomy; Result Unstructured Data: Test Result:unknown results; Test Name: Platelet count; Result Unstructured Data: Test Result:<150 A-109/L; Test Name: Platelet count; Result Unstructured Data: Test Result:Lowest platelet count before vaccine - 279; Test Date: 20210318; Test Name: Platelet count; Result Unstructured Data: Test Result:ICU - 35; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC Split Type: GBPFIZER INC2021422400

Write-up: Intestinal ischaemia/Bowel ischaemia; Thrombosis mesenteric vein/Mesenteric venous thrombosis; hypotension; abdominal pain; tachycardia; Thrombocytopenia; This is a spontaneous report from a contactable Physician. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202104121512339200, Safety Report Unique Identifier GB-MHRA-ADR 25126179. A 55-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: not known), via an unspecified route of administration on 18Feb2021 at single dose for COVID-19 vaccination. Medical history included gastrointestinal disorder, laparotomy (Previous neonatal laparotomy), intestinal malrotation (Known congenital malrotation of gut, unknown if ongoing), colon adenoma (unknown if ongoing), recurrent abdominal pain after food. Otherwise fit and well. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. The patient''s concomitant medications were not reported. The patient experienced thrombosis mesenteric vein on 17Mar2021, intestinal ischaemia on 21Mar2021, hypotension, abdominal pain, tachycardia and thrombocytopenia in 2021. Patient having laparoscopic right hemicolectomy for large colonic adenoma. History of malrotation of gut (congenital). Straightforward surgery, no intraoperative complications. Within 2 hours of surgery patient had deteriorated with worsening abdominal pain, hypotension and tachycardia and was taken back to theatre. This revealed global ischaemia of small bowel, cause not evident. Developed low platelet count in intensive care unit (ICU) (35). Subsequently died 4 days later. Post-mortem in 2021 revealed thrombosis of abnormal small bowel venous drainage (no superior mesenteric vein (SMV) and small bowel draining via dialted inferior mesenteric vein (IMV) into portal vein) with no obvious surgical cause. Patient has not tested positive for COVID-19 since having the vaccine. Reaction: this report was related to possible blood clots or low platelet counts. Thromboembolic event / Thombocytopenia additional questions: the specific details of the thromboembolic event was Mesenteric venous thrombosis diagnosed by Post-mortem. Platelet count was less than 150 A-109/L. It was unknown if the D-dimer more than 4000, if anti-PF4 antibodies identified. There was not any additional medical history, not already provided, that relates to previous venous or arterial thromboses, but patient had been investigated for recurrent abdominal pain after food. Patient had not had any previous reactions to medications, especially heparin or anticoagulants. Patient did not have confirmed or suspected autoimmune or inflammatory disease, including vasculitis. Patient did not have history of, or current, malignancy. Patient did not currently smoke. The lowest platelet count after vaccine (usual normal range 150-450) was 35 measured on 18Mar2021. The last platelet count (usual normal range 150-450) before vaccine was 279. Patient was not reviewed by a haematologist. No haemorrhage was identified. Patient did not have a history of, or concurrent, intracranial malignancy. Not have concurrent or recent intracranial infections. Patient had not have recent surgical or medical interventions to the central nervous system (including lumbar puncture). Patient had not have a recent trauma/head injury. The patient also underwent lab tests and procedures which included Abdomen CT: revealed abnormal venous drainage of small bowel, Absent SMV with main drainage of small bowel via tortuous/dilated IMV to portal vein; re-look laparotomy: unknown results in 2021; platelet count (normal range: 150-450): lowest platelet count before vaccine - 279 and less than 150 A-109/L on unspecified dates, in ICU - 35 on 18Mar2021; COVID-19 virus test: No - Negative COVID-19 test on an unspecified date; blood pressure: hypotension and heart rate: tachycardia both in 2021. The patient died on 21Mar2021. An autopsy was performed. The outcome of the event thrombocytopenia was unknown, outcome of the other events was fatal. This report was reported as serious with seriousness criteria death and Other medically important condition. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Intestinal ischaemia/Bowel ischaemia; Thrombosis mesenteric vein/Mesenteric venous thrombosis; hypotension; abdominal pain; tachycardia


VAERS ID: 1245762 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-10
Onset:2021-02-10
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19 immunisation, Cardiac arrest, Cerebral thrombosis, Seizure
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Systemic lupus erythematosus (broad), Arrhythmia related investigations, signs and symptoms (broad), Ischaemic central nervous system vascular conditions (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Convulsions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Cardiomyopathy (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Hypoglycaemia (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 48
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetic nephropathy
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021424802

Write-up: seizures; cardiac arrest; COVID-19 immunization; cerebral sinus thrombosis; This is a spontaneous report from a contactable physician. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-EYC 00248005, Safety Report Unique Identifier GB-MHRA-ADR 25152625. A 62-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 10Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 vaccination. Medical history included diabetic nephropathy. The patient''s concomitant medications were not reported. The patient experienced COVID-19 immunization on 10Feb2021. Clinical course: This patient received Pfizer COVID-19 vaccination on 10Feb2021. According to information from daughter the deceased was poorly since the vaccination. However, he had diabetic nephropathy requiring dialysis. He developed seizures 4x on 28Mar2021 and went to cardiac arrest in Mar2021. During CPR he aspirated and remined in ITU. He died on 31Mar2021. Reporter performed the post-mortem and diagnosed cerebral sinus thrombosis (CST) in 2021. Histology was pending. It was likely that the CST was not related to vaccination due to long interval between vaccination and CST. The patient died on 31Mar2021. The case was reported as serious (death). Outcome of events was fatal. No follow-up attempts are possible, information on lot/batch number cannot be obtained.; Reported Cause(s) of Death: COVID-19 immunization; seizures; cardiac arrest; Autopsy-determined Cause(s) of Death: cerebral sinus thrombosis


VAERS ID: 1245828 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-21
Onset:2020-12-27
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ0553 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Cerebral thrombosis, Cerebrovascular accident, Magnetic resonance imaging, SARS-CoV-2 test
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-04
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Disease risk factor (high risk of blood clotting); Hospitalization
Allergies:
Diagnostic Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:confirmed severity and damage caused by blood clot; Test Name: COVID-19 virus test; Test Result: Negative
CDC Split Type: GBPFIZER INC2021422359

Write-up: Stroke; blood clot on the base of his brain; This is a spontaneous report from a contactable consumer. This is a report received from the Agency Regulatory Authority. Regulatory authority report number GB-MHRA-WEBCOVID-202104071745142200, Safety Report Unique GB-MHRA-ADR 25107985 An 85-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, also reported as Astra Zeneca vaccine), dose 1 via an unspecified route of administration on 21Dec2020 (Lot Number: EJ0553) as single dose for COVID-19 vaccination. Medical history included patient was discharged from hospital around 10Dec2020, with his discharge notes noting that he was at very high risk of blood clotting (unknown if ongoing) and had been taken off a blood thinning medication (not warfarin) but this was withdrawn when in hospital, about one month before vaccine. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. The patient''s concomitant medications were reported as anticoagulant from Nov2020. The patient experienced clot blood and stroke, both on 27Dec2020 which causing death. He had the Astra Zeneca vaccine around 21Dec2020. He had a stroke/ blood clot on the base of his brain on either the 27Dec or 28Dec. While the clot didn''t immediately cause death, it caused brain death. The patient underwent lab tests and procedures which included magnetic resonance imaging (MRI): confirmed severity and damage caused by blood clot, negative COVID-19 virus test on an unknown date. Patient has not tested positive for COVID-19 since having the vaccine. The patient died on 04Jan2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Thrombosis cerebral; stroke


VAERS ID: 1245949 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-26
Onset:2021-03-07
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Asthenia, Circulatory collapse, Diarrhoea, Dyspnoea, Influenza like illness, Loss of consciousness, Mobility decreased, Syncope, Thrombosis
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Pseudomembranous colitis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Parkinson-like events (broad), Thrombophlebitis (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (narrow), Noninfectious diarrhoea (narrow), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetic
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2021431965

Write-up: blood clot; severe diarhoea; flu - like symptoms; very weak, unable to drive; unable to drive; he collapsed and died; started having breathing problems; he blacked out and collapsed, he fainted; blacked out and collapsed; This is a spontaneous report from a contactable consumer or other non hcp. A 56-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Feb2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history included diabetes. The concomitant medications were not reported. The Patient (good health, diabetic) had the first dose of the vaccine on the 26Feb2021 after which he started feeling very sick (severe diarhoea, flu like symptoms, very weak, unable to drive) on unknown date. After a couple of days, the patient started feeling better (not great, but okey). On 07Mar2021 he blacked out and collapsed, he fainted. He was okay later on. On 10Mar2021, the patient started having breathing problems, he collapsed. The patient recovered from syncope, loss of consciousness; the patient was recovering from diarrhea, flu like symptoms, very weak, unable to drive, the outcome of dyspnea and circulatory collapse was unknown. The patient died on unknown date. The coroner has investigated the body and he said that death was due to blood clot occurred on unknown date. Lot/batch number has been requested.; Reported Cause(s) of Death: blood clot


VAERS ID: 1250237 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-02
Onset:2021-04-03
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Angiogram, Aphasia, Blood pressure measurement, Body temperature, Cerebral thrombosis, Computerised tomogram head, Diabetes mellitus management, Facial paralysis, Haematoma, Heart rate, Hemiplegia, International normalised ratio, Nystagmus, Oxygen saturation, Patient uncooperative, Posture abnormal
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Hearing impairment (broad), Vestibular disorders (broad), Ocular motility disorders (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-06
   Days after onset: 3
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: BETALOC ZOK; ALLOPURINOL; STACYL; MICTONETTEN; OMEPRAZOL; FURON [FUROSEMIDE SODIUM]; PREDUCTAL PROLONG; MONOMACK
Current Illness: Asymptomatic bacteriuria; Atrial fibrillation paroxysmal (no preemptive anticoagulation therapy because of hemoptysis); Dyslipidemia; Gastroesophageal reflux; GDU; Hypertension arterial; Ischemic heart disease; Nephropathy (chronic); Osteopenia; Osteoporosis; Type II diabetes mellitus; Vertebrogenic pain syndrome
Preexisting Conditions: Medical History/Concurrent Conditions: Grawitz tumor; Infarct myocardial; Nephrectomy (left side); Radiofrequency ablation; Transient ischaemic attack (expressive phatic disorder)
Allergies:
Diagnostic Lab Data: Test Date: 20210403; Test Name: CT angiography; Result Unstructured Data: Test Result:obstruction of arteria carotis media sinistra; Comments: obstruction of arteria carotis media sinistra - segment M1 (Alberta stroke programme early CT score - 9); Test Date: 20210403; Test Name: Blood pressure; Result Unstructured Data: Test Result:147/93 mmHg; Test Date: 20210403; Test Name: Body temperature; Result Unstructured Data: Test Result:36.5 Centigrade; Test Date: 20210403; Test Name: Brain computerized tomography; Result Unstructured Data: Test Result:chronic ischemic changes; Comments: nativ: chronic ischemic changes, it seems that there are only minor changes on the left side,; Test Date: 20210403; Test Name: Glycemia control; Result Unstructured Data: Test Result:6.7 mmol/L; Test Date: 20210403; Test Name: Heart rate; Result Unstructured Data: Test Result:95; Comments: Units:/min; Test Date: 20210403; Test Name: International normalized ratio; Result Unstructured Data: Test Result:1,2; Test Date: 20210403; Test Name: O2 saturation; Test Result: 91 %
CDC Split Type: CZPFIZER INC2021430198

Write-up: blood clots in brain vessels; right hip and right thigh hematomas; right-sided plegia of upper and lower limb; central facial palsy right-sided; she does not cooperate; complete aphasia; she moves eyeballs to the left, cannot look to the right; Head posture abnormal; This is a spontaneous report downloaded from the Medicines Agency (MA) -WEB with regulatory authority number CZ-CZSUKL-21004025. An 88-years-old female patient received her second dose of bnt162b2 (COMIRNATY), intramuscular on 02Apr2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. Medical history included ongoing osteoporosis, ongoing Gastroesophageal reflux, Transient ischaemic attack from Sep2020 (expressive phatic disorder), Radiofrequency ablation from 2016 to 2016, ongoing Vertebrogenic pain syndrome, ongoing type 2 diabetes mellitus, ongoing Asymptomatic bacteriuria, ongoing osteopenia, ongoing Ischemic heart disease, ongoing GDU, ongoing Nephropathy (chronic), ongoing Hypertension arterial, ongoing Atrial fibrillation paroxysmal (no preemptive anticoagulation therapy because of hemoptysis), ongoing Dyslipidemia, Grawitz tumor, Infarct myocardial, Nephrectomy from 1997 to 1997 (left side). Concomitant medications included metoprolol succinate (BETALOC ZOK); allopurinol; acetylsalicylic acid (STACYL); propiverine hydrochloride (MICTONETTEN); omeprazole (OMEPRAZOL); furosemide sodium (FURON [FUROSEMIDE SODIUM]); trimetazidine hydrochloride (PREDUCTAL PROLONG); isosorbide mononitrate (MONOMACK). The patient received her first dose of bnt162b2 (COMIRNATY) on an unspecified date for covid-19 immunisation. The patient experienced blood clots in brain vessels, right-sided plegia of upper and lower limb , central facial palsy right-sided, she does not cooperate, complete aphasia, she moves eyeballs to the left, cannot look to the right, head posture abnormal on 03Apr2021 and right hip and right thigh hematomas on an unspecified date. The event cerebral thrombosis was assessed as fatal, life-threatening, hospitalization on an unspecified date, medically significant and disablity. The patient underwent lab tests and procedures which included CT angiography: obstruction of arteria carotis media sinistra (obstruction of arteria carotis media sinistra - segment M1 (Alberta stroke programme early CT score - 9), blood pressure: 147/93 mmhg, body temperature: 36.5 centigrade, Brain computerized tomography: chronic ischemic changes (nativ: chronic ischemic changes, it seems that there are only minor changes on the left side), Glycemia control: 6.7 mmol/l, heart rate: 95/min , international normalised ratio: 1,2 and oxygen saturation: 91 % on 03Apr2021. Therapeutic measures were taken as a result of blood clots in brain vessels (cerebral thrombosis). Outcome of the event cerebral thrombosis was fatal while outcome of the event Hemiplegia was not recovered. Outcome of the remaining events was unknown. The patient died on 06Apr2021 due to cerebral thrombosis. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained; Reported Cause(s) of Death: blood clots in brain vessels


VAERS ID: 1250305 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-26
Onset:2021-04-05
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-24
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9470 / UNK LA / OT

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time abnormal, Blood chloride, Blood creatine phosphokinase, Blood fibrinogen, Blood pressure measurement, Blood sodium, Body temperature, Cerebral haemorrhage, Coma scale, Computerised tomogram, Creatinine renal clearance, Disseminated intravascular coagulation, Fall, Hyperchloraemia, Hypernatraemia, Lymphocyte count, Lymphopenia, Malaise, Platelet count, Prothrombin level abnormal, Prothrombin time, Prothrombin time ratio, Rhabdomyolysis, Thrombocytopenia, Thrombosis, Ultrasound Doppler
SMQs:, Rhabdomyolysis/myopathy (narrow), Liver-related coagulation and bleeding disturbances (narrow), Haematopoietic leukopenia (narrow), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Accidents and injuries (narrow), Tubulointerstitial diseases (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-11
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: BISOPROLOL; XARELTO
Current Illness: Fibrillation atrial (treated with Bisoprolol and Xarelto); Intoxication (active)
Preexisting Conditions: Medical History/Concurrent Conditions: Arthritis; Hypertension; Shoulder osteoarthritis; Shoulder prosthesis user
Allergies:
Diagnostic Lab Data: Test Date: 20210409; Test Name: hyperchloremia; Result Unstructured Data: Test Result:130 mmol/L; Comments: hyperchloremia; Test Date: 20210409; Test Name: rhabdomyolysis CPK; Result Unstructured Data: Test Result:$g8000; Comments: rhabdomyolysis; Test Date: 20210409; Test Name: fibrinogen; Result Unstructured Data: Test Result:0.74; Test Date: 20210409; Test Name: blood pressure; Result Unstructured Data: Test Result:hypotension; Test Date: 20210409; Test Name: hypernatremia; Result Unstructured Data: Test Result:170 mmol/L; Comments: hypernatremia; Test Date: 20210409; Test Name: body temperature; Result Unstructured Data: Test Result:hypothermic; Test Date: 20210409; Test Name: Glasgow coma scale; Result Unstructured Data: Test Result:13; Test Date: 20210409; Test Name: CT scan; Result Unstructured Data: Test Result:Balthazar pancreatitis D, mural thrombus of the ao; Comments: Balthazar pancreatitis D, mural thrombus of the aorta 4th portion; Test Date: 20210409; Test Name: clearance; Result Unstructured Data: Test Result:30; Test Date: 20210409; Test Name: lymphopenia; Result Unstructured Data: Test Result:216; Comments: lymphopenia; Test Date: 20210409; Test Name: thrombocytopenia; Result Unstructured Data: Test Result:34000/mm3; Comments: thrombocytopenia; Test Date: 20210409; Test Name: PT; Test Result: 38 %; Test Date: 20210409; Test Name: aPTT ratio; Result Unstructured Data: Test Result:1.3; Comments: with Xarelto; Test Date: 20210409; Test Name: Ultrasound Doppler; Result Unstructured Data: Test Result:right humeral artery occlusion; Comments: right humeral artery occlusion, right superficial femoral artery occlusion and right popliteal artery
CDC Split Type: FRPFIZER INC2021431341

Write-up: hypernatremia (170mmol / l); hyperchloremia (130mmol / l); lymphopenia at 216; rhabdomyolysis CPK$g 8000; PT 38%; aPTT ratio at 1.3; malaise; probable fall without witness (mechanism unknown); Disseminated intravascular coagulation; Thrombosis multiple; Thrombocytopenia; Cerebral hemorrhagic rearrangement; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB FR-AFSSAPS-MP20211145, Safety Report Unique Identifier FR-AFSSAPS-2021037785. A 72-year-old male patient received bnt162b2 (COMIRNATY; lot ER9470), intramuscular, administered in left arm on 26Mar2021 as single dose for COVID-19 immunisation. Medical history included ongoing fibrillation atrial treated with Bisoprolol and Xarelto, hypertension, ongoing chronic intoxication (active), arthritis, shoulder osteoarthritis, and bilateral shoulder prosthesis. Concomitant medications included bisoprolol, and rivaroxaban (XARELTO), both for atrial fibrillation. On 05Apr2021, 10 days post-vaccination, the patient experienced malaise, probable fall without witness (mechanism unknown), and prolonged ground station. On 09Apr2021, 14 days post-vaccination, the patient was found on the ground, face down, Glasgow was 13, hypotensive, hypothermic, and no respiratory distress. At the emergency department: hypernatremia (170mmol / l), hyperchloremia (130mmol / l), clearance at 30, thrombocytopenia (34000 / mm3), lymphopenia at 216, rhabdomyolysis CPK$g 8000, probable disseminated intravascular coagulation (DIC) with fibrinogen consumed at 0.74, PT 38% , aPTT ratio at 1.3 (with Xarelto). Computerised tomogram (CT) showed Balthazar pancreatitis D, mural thrombus of the aorta 4th portion and ultrasound doppler showed right humeral artery occlusion, right superficial femoral artery occlusion and right popliteal artery. Patient care in intensive care: Multivisceral failure at H12 of the care. Cardiologist opinion included extensive intra-cardiac thrombus and cerebral hemorrhagic rearrangement. It was concluded that probable DIC with multiple arterial thrombosis and thrombocytopenia on day 10 to day 14 post-vaccination, leading to the death of the patient with hypertension and anticoagulated atrial fibrillation. The patient died on 11Apr2021 due to cerebral hemorrhagic rearrangement, disseminated intravascular coagulation, thrombosis multiple and thrombocytopenia. An autopsy was not performed. Outcome of the rest of events was unknown. No follow-up attempts are possible, no information is expected.; Sender''s Comments: Based on event-vaccine chronological association a causal relationship between reported events and BNT162B2 (COMIRNATY0 vaccine cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: Cerebral hemorrhagic rearrangement; Disseminated intravascular coagulation; Thrombosis multiple; Thrombocytopenia


VAERS ID: 1257555 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-15
Onset:2021-03-01
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER2659 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Blood lactic acid, Computerised tomogram, Disseminated intravascular coagulation, Gastrointestinal necrosis, Intestinal ischaemia, Rheumatoid arthritis, Splenic infarction, Thrombosis, Urinary tract infection, Urosepsis
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (narrow), Arthritis (narrow), Sepsis (narrow), Opportunistic infections (broad), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-31
   Days after onset: 29
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: DULOXETIN KRKA; PREDNISOLON "DLF"; EMTHEXATE [METHOTREXATE SODIUM]; ALENDRONAT TEVA
Current Illness: Rheumatoid arthritis
Preexisting Conditions: Medical History/Concurrent Conditions: Depression; Osteoporosis
Allergies:
Diagnostic Lab Data: Test Date: 20210328; Test Name: Lactate; Result Unstructured Data: Test Result:Increased; Test Date: 20210328; Test Name: CT scan; Result Unstructured Data: Test Result:Spleen infarct and possible intraabdominal abscess; Comments: Inflammatory process similar to the left kidney (pyelonephritis with incipient abscessing). Small high attenuating change in right liver patch, nonspecific, can be clarified with ultrasound with contrast low-attenuating areas in the liver. The usual place in segment 4 around the gallbladder - may be focal fat infiltration. Multiple microcysts in the kidneys and cyst in the right kidney. Gallstones in the gallbladder.; Test Date: 20210330; Test Name: CT scan; Result Unstructured Data: Test Result:High suspicion of ischemia in the small intestine; Comments: in the small pelvis. Note Bowel ischemia in the right colon. Right Colon: Sign of peritonite. Partial regression of abscess in the left kidney. Infarction in the spleen. Paralytic ileus in small intestine and colon. Pleural fluid bilaterally mild degree.
CDC Split Type: DKPFIZER INC2021436015

Write-up: Short and severe progress with Ischaemia bowel; Abdominal pain; Splenic infarction; Admitted with aggravated rheumatoid arthritis; Urinary tract infection; Necrosis bowel - the entire colon was necrotic; Disseminated intravascular coagulation - it is difficult to determine whether sepsis or DIC came first; Urosepsis - ischemia bowel, possible liver thrombosis and splenic infarction are possible due to urosepsis; Possible liver thrombosis; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB [DK-DKMA-WBS-0061040] via the Agency. A 76-year-old female patient received the first dose of BNT162B2 (COMIRNATY, Lot Number: ER2659; Expiration Date: 30Jun2021) via intramuscular at single dose on 15Mar2021 for covid-19 immunisation. Medical history included ongoing rheumatoid arthritis; osteoporosis; depression. Concomitant medications included duloxetine hydrochloride (DULOXETIN KRKA, tablet) for depression from 28Feb2020; prednisolone (PREDNISOLON "DLF", tablet) for adrenocortical steroid therapy from 17Nov2020; methotrexate sodium (EMTHEXATE, tablet) for rheumatoid arthritis from 19Jul2018; alendronate sodium (ALENDRONAT TEVA, tablet) for osteoporosis from 28Dec2018. The patient experienced possible liver thrombosis in Mar2021; occurrence of abdominal pain on 28Mar2021; admitted with aggravated rheumatoid arthritis on 27Mar2021; disseminated intravascular coagulation - it was difficult to determine whether sepsis or DIC came first in Mar2021; short and severe progress with ischaemia bowel on 28Mar2021; urosepsis - ischemia bowel, possible liver thrombosis and splenic infarction were possible due to urosepsis in Mar2021; splenic infarction on 28Mar2021; urinary tract infection on 25Mar2021; necrosis bowel - the entire colon was necrotic in Mar2021. As a consequence of ischemia bowel, the patient experienced the following consequences colon necrotic and only 2 meters vital small intestine. The patient underwent lab tests and procedures which included lactate increased on 28Mar2021. CT scan on 28Mar2021: Spleen infarct and possible intraabdominal abscess. Inflammatory process similar to the left kidney (pyelonephritis with incipient abscessing). Small high attenuating change in right liver patch, nonspecific, can be clarified with ultrasound with contrast low-attenuating areas in the liver. The usual place in segment 4 around the gallbladder - may be focal fat infiltration. Multiple microcysts in the kidneys and cyst in the right kidney. Gallstones in the gallbladder. CT scan on 30Mar2021: High suspicion of ischemia in the small intestine in the small pelvis. Note Bowel ischemia in the right colon. Right Colon: Sign of peritonite. Partial regression of abscess in the left kidney. Infarction in the spleen. Paralytic ileus in small intestine and colon. Pleural fluid bilaterally mild degree. The ADRs were by the reporter reported as being fatal on 31Mar2021. The patient was treated antibiotic due to urinary tract infection. There was performed a medical procedure on 30Mar2021: Due to suspicion of ischemia bowel the patient was operated. Under the operation the entire colon was found necrotically and only 2 meters of vital small intestine. Pale gallbladder and ventricle and stasis-like liver. The patient died on 31Mar2021. An autopsy was performed and results were not provided. Reported causes of death were ischaemia bowel, disseminated intravascular coagulation and urosepsis. The outcome of events ischaemia bowel, disseminated intravascular coagulation and urosepsis was fatal. The outcome of rest events was unknown. Causality: In the process it was difficult to determine whether sepsis or DIC came first, as the patient had abdominal pain, splenic infarction and lactate increased already on the 28Mar2021. The reporter informs that there has been order a autopsy on the patient, but there is no answer yet. Sender Comment: Additional test information: CT scan 28Mar2021: Change in right liver patch: can be clarified with ultrasound with contrast low-attenuating areas in the liver." No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Urosepsis; Disseminated intravascular coagulation; Ischaemia bowel


VAERS ID: 1259897 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-19
Onset:2021-04-02
   Days after vaccination:14
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER7812 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Activated partial thromboplastin time, Blood creatinine, Blood fibrinogen, Blood glucose, Blood pressure measurement, Blood urea, Cerebral venous sinus thrombosis, Computerised tomogram, Electrocardiogram, Haematocrit, Haemoglobin, Haemorrhage intracranial, International normalised ratio, Mean cell volume, Platelet count, SARS-CoV-2 test, White blood cell count
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, venous (narrow), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-08
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: EUTIROX; OMEPRAZOLE; PARACETAMOL; ALLOPURINOL [ALLOPURINOL SODIUM]; AMERIDE [AMILORIDE HYDROCHLORIDE;HYDROCHLOROTHIAZIDE]; EBASTEL FORTE FLAS
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Allergic rhinitis; Anxiety disorder; Chronic kidney disease; Dyslipidemia; Hemithyroidectomy; Hyperhidrosis; Hypertension; Hyperuricemia; Hypothyroidism; Insomnia; Obesity; Osteoarthritis; Parathyroid adenoma removal; Sinus tachycardia
Allergies:
Diagnostic Lab Data: Test Date: 20210403; Test Name: APTT; Result Unstructured Data: Test Result:30.7 sg; Comments: ratio: 0.99; Test Date: 20210403; Test Name: Creatinine; Result Unstructured Data: Test Result:1.15; Test Date: 20210403; Test Name: Fibrinogen; Test Result: 527 mg/dl; Test Date: 20210403; Test Name: Glucose; Test Result: 182 mg/dl; Test Date: 20210403; Test Name: BP; Result Unstructured Data: Test Result:180/80 mmHg; Test Date: 20210403; Test Name: Urea; Result Unstructured Data: Test Result:83.2; Test Date: 20210403; Test Name: CT; Result Unstructured Data: Test Result:Enlargement of the foci of acute; Comments: Enlargement of the foci of acute intraparenchymal hemorrhage in the upper right parietal region with a slight increase in perilesional edema and fof the acute SAH occupancies in the right parietoocipital sulci. All of this exerting a greater mass effect on the grooves of the right frontoparietal convexity and on the ipsilateral LV, now observing complete collapse of the occipital horn; Test Date: 20210403; Test Name: CT; Result Unstructured Data: Test Result:right parietal lobar hemorrhage; Comments: right parietal lobar hemorrhage secondary to massive thrombosis of the superior sagittal venous sinus and right transverse (partial left transverse).; Test Date: 20210404; Test Name: CT; Result Unstructured Data: Test Result:increased bleeding; Comments: increased bleeding and edema with mass effect that displaces the midline and collapses ventricles. Conclusion: Increased size of right intraparenchymal and subarachnoid hematomas with greater mass effect and herniation patterns. right parietal lobar hemorrhage secondary to massive thrombosis of the superior sagittal venous sinus and right transverse (partial left transverse); Test Name: Electrocardiogram; Result Unstructured Data: Test Result:sinus rhythm at 100 bpm; Comments: PR 180 msec, 0? axis, QRS less than 120 msec without repolarization alterations; Test Date: 20210403; Test Name: Hematocrit; Test Result: 36.5 %; Test Date: 20210403; Test Name: Hemoglobin; Result Unstructured Data: Test Result:12.2 g/dl; Test Date: 20210403; Test Name: INR; Result Unstructured Data: Test Result:0.98; Comments: TP ratio 0.98; Test Date: 20210403; Test Name: MCV; Result Unstructured Data: Test Result:86.4 fL; Test Date: 20210403; Test Name: Platelet count; Result Unstructured Data: Test Result:280000; Comments: 21-23hrs.; Test Date: 20210403; Test Name: Platelet count; Result Unstructured Data: Test Result:331000; Comments: TP 100%; Test Date: 20210403; Test Name: SARS-CoV-2 test; Result Unstructured Data: Test Result:Negative; Test Date: 20210403; Test Name: Leukocytes; Result Unstructured Data: Test Result:11.500?L; Comments: (N 78.8% / L 13.5 / M 6.5 / E 0.6 / B 0.6)
CDC Split Type: ESPFIZER INC2021441377

Write-up: Haemorrhage intracranial; Cerebral venous sinus thrombosis; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB ES-AEMPS-830659. A 87-years-old female patient received bnt162b2 (COMIRNATY), dose 2 intramuscular on 19Mar2021 (Batch/Lot Number: ER7812) as 0.3 mL, single for covid-19 immunisation. Medical history included obesity, chronic kidney disease, hypertension, dyslipidaemia, hyperuricaemia, hypothyroidism, anxiety disorder, hyperhidrosis, sinus tachycardia, osteoarthritis, allergic rhinitis, insomnia, IQ (08Jun2011) excision of parathyroid adenoma and right hemithyroidectomy (PA - compatible with parathyroid adenoma (0.6 g) non-encapsulated papillary thyroid carcinoma with microfollicular pattern (0.6x0.5x0.5), no evidence of angiolymphatic or perineural invasion (multinodular goiter)). No known drug allergies. Concomitant medications included levothyroxine sodium (EUTIROX); omeprazole (OMEPRAZOLE); paracetamol (PARACETAMOL); allopurinol sodium (ALLOPURINOL [ALLOPURINOL SODIUM]); amiloride hydrochloride, hydrochlorothiazide (AMERIDE [AMILORIDE HYDROCHLORIDE;HYDROCHLOROTHIAZIDE]); ebastine (EBASTEL FORTE FLAS). The patient previously took the first dose bnt162b2 (COMIRNATY, lot number EP9598), intramuscular on 26Feb2021 for COVID-19 immunisation. The patient experienced haemorrhage intracranial on 02Apr2021, cerebral venous sinus thrombosis on 02Apr2021. Both events were considered as serious with fatal outcome and hospitalization. She was admitted on 03Apr2021 due to right parietal hemorrhage in the context of extensive venous sinus thrombosis affecting the upper longitudinal sinus and both predominantly right transverse sinuses in the context of left hemiparesis, the patient began symptoms on 02Apr2021 at 10:30 p.m. Upon admission, she presented a PA (Blood pressure measurement) 180 / 80mmHg, which corrected by itself without treatment with the rest of the correct constants, BMTEST 170 mg / dL, and the general analysis showed 331,000 platelets with normal coagulation. Sodium heparin pump anticoagulation was started on 03Apr2021. Due to worsening of the symptoms and drowsiness, several control CTs (Computerized tomograms) were performed later, the last one performed on 04Apr2021 shows increased bleeding and edema with a mass effect that displaces the midline and collapses ventricles, which is why anticoagulant treatment is suspended. The family is informed of the severity of the patient and a consensus is reached on the adequacy of the therapeutic effort. On 08Apr2021 the patient died. The patient underwent lab tests and procedures which included: Electrocardiogram: sinus rhythm at 100 bpm, PR 180 msec, 0 axis, QRS less than 120 msec without repolarization alterations; Analytical (03Apr2021 21:00-06:00): Hematology: Leukocytes 11,500 / uL, (N 78.8% / L 13.5 / M 6.5 / E 0.6 / B 0.6), Hties 4, 23, Hb (hemoglobin) 12.2 g / dL, Hcto (Hematocrit) 36.5%, MCV (Mean cell volume) 86.4 fL, Platelets 331000 (TP 100%), INR (International normalised ratio) 0.98 (TP ratio 0.98), APTT (Activated partial thromboplastin time) 30.7 sg (APTT ratio 0.99), Fibrinogen 527 mg /dL. Biochemistry: Glucose 182 mg / dL, Urea 83.2, Creatinine 1.15. Blood pressure measurement: 180/80 mmhg on 03Apr2021. Simple and venous sinus computed tomography (CT) (03Apr2021):right parietal lobar hemorrhage secondary to massive thrombosis of the superior sagittal venous sinus and right transverse (partial left transverse). CT (03Apr2021): Enlargement of the foci of acute intraparenchymal hemorrhage in the upper right parietal region with a slight increase in perilesional edema and fof the acute SAH occupancies in the right parietoocipital sulci. All of this exerting a greater mass effect on the grooves of the right frontoparietal convexity and on the ipsilateral LV, now observing complete collapse of the occipital horn. Analytical (03Apr21-23h): 280,000 platelets. CT (04Apr2021): increased bleeding and edema with mass effect that displaces the midline and collapses ventricles, Conclusion: Increased size of right intraparenchymal and subarachnoid hematomas with greater mass effect and herniation patterns. Sars-cov-2 test (PCR): negative on 03Apr2021. It is medications prescribed before admission reported and maintained during admission: Levothyroxine (Eutirox ), Omeprazole, Paracetamol. Withdrawn upon admission: allopurinol, Ameride, Ebastel forte. Therapeutic measures were taken as a result of events. The patient died on 08Apr2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Reporter''s Comments: 87-year-old woman. No known drug allergies. As AP (Pathological history) highlights: HT (Hypertension), DLP (Dyslipidemia), Hyperuricemia, Obesity, Chronic kidney disease, IQ (08Jun2011) excision of parathyroid adenoma + right hemithyroidectomy. PA - compatible with parathyroid adenoma (0.6 g) non-encapsulated papillary thyroid carcinoma with microfollicular pattern (0.6x0.5x0.5), no evidence of angiolymphatic or perineural invasion (multinodular goiter), Hypothyroidism, Anxiety disorder, Hyperhidrosis, Sinus tachycardia, Osteoarthritis, Allergic rhinitis, Insomnia. She was admitted on 03Apr2021 due to right parietal hemorrhage in the context of extensive venous sinus thrombosis affecting the upper longitudinal sinus and both predominantly right transverse sinuses in the context of left hemiparesis, the patient began symptoms on 02Apr2021 at 10:30 p.m. Upon admission, she presented a PA (Blood pressure measurement) 180 / 80mmHg, which corrected by itself without treatment with the rest of the correct constants, BMTEST 170 mg / dL, and the general analysis showed 331,000 platelets with normal coagulation. Sodium heparin pump anticoagulation was started on 03Sep2021. Due to worsening of the symptoms and drowsiness, several control CTs (Computerized tomograms) were performed later, the last one performed on 04Apr2021 shows increased bleeding and edema with a mass effect that displaces the midline and collapses ventricles, which is why anticoagulant treatment is suspended. . The family is informed of the severity of the patient and a consensus is reached on the adequacy of the therapeutic effort. On 08Apr2021 the patient died. - Electrocardiogram: sinus rhythm at 100 bpm, PR 180 msec, 0 axis, QRS less than 120 msec without repolarization alterations - Analytical (03Apr2021 21:00-06:00): Hematology: Leukocytes 11,500 / uL, (N 78.8% / L 13.5 / M 6.5 / E 0.6 / B 0.6), Hties 4, 23 mill /uL, Hb (hemoglobin) 12.2 g / dL, Hcto (Hematocrit) 36.5%, MCV (Mean cell volume) 86.4 fL, Platelets 331000 / uL, TP 100%, INR (International normalised ratio) 0.98 TP ratio 0.98, APTT (Activated partial thromboplastin time) 30.7 sg, APTT ratio 0.99 Fibrinogen 527 mg / dL. Biochemistry: Glucose 182 mg / dL, Urea 83.2, Creatinine 1.15. - Simple and venous sinus computed tomography (CT) (03Apr2021): right parietal lobar hemorrhage secondary to massive thrombosis of the superior sagittal venous sinus and right transverse (+ partial left transverse). - PCR SARS-COV2 (03Apr2021): negative. - CT (03Apr2021): Enlargement of the foci of acute intraparenchymal hemorrhage in the upper right parietal region with a slight increase in perilesional edema and fof the acute SAH occupancies in the right parietoocipital sulci. All of this exerting a greater mass effect on the grooves of the right frontoparietal convexity and on the ipsilateral LV, now observing complete collapse of the occipital horn. - Analytical (03Apr21-23h): 280,000 platelets. - CT (04Apr2021): Conclusion: - Increased size of right intraparenchymal and subarachnoid hematomas with greater mass effect and herniation patterns. Medications prescribed before admission (chronic medication) and maintained during admission: Levothyroxine (Eutirox) 75 microgr every 24h, Omeprazole 20 mg every 24h, Paracetamol 1 gc / 8h. Withdrawn upon admission: allopurinol 100mg every 24h, Ameride 5/50 mg every 24h, Ebastel forte 1 tablet / 24h. VO; Reported Cause(s) of Death: Haemorrhage intracranial; Cerebral venous sinus thrombosis


VAERS ID: 1260535 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:0000-00-00
Onset:2021-04-12
Submitted: 0000-00-00
Entered: 2021-04-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET7205 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Femur fracture
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITPFIZER INC2021441472

Write-up: Deep vein thrombosis in the leg with death due to probable massive pulmonary embolism; Deep vein thrombosis in the leg with death due to probable massive pulmonary embolism; This is a spontaneous report from a contactable physician downloaded from the Agency Regulatory Authority-WEB, regulatory authority number IT-MINISAL02-716464. A 82-year-old male patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, Batch/Lot Number: ET7205), via an unspecified route of administration in right shoulder on an unspecified date at 17:01 PM as single dose for COVID-19 immunization. Patient''s medical history included femur fracture from 01Aug2019 to unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced embolism lung and DVT on 12Apr2021. The event described as deep vein thrombosis in the leg with death due to probable massive pulmonary embolism. The seriousness was fatal. The patient died on 12Apr2021. It was not reported if an autopsy was performed. The outcome of event was fatal.; Reported Cause(s) of Death: probable massive pulmonary embolism


VAERS ID: 1265500 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-21
Onset:2021-04-12
   Days after vaccination:81
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH NOT KNOWN / 1 - / -
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: